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PREFACE 
This thesis is a description of the work carried out in the Department of Chemical 
Engineering, Imperial College London, between October 2007 and August 2011, under 
the supervision of Professor Sergei G. Kazarian. Except where acknowledged, the 
material is the original work of the author and no part of it has been submitted for a 
degree at any other university.  
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ABSTRACT 
Orally administered compressed tablets are the most commonly used dosage form. 
Understanding the physical and chemical processes involved in drug release from 
tablets is critical for designing more effective formulations. Attenuated Total Reflection 
Fourier Transform Infrared (ATR-FTIR) spectroscopic imaging is a powerful 
chemically specific and spatially resolved analytical approach. Effective uses for this 
technology have been found in the field of pharmaceutics, studying the compaction and 
dissolution of oral dosage formulations. However, the full potential of this technology is 
yet to be explored. 
This thesis describes work that further explores the applications of FTIR imaging 
through the use of model pharmaceutical formulations. The work is broadly split into 
three sections: quantification of imaging data, dissolution of pH modified formulations 
and application to structured tablets. 
The in situ compaction of model drug tablets with different polymer matrices was 
studied using ATR-FTIR imaging. The choice of polymer strongly affected the 
distribution of the drug at the tablet surface. X-ray tomography was used as a 
complementary technique, verifying the distribution of drug particles within the 
compacted matrices. Statistical analysis was applied to investigate obtaining 
quantitative data such as particle size and component loading from the image data. 
Previous work using ATR-FTIR imaging has shown the ability of the approach to detect 
crystallisation of ibuprofen during dissolution. The dissolution of ibuprofen from 
HPMC matrices containing pH modifying compounds was studied. FTIR imaging 
showed that tablets containing acidic compounds slowed the dissolution of crystalline 
ibuprofen domains. The formation of soluble and insoluble salts of the drug was seen in 
tablets containing basic compounds. 
 As FTIR imaging supplies both chemical and spatial information it was applied to 
study structured tablets, both tablet-in-tablet structures and multilayer formulations, in 
conjunction with visible optical video analysis. The tablet-in-tablet structures were used 
to create delayed release formulations, in which both the core and shell materials were 
used to control release.  pH resistant formulations were also developed for the release of 
pH labile drugs. FTIR imaging supplied vital information on the rate of ingress of water 
fronts, the movement of swelling polymers and the chemical state of the drug. 
Multilayer formulations were investigated for studies of biphasic release and also in 
order to compare the dissolution performance of tablets in the custom ATR flow cell 
with that found in the industry standard USP tests.  
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XF, min Minimum Feret diameter m 
Y 2D matrix - 
z Vertical distance from ATR crystal m 
   
 
Greek Letters 
 ϵ Deformation strain  - 
ε Molar absorptivity  L.mol-1.cm-1 
θ Angle of incidence rad 
θc Critical angle rad 
λ Wavelength of light m 
λc Spectral data points - 
σd Deformation stress MPa 
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LIST OF ABBREVIATIONS 
 
Abbreviation Description 
a.u. Arbitrary Units 
ADC Analogue to digital converter 
AFM Atomic Force Microscopy 
API Active Pharmaceutical Ingredient 
ATR Attenuated Total Reflection 
CCD Charge Coupled Device 
CMC Carboxymethylcellulose 
CO Corrective Optics 
DESI-MS Desorption Electrospray Ionization Mass Spectrometry 
DTA Doctoral Training Accounts 
DTGS Deuterated Triglycine Sulfate 
EPSRC Engineering and Physical Sciences Research Council  
FA Factor Analysis 
FALLS Forward Angle Laser Light Scattering 
FaSSIF Fasted State Simulated Intestinal Fluid 
FeSSIF Fed State Simulated Intestinal Fluid 
FDA Food and Drug Administration 
FOV Field of View 
FPA Focal Plane Array 
FT Fourier Transform 
FTIR Fourier Transform Infrared 
FT-NIR Fourier Transform Near-Infrared 
GI Gastrointestinal 
HPC Hydroxypropyl Cellulose 
HPMC Hydroxypropyl Methylcellulose 
HPMCAS Hydroxypropyl Methylcellulose Acetate Succinate 
IR Infrared 
MCC Microcrystalline Cellulose 
MCT Mercury Cadmium Telluride 
MIR Mid-Infrared 
MRI Magnetic Resonance Imaging 
NA Numerical Aperture 
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NIR Near-Infrared 
NIRS Near-Infrared Spectroscopy 
NME New Molecular Entity 
N-PLS Multilinear Partial Least Squares 
NSAID Nonsteroidal Antiinflammatory Drugs 
PARAFAC Parallel Factor Analysis 
PCA Principal Component Analysis 
PDMS Polydimethylsiloxane 
PEG Polyethylene Glycol 
PEO Polyethylene Oxide 
PLS Partial Least Squared 
PMMA Poly(methyl methacrylate) 
PVA Polyvinyl Alcohol 
PVP Polyvinylpyrrolidone 
RGB Red Green Blue 
SEM Scanning Electron Microscopy 
SNR Signal-to-Noise Ratio 
SORS Spatially Offset Raman Spectroscopy 



























  Chapter 1: Introduction 
 





The pharmaceutical industry is one of the largest industries in the world, with sales in 
2010 of around $825 billion, which are expected to cross the $1 trillion mark sometime 
around 2013-2014 (Gatyas and Savage, 2009, Berkot, 2010). The cost of bringing a new 
drug to market currently stands at around $1 billion, over the course of eight years on 
average (Tufts, 2010). Over the last 30 years the level of annual spending on research 
and development has increased drastically. In the U.S. alone the level of spending on 
research and development (adjusted for inflation) has risen from $4 billion each year in 
1970 to $40 billion in 2005 as shown in Figure 1-1. 
 
 
Figure 1-1. Estimate of U.S. drug industry spending on research and development from 
1970 to 2005, compared with approval rate for new molecular entities (NMEs) in the same 
period. Adapted from (CBO, 2006). 
 
Despite the large increase in spending on research in development, there has been no 
such change in the number of new drugs approved. Therefore the level of spending per 
drug has increased significantly. While a large part of this investment is spent on 
clinical trials, an important part of the development phase of any product is formulation 
design. Well designed formulations improve the efficiency and efficacy of a treatment, 
while failures in this design process can be extremely costly (Bauer et al., 2001). 
 
The most commonly used delivery method for drugs are tablets, accounting for almost 
half of the drug products approved by the Food and Drug Administration (FDA), as they 
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important. The main aim of formulation design in tablets is to develop a tablet which 
will deliver the required amount of the drug to the patient at a rate which provides the 
maximum therapeutic benefit. Formulation scientists seek to develop novel 
formulations providing more control over the release of the drug in the patient. In order 
to do this they must understand the characteristics of the components involved. The 
active pharmaceutical ingredient (API) or drug is often mixed with a polymer, referred 
to as an excipient. The polymer can have several important functions. The first is to act 
as a carrier for the API. The API is mixed with the polymer, either mechanically or 
through a solvent preparation process where the drug is dispersed within the polymer. 
The polymers also serve as binders, allowing the formulation to be compacted into a 
tablet with sufficient mechanical integrity. Often the inherent dissolution characteristics 
of the pure drug compound are unsuitable for drug release and the polymer is used to 
enhance and control the release of drug.  
 
The effects of the excipients on drug release are of great interest to pharmaceutical 
scientists designing controlled release formulations. Consequently there is significant 
interest in developing a better understanding of the physical and chemical processes 
which determine the release mechanisms of the drug. 
 
Dissolution tests are the standard methodology for examining the dissolution profile of 
a tablet; however they provide little information concerning the behaviour of the matrix 
and processes within the matrix. Novel chemical imaging techniques promise to provide 
new insight into these processes. ATR-FTIR spectroscopic imaging is a powerful 
spatially resolved and chemically specific analytical approach. Using this methodology 
it is possible to analyse the concentration and spatial distributions of the components in 
a sample. It has been shown to be highly effective for studying the in situ compaction 
and dissolution of pharmaceutical formulations (Chan et al., 2005, van der Weerd et al., 
2004, Kazarian and Chan, 2003). However, the full potential of applying this imaging 
approach to studies of tablet dissolution has yet to be realised.   
 
1.2 Objectives 
The main objective of the work presented in this thesis is to use model pharmaceutical 
formulations to further investigate and develop the applications of ATR-FTIR imaging 
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in the field of pharmaceutical science. Two facets of tablet behaviour were investigated, 
compaction and dissolution. One of the advantages of the ATR-FTIR imaging approach 
is the ability to use complementary analytical techniques. UV/Vis, X-ray 
microtomography and visible optical imaging were used to provide supplementary 
information, offering a more global view of the processes being studied. 
 
The spatial and chemical information provided by using FTIR spectroscopic imaging in 
ATR mode with a diamond crystal provide a range of investigative opportunities. The 
major objectives of this work are presented below: 
 
1. To study the in situ compaction of pharmaceutical formulations, to determine 
the ability of ATR-FTIR imaging to distinguish the compaction properties of 
different formulations. 
 
2. The validity of FTIR imaging in ATR mode to study particles in compacted 
matrices was investigated. This was done by comparing FTIR data with 3D 
imaging data and through statistical analysis of particle size and component 
coverage at the surface of the samples. 
 
3. The novel application of FTIR imaging to study the effects of modifying the pH 
microenvironment of a tablet matrix was tested. This was done by adding pH 
modifying compounds to the matrix to study the effect of the dissolution of 
domains of a weakly acidic drug. 
 
4. The feasibility of using ATR-FTIR imaging to study the structure and 
dissolution of structured tablets, both multilayer and compressed coating 
formulations, was assessed. The chemical and spatial information provided by 
the approach was able to provide valuable information on how the ingress of 
water influenced the behaviour of the tablet sections and reveal the presence of 
any interactions between them. 
 
5. The dissolution profiles of tablets in the custom flow through apparatus designed 
for FTIR imaging was compared with those of tablets dissolved in USP 
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dissolution apparatus. This may help facilitate an understanding of how valid it 
is to compare data gathered using these different methodologies. 
 
In summary the main aims of this work are to further investigate the possibilities of 
using ATR-FTIR imaging to study pharmaceutical formulations. Both compaction and 
dissolution of these systems were investigated to understand and demonstrate the 
benefits that this powerful analytical approach can bring. 
 
1.3 Thesis Outline 
This thesis continues the application of ATR-FTIR imaging to pharmaceutical 
formulations. Chapters 2, 3 and 4 contain a review of relevant literature, which serve as 
a background for the research presented thereafter. Chapter 2 begins with an 
introduction to pharmaceutical formulations, specifically compaction and controlled 
release studies, before moving on to discuss pH modification and structured tablets. 
Chapter 3 covers the various relevant analytical approaches which have been applied to 
study pharmaceuticals, while Chapter 4 discusses FTIR spectroscopy and imaging. 
Chapter 5 then presents a general description of the experimental techniques and 
sampling methodologies used. The modifications made to these approaches for each 
section of work are discussed in the relevant chapters. 
 
The presentation of results begins in Chapter 6, which is split into two sections. The 
first section covers the compaction of caffeine tablets with different polymer matrices, 
while the second section compared the FTIR data gathered at the surface with X-ray 
microtomography data of the tablet. Chapter 7 investigates the possibility of 
determining properties of a tablet such as component loading and particle size from 
FTIR imaging data, using statistical analysis to determine whether the data have 
achieved statistical significance. The work in Chapter 8 considers the application of 
FTIR imaging to studying the dissolution of crystalline ibuprofen from matrices 
containing pH modifying compounds and the effects of salt formation during 
dissolution. Chapter 9 demonstrates the use of FTIR imaging, in conjunction with 
UV/Vis dissolution profile data and visible optical imaging, to study the dissolution of 
tablet-in-tablet structured dosage forms. These tablets were used to create delayed 
release profiles and pH resistant formulations for the delivery of pH labile drugs. 
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Chapter 10 continues the work with structured tablets, presenting an investigation of 
multilayer formulations. The first section sees the use of these formulations to provide 
biphasic release, while the second section uses the structure of these tablets as a method 
to compare the dissolution profiles of tablets in the USP type I apparatus and the custom 
ATR-FTIR flow through cell. The thesis then concludes in Chapter 11 with a summary 
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2 Pharmaceutical Formulations 
2.1 Introduction 
This chapter contains a review of pharmaceutical literature relevant to the topics 
covered in this thesis. The chapter starts with an introduction to tablet compaction, 
covering compaction processes and methods and the surface characteristics of 
compacted formulations. 
 
Section 2.3 begins with an introduction to controlled release and its advantages for drug 
delivery. This is followed by a discussion of swellable polymers and their dissolution 
properties before introducing some models for drug release. 
 
Sections 2.5 onwards discuss literature concerning the types of formulations studied for 
dissolution in the thesis. This includes, microenvironmental pH modification, ibuprofen 
dissolution and structured tablets specifically, tablet-in-tablet and multilayer 
formulations. 
 
Drugs administered via solid oral dosage forms are almost never taken in an undiluted 
form. Instead the active pharmaceutical ingredient (API) is generally given in tablet 
form. Tablets generally consist of a mixture of the drug and other powdered 
components which are compressed into a solid tablet or compact (Nystrom and Karehill, 
1996).  The addition of the other components is designed to influence various 
characteristics of the final formulation (Jain, 1999). These additives are referred to as 
excipients. The most important functions of excipients are: guaranteeing the dosage, 
stability and bioavailability of the API (Pifferi and Restani, 2003). Excipients can also 
have many other properties, such as pH modifiers, disintegrants, release modifiers, 
flavour masking and lubricants (Pifferi et al., 1999). 
 
2.2 Tablet compaction 
Compaction is an important step in tablet processing. The mechanical strength and 
dissolution behaviour of the resulting tablets are strongly affected by the compaction 
properties of the ingredients, the compaction processes they undergo and the subsequent 
densities of the formulations produced.  
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Many drug compounds do not exhibit favourable compaction properties and therefore, it 
is important to choose excipients which form a strong coherent structure following 
compaction (Chan et al., 2005, Jain, 1999). The simplest method used for compaction 
of tablets is direct compression in which the constituent powders of the tablet are simply 
mixed and compacted, although drug content in these formulations is usually less than 
30 wt% (Jivraj et al., 2000). 
 
2.2.1 Compaction process 
The first stage of compaction is to pour the powder material into a die cavity; at this 
stage the particles are loosely packed. A punch is then lowered into the die above the 
powder and compaction commences. Firstly the particles rearrange resulting in a 
decrease in volume due to a closer packing structure. This is then followed by elastic 
(reversible) and plastic (irreversible) deformation of the particles. As compaction 
progresses the density of the powders continues to increase due to continued particle 
deformation and particle fracture, depending on the properties of the powder (Jivraj et 
al., 2000). For example, microcrystalline cellulose (MCC) undergoes plastic 
deformation during densification, whereas in ceramic type materials, particles are 
usually either crushed or fractured (Cunningham et al., 2004). 
 
The most important factor in determining how a powder blend behaves when being 
compacted into tablet form is the deformation behaviour (Jain, 1999). As discussed 
above this may take the form of elastic, plastic or brittle fracture deformations. These 
deformations have been characterised by a number of parameters, of which the Young’s 
modulus, yield stress and fracture toughness are important (Duncan-Hewitt and 
Weatherly, 1989). The way a material behaves following exposure to one of these 
deformation stresses, σd ,is a result of the on the deformation mode and the mechanical 
properties of a material (Rowe and Roberts, 1996). The Young’s modulus (E) is the 
ratio of the uniaxial stress to the uniaxial (deformation) strain (ϵ) in the range of stress 
for which Hook’s law holds (Equation 2-1) and is therefore a measure of the elastic 
properties of the material (Cottrell, 1964). 
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       Equation 2-1 
 
 Plastic deformation is dependent on yield stress and fracture toughness. When the yield 
stress, σy, is exceeded the particles no longer behave elastically and begin to flow and 
break as given by Equation 2-2 (Rowe and Roberts, 1996). 
 
       Equation 2-2 
 
For a plastic material yield stress is proportional to indentation hardness (H) Equation 
2-3 (Rowe and Roberts, 1996). 
 
 






The tendency of a material to undergo brittle fracture is dependent on the fracture 
toughness of the material. This is a measure of how much the contact areas between 
particles crush and fracture under compaction (Duncan-Hewitt, 1993). The brittle 
fracture stress is given by Equation 2-4 where Ag is a constant dependent on geometry 
and the application of stress, d is the particle diameter and KIC is the critical stress 
intensity factor, which describes how much stress would be needed to initiate 
catastrophic crack propagation. This is given by Equation 2-5 where R is the fracture 
toughness of the material (Rowe and Roberts, 1996). 
 
 
   





          
   
 Equation 2-5 
 
The type of deformation exhibited by a compound is dependent on the properties of the 
materials in the compact described above and the mechanism of compaction. Exact 
prediction of material behaviour is non-trivial however, the expected behaviour of 
pharmaceutical compounds based on the parameters described above has been 
summarised by Roberts and Rowe (Roberts and Rowe, 1987). Materials like 
microcrystalline cellulose, with low values for Young’s modulus, hardness and yield 
 Chapter 2: Pharmaceutical Formulations 
 
- 39 - 
 
stress can be described as soft. These materials will be ductile and will exhibit plastic 
flow whereas, drugs such as paracetamol and caffeine can be considered as moderately 
hard and are brittle. These materials will exhibit a mixture of fracturing and plastic flow 
under compaction (Roberts and Rowe, 1987). 
 
 
Compaction of pharmaceutical powders can be strongly affected by environmental 
conditions. Humidity can have significant effects on pharmaceutical powder 
compaction, for example moisture present in the matrix can act as a lubricant or 
plasticiser, which will increase the resulting tablet density (Giordano et al., 1990, 
Elkhider et al., 2007, Khan et al., 1981). Formulations produced at a greater relative 
humidity will have different physical properties, such as exhibiting greater compaction 
densities or being mechanically stronger (Ahlneck and Alderborn, 1989), or in some 
cases capping (Khan et al., 1981). Other components specifically designed to lubricate 
the powders during compaction, such as magnesium stearate, can also be added to the 
matrix (Allen and Luner, 2000).  
 
2.2.2 Analysis of surface characteristics 
There has been great interest in the surface properties of compacted pharmaceutical 
tablets, and several methods have been used for studying the surface characteristics. 
Scanning electron microscopy (SEM) has been used to provide qualitative information 
about the surface. Karehill et al. used SEM to study double layer tablets following 
compression (Karehill et al., 1990). They established that the strength of bonding 
between the layers of the tablets reduced with decreasing surface roughness for 
plastically deforming components. Fracturing materials did not exhibit the same trend 
as the area of contact was at its greatest immediately following their initial fracturing 
(Karehill et al., 1990). 
 
Atomic force microscopy (AFM) allows quantitative surface roughness data to be 
gathered with very high spatial resolution. This approach requires contact with the 
sample and can result in damage to the surface (Poon and Bhushan, 1995). Non-contact 
optical profilometry offers a non-destructive alternative for quantitative assessment of 
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surface characteristics. It requires minimal sample preparation and can produce spatial 
resolutions of approximately 1 µm (Silvennoinen et al., 1999). 
 
While these approaches are very effective for generating spatial information regarding 
the surface of a tablet, they only provide data describing the surface roughness. No 
chemical information is provided, which is necessary for describing the distribution of 
components within the tablet matrix. In order to do this it is necessary to use chemically 
specific imaging approaches such as FTIR imaging or NIR imaging (Hilden et al., 2008, 
Chan et al., 2005, Elkhider et al., 2007). These approaches are described in greater 
detail in Section 3.5 and Section 4.2. 
 
2.2.3 Lab scale compaction 
Industrial tablet compaction systems use rotary presses which operate at high speed. 
However, on a lab scale using custom tablets, this is not feasible. During the 
development stages of a formulation single station presses are often used. When 
studying tablet dissolution using FTIR imaging, custom made tablet compaction 
systems have been used (Chan et al., 2005, van der Weerd et al., 2004). The pressures 
exerted on the powders in these cells can be as high as 120 MPa (Elkhider et al., 2007), 
which is relatively low compared to pressures of up to 500 MPa used in standard 
compaction in industry (Nystrom and Karehill, 1996). However, for controlled release 
systems it has been shown that a significant difference in the compaction force used, 
and consequently void fraction, between formulations will only manifest as a small 
difference in dissolution performance (Bettini et al., 1994). 
 
2.3 Introduction to controlled release 
A large number of drug delivery methods are available to formulation scientists; 
however tablets delivered via the oral route remain the most popular today (Fass et al., 
2009). Controlled release tablets commonly consist of the drug or active pharmaceutical 
ingredient (API) and a polymer bulk as the two most important constituents. The 
polymer is normally a chemically inert component which is used to aid in the formation 
of the tablet and in controlling the release (Colombo et al., 2000). A significant amount 
of work has been done in the development of polymeric controlled drug release 
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formulations (Colombo, 1993). The aim of using controlled release systems is to 
improve the efficiency and effectiveness of the delivered drug in treating the patient 
(Uhrich et al., 1999).  
 
Controlled release formulations have myriad advantages among which some of the most 
significant are reducing the toxicity of the drug, improving the efficacy, greater 
convenience and also better patient compliance (Uhrich et al., 1999). A common usage 
of controlled release is to produce sustained release formulations, which prolong the 
release of drug from the tablet matrix by slowing the erosion of the tablet and increasing 
the diffusion pathlength (Sung et al., 1996, Mitchell et al., 1993). Controlled release 
formulations can also be designed to have a range of other functions (Peppas et al., 
2000), such as being, pH active (Badawy and Hussain, 2007) and environmentally 
responsive (Qiu and Park, 2001). 
 
An example of a significant advantage of temporal controlled (sustained) release dosage 
forms is presented in Figure 2-1. This shows a comparison between the performance of 
controlled release formulations and non controlled release methodologies such as 
injections. The dosage of the controlled release formulation spends a much larger 
fraction of the time period within the therapeutic range (Langer and Peppas, 1983). 
 
Figure 2-1. Comparison of the performance of controlled release formulation (solid line) 
and repeated dosage (dashed line) in terms of drug concentration in blood plasma over 
time. The grey box denoted the therapeutic range. 
 
In the repeated dosage case in Figure 2-1 there is a peak immediately following 
administration of the dosage to toxic levels, which is subsequently falls rapidly to below 















Dose 1 Dose 2 Dose 3 Dose 4
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patient as not only does the dosage spend less time spent above the toxic level, but also 
above the minimum effective level (Uhrich et al., 1999, Lopina and Kanjickal, 2004). 
This is an example of one way in which controlled release systems can improve the 
reliability, patient safety and effectiveness of drug treatments. 
 
2.3.1 Swellable polymers 
In oral controlled release formulations, the polymer bulk of the tablet is used to create 
the controlled release properties of the tablet. Commonly these polymers are 
hydrophilic swellable polymers (Hogan, 1989). In drug delivery these polymers are 
often referred to as hydrogels, although they are technically not. Hydrogels are 
hydrophilic macromolecular compounds which maintain their shape following swelling 
due to permanent links in the molecular network (Lee, 1985). Swellable hydrophilic 
polymers are different in that they do not maintain their shape following swelling 
(Colombo, 1993). Swellable matrix systems in general take the form of compressed 
powders in monolithic tablet form (Colombo et al., 2000). The polymers used are often 
cellulose derivatives in which the controlled release properties are derived from their 
swelling behaviour. The swelling behaviour is caused by the formation of an expanding 
gel layer around the tablet on contact with water. 
 
Of the many polymers used in controlled release, hydroxypropyl methylcellulose 
(HPMC) is perhaps the most important (Siepmann and Peppas, 2001). It is a water 
soluble cellulose ether, derived from cellulose (Colorcon, 2009b), the generalised 
chemical structure is shown in Figure 2-2. Reasons for its popularity are, that it is non-
toxic, possesses favourable compaction properties and can be used in formulations with 
high drug loadings while still exhibiting controlled release (Pham and Lee, 1994). It is 
also nonionic and will not form complexes with ionic species such as metal salts, is 
stable over a wide range of pH (2.0 to 13.0) and it is metabolically inert (Colorcon, 
2009b). 
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Figure 2-2. Image showing the chemical structure of HPMC. Where R represents –CH3, a 
–CH2CH(CH3)OH group, or –H (Siepmann and Peppas, 2001). 
 
The dissolution properties of HPMC are determined by three factors: (1) the methoxy 
group content; (2) the hydroxylpropoxy group content; (3) the molecular weight. The 
United States Pharmacopeia defines four types HPMC based on the methoxy group 
content and hyroxypropoxy group content. These are: HPMC 1828, HPMC 2208, 
HPMC 2906, HPMC 2910, where the first two numbers represent the –OCH3 
percentage and the second two numbers indicate the –OCH2CH(CH3)OH percentage 
(Siepmann and Peppas, 2001). These factors all influence the physicochemical 
properties of the polymer. This manifests itself primarily through differences in the 
behaviour of the gel layer. The greater the molecular weight of the polymer chains 
involved, the higher the viscosity of the gel formed (Colorcon, 2009a).  
 
The glass transition temperature (Tg), which is very important to the dissolution 
properties has been reported as lying between 154 and 184°C (Johnson et al., 1991, 
Siepmann and Peppas, 2001). During dissolution the dissolution medium enters the 
polymer matrix. The solvent acts as a plasticiser, increasing the mobility of the polymer 
chains, causing them to transition from being in the glassy state to the rubbery state 
(Lee and Peppas, 1987). The solvent effectively lowers the glass transition temperature 
of the matrix, therefore compounds with a lower initial glass transition temperature 
require less solvent to undergo the glassy/rubbery transition. 
 
2.3.2 Dissolution of swellable polymers 
Dry HPMC exists as a glassy (amorphous) polymer. Upon contact with water HPMC 
based tablets will go through several processes: 
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1. Water intake into the matrix.  The water serves as a plasticizer lowering the Tg of 
the HPMC. As Tg lowers the polymer transitions from being in the glassy state to 
the rubbery state. 
2. The HPMC swells forming a gel and the dimensions of the tablet increase. 
3. The presence of water facilitates dissolution of the drug which begins to diffuse 
out of the tablet. Only dissolved drug can diffuse, non-dissolved drug will not, 
though translocation of drug particles may occur due to the expansion of the 
polymer matrix. 
4. As the water content rises the gel becomes more swollen and the diffusivity of the 
drug increases. 
5. As the polymer becomes completely saturated with water it will begin to dissolve 
however, drug dissolution may long since have been completed. 
 
The formation of the gel layer is the most important part of the controlled release 
process from tablets containing swellable polymers. The formation of the gel layer is 
what shapes the performance of drug release (Sung et al., 1996). If the initial gel layer 
forms too slowly water ingress through the matrix is rapid causing the matrix to 
disintegrate and the drug to dissolve prematurely. The gel layer is defined as the 
distance between the penetration and dissolution fronts (Harland et al., 1988).  
 
It is for its gel forming properties that HPMC is seen as a suitable polymer for 
controlled release formulations, whereas polymers such as hydroxypropyl cellulose 
(HPC) and carboxymethyl cellulose (CMC) do not establish a gel layer in a sufficiently 
short space of time (Colombo et al., 2000). These polymers may be added to HPMC 
matrices to adjust the release properties, where HPC has been seen to increase the rate 
of release from HPMC matrices (Vueba et al., 2006) and CMC has been used to slow 
release (Dabbagh et al., 1999). 
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Figure 2-3. Schematic diagram of swelling tablet (Pham and Lee, 1994, van der Weerd and 
Kazarian, 2004b). 
 
The major features of a dissolving swellable tablet are illustrated in Figure 2-3. The 
barrier of the gel layer serves to regulate water ingress and consequently drug 
dissolution and diffusion within the matrix. The gel begins to form upon contact with 
water; at this point the polymer chains are still highly entangled. Further outwards from 
the point of swelling onset the water content of the gel is much greater and the 
entanglement of the polymers is looser, this marks the onset of the diffusion layer of the 
gel, where full gellifiaction has occurred. At the outer edge of the gel layer the water 
content of the gel reaches the extent at which full disentanglement of the chains occurs, 
this is defined as full dissolution of the polymer (Kazarian and van der Weerd, 2008, 
Narasimhan and Peppas, 1996, Colombo et al., 2000). The entanglement of the polymer 
chains at various stages is illustrated in Figure 2-4. 
 
Figure 2-4. Polymer chain disentanglement (a) initial glassy entangled state (b) partial 
disentanglement in diffusion layer (c) total disentanglement in erosion/dissolution layer 
(Narasimhan and Peppas, 1996). 
 
The exact determination of these fronts in certain systems is somewhat disputed with 
several groups postulating what they believe is the most correct interpretation (Gao and 
Meury, 1996, Bettini et al., 2001), the approaches to study these phenomena are 
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and van der Weerd (Kazarian and van der Weerd, 2008), with the aid of FTIR imaging 
as follows (inside to outside): 
 
1. True water penetration front exhibiting partial dissolution of the drug and only 
limited gelling of the polymer. 
 
2. Total gellification of the HPMC, through which diffusion of the drug occurs. 
 
3. Erosion/dissolution front of the polymer. 
 
2.3.3 Drug release mechanism 
In order for the drug within the matrix to dissolve out of the tablet and into the 
dissolution medium it must diffuse through the gel layer of the swelling tablet. 
Therefore the thickness and concentration of polymer in the gel layer are important 
factors in the release of the drug. The gel layer thickness is dependent on the rate of 
penetration of the dissolution medium, the disentanglement of the polymer chains and 
mass transfer of the polymer and drug in the dissolution medium (Pham and Lee, 1994). 
 
Initially penetration of the dissolution medium into the matrix is the dominant process, 
while relatively little disentanglement of the polymer chains is seen. This leads to 
formation of the gel layer. As the thickness of the gel layer increases then the path 
length for diffusion increases, slowing the intake of the solvent. This leads to a slowing 
of the swelling as penetration and disentanglement rates begin to coincide. The 
thickness of the gel layer only begins to decrease once the majority of the polymer has 
entered the rubbery phase and the disentanglement/erosion rate begins to dominate.  The 
lower the viscosity of the HPMC the faster it will both swell and erode (Pham and Lee, 
1994). For highly soluble drugs diffusion through the gel layer is the dominant release 
process whereas, for insoluble drugs release mainly occurs due to erosion processes 
(Sung et al., 1996). 
 
2.4 Modelling of drug release 
As described above, the release kinetics from swellable erodible formulations are 
governed primarily by matrix erosion (polymer dissolution) and drug diffusion. 
Significant work has been done to model drug release from dissolving polymer systems. 
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The most well known model is probably the Higuchi model (Higuchi, 1961), which 
when presented in its most basic form is shown in Equation 2-6. 
 
   
  
 √             
Equation 2-6 
 
Where Mt is the cumulative drug released at time t, As is the surface area of the 
controlled release system exposed to the dissolution medium. D is the diffusivity of the 
drug in the polymer, c0 is the initial drug concentration and cs is the solubility of the 
drug in the polymer. Equation 2-6 can be condensed to Equation 2-7. 
 
   
  
  √  
Equation 2-7 
 
Where M∞ is the total amount of drug released given infinite time and K is a constant 
which is based on the design variables of the system (Siepmann and Peppas, 2001). The 
advantage of this model is its simplicity as the drug release fraction is proportional to 
the square root of time. However, it is not without its drawbacks and when it is applied 
then the following major assumptions should be considered, most of which make this 
model inappropriate for HPMC based systems: 1) Initial drug concentration must be 
much greater than the solubility of the drug. 2) There should be negligible swelling or 
polymer dissolution. 3) Perfect sink conditions are maintained. 4) Finally, drug 
diffusivity does not change (Siepmann and Peppas, 2001). 
 
2.4.1 Power law model 
An equation which has become very common for analysing controlled release 
formulations is that proposed by Ritger and Peppas as shown in Equation 2-8 (Ritger 
and Peppas, 1987a). 
 
   
  
     
Equation 2-8 
 
It is a power law, much like the condensed version of the Higuchi model shown in 
Equation 2-7. However, in this equation k is a kinetic constant and n is a diffusional 
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exponent. The value of n can be varied for different geometries and release regimes and 
the equation is valid for the first 60% of drug released. For Fickian diffusion, depending 
on the aspect ratio of the tablet, the value of n can range between 0.43 and 0.50. For 
non-Fickian diffusion the value of n ranges between 0.43 and 1. These values are 
summarised in Table 2-1 (Ritger and Peppas, 1987b). 
 
Table 2-1. Value of exponent n for various geometries and drug release mechanisms 
Diffusional exponent, n Drug release mechanism 
Thin Film Cylindrical sample Spherical sample  
0.5 0.45 0.43 Fickian diffusion 
0.50 < n < 1.00 0.45 < n < 0.89 0.43 < n < 0.85 Anomalous (non-Fickian) transport 
1.0 0.89 0.85 Case-II transport 
 
The power law is still subject to many of the same limitations of the Higuchi model, 
such as negligible size change, constant diffusivities and perfect sink conditions. 
Equation 2-8 describes two physical effects on the dissolution of tablets. If n = 0.5 then 
dissolution is purely diffusion controlled however, if n = 1 then dissolution is governed 
by Case-II transport (for slab type geometry). In Case-II transport the relaxation of the 
polymer chains in the matrix governs the release of the drug (Ritger and Peppas, 
1987b). If the value of the exponent n lies between the 0.5 and 1 then the release is 
termed as anomalous, meaning there is a contribution from both the Fickian and Case II 
transport modes. For cylindrical tablets containing HPMC it has been shown that the 
value of n is approximately 0.6 (Skoug et al., 1993). When the value of n is close to 1 a 
constant release rate (zero-order release) will be produced, which can be obtained in 
monolithic forms through careful polymer selection. This has been achieved using low 
molecular weight PVA. The value of n was found to be very close to 1.0 indicating 
erosion controlled release (Conte et al., 1988). Baveja et al. were able to obtain zero-
order release from HPMC matrices by adding CMC to control swelling. It was found 
that the value of n was 0.89. The zero-order kinetics were attributed to the fact that a 
constant diffusional path length was maintained (Baveja et al., 1987). 
 
A similar equation to that seen in Equation 2-8 has been introduced by Peppas and 
Sahlin in which the Fickian and non-Fickian contributions are separated into two terms 
as shown in Equation 2-9 (Peppas and Sahlin, 1989). 
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Equation 2-9 
 
Where k1 is the diffusional constant and k2 is the relaxational constant and m is the 
diffusional exponent. The advantage of using this approach is that the relative 











Where R is the relaxational contribution and F is the Fickian contribution. This equation 
has been used by Bettini et al. to monitor the R/F ratios of drug release from cylindrical 
tablet matrices with impermeable caps on the top and bottom (Bettini et al., 1994). It 
was found that the R/F ratio was much larger for tablets with the impermeable 
coverings, indicating that the relaxational contribution is much more important for these 
formulations. 
 
2.5 Microenvironmental pH modification 
The performance of a dissolving drug can be modulated by adding acidic and basic 
compounds to the tablet matrix. This has the effect of modifying the pH of the tablet 
microenvironment.  
 
2.5.1 Selection of pH modifier 
The selection of a pH modifier can be very complex as the concept of pH cannot strictly 
be applied to solid formulations (Badawy and Hussain, 2007). It has been suggested that 
a suitable means for selection of a pH modifier should be based on the pH of saturated 
solutions (Badawy et al., 1999). In that study it was found that fumaric acid and citric 
acid despite having similar pKa values had distinctly different saturated pH values. The 
pH value of citric acid was found to be around 0.4 and fumaric acid 2.5. However, this 
is not necessarily representative of the pH within the matrix. It is a measure of what the 
highest pH would be, though this may just be with very small localised domains, but it 
is a standard by which to compare possible pH modifiers. 
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2.5.2 Measurement of pH in pharmaceuticals 
Several methodologies have been used in attempts to measure the pH within 
pharmaceutical formulations. The slurry method uses a pH meter to measure the pH of a 
slurry of the formulation (Badawy et al., 1999). However, the measured pH of the slurry 
depends on the concentration of the slurry used and will obviously differ from the pH in 
the solid tablet form. Other methods used include pH microprobes (Doherty and York, 
1989) and the addition of pH indicator dyes to the system (Zinchuk et al., 2005). The 
advantage of adding indicator dyes to the system is that it is a simple approach which 
gives an indication of pH within the matrix that can be observed with a standard video 
camera. 
 
2.5.3 pH modification in controlled release formulations 
There are many examples in literature of adding pH modifiers to tablet matrices to 
adjust the solubility of weakly basic drugs (Streubel et al., 2000a, Thoma and Zimmer, 
1990, Tatavarti and Hoag, 2006). In these formulations, the addition of acidic 
compounds will increase the rate of release of the drugs from the formulations and the 
addition of basic compounds will result in diminished release. Thoma and Zimmer 
tested the effects of a range of acids on the dissolution of noscapine hydrochloride 
(Thoma and Zimmer, 1990). It was found that low solubility acids did not maintain a 
low enough pH, while highly soluble acids dissolved out of the matrix too rapidly. 
Succinic acid was found to be the most successful due to a solubility which allowed it to 
maintain a low pH environment without dissolving out of the formulation too rapidly 
(Thoma and Zimmer, 1990). Less work exists on the use of pH modifiers for controlling 
the release of weakly acidic drugs (Riis et al., 2007, Pygall et al., 2009, Rao et al., 
2003, Fuder et al., 1997). It should, however, be equally effective.  
 
Enteric polymers have been used to enhance the release of pH sensitive drugs. Polymers 
such as Eudragit and Carbopol exhibit pH dependent solubility and can be used to 
“program” formulations to release the drug at the correct point in the body. Indeed these 
polymers have their own effect on the pH of the matrix and it has been shown by 
Tatavarti et al. that this effect may be as significant in enhancing the release of drugs as 
the increased dissolution rate of the polymers (Tatavarti et al., 2004). 
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2.5.4 Dissolution of ibuprofen 
 Ibuprofen is one of the most commonly taken drugs in the world, the UK market alone 
for ibuprofen is £300 million a year. However, it is poorly soluble in water and may 
crystallise in the gut where these crystalline deposits can irritate the lining of the gut 
causing stomach ulcers (Lanza et al., 1979). In elderly patients, taking this drug over the 
long term can be a significant problem.  
 
Several approaches have been used to enhance and control the release of ibuprofen. 
Ibuprofen can be dispersed in water soluble polymers such a polyethylene glycol (PEG) 
(Najib and Salem, 1987) or creating complexes with cyclodextrins (Mura et al., 1998). 
 
The solubility of the compound increases above pH 5.5 (Levis et al., 2003) as ibuprofen 
is a weak acid and hence is much more soluble in basic conditions. It will even 
crystallize when dissolving in neutral pH (Kazarian and Chan, 2003). However, raising 
the pH of the tablet microenvironment may improve the dissolution of ibuprofen from 
solid tablet matrices. 
 
Upon the addition of ionic species to the matrix, salts may be formed with oppositely-
charged drugs, of both low solubility and high solubility (Feely and Davis, 1988). When 
using pH modified formulations, the pH is adjusted within the tablet matrix; therefore it 
is important to understand the behaviour of the drug within the matrix. This may take 
the form of increased or decreased solubility of the drug, or the formation of salts. 
 
2.6 Structured tablets 
As described above pharmaceutical tablets are generally simple monolithic structures. 
There may also be a thin coating on the formulation to improve the aesthetics or 
facilitate easy swallowing. Through the use of excipients, such as HPMC, these 
formulations can achieve controlled and extended release profiles as discussed in 
Section 2.3. In order to exert more control over the release of the API from the 
formulation it is possible to construct more complex tablet structures. Multilayer and 
tablet-in-tablet formulations will be discussed in detail below.  
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2.6.1 Tablet-in-tablet structures 
Pharmaceutical tablets often have external coatings, which can be used for something as 
simple as masking the bitter taste of the API underneath; however, they are regularly 
used to control or enhance the release of the API in some way. Film coating systems 
have been used for coating tablets, although, this is not always a favourable technique 
due to the solvents used to prepare such tablets and legislation on exposure limits for 
workers (Bose and Bogner, 2007). Compression coating is an effective method for 
coating tablets, in which a shell section can be directly compacted around the core 
section carrying the drug payload (Ozeki et al., 2004). A schematic diagram of the 
formulation structure is shown in Figure 2-5.  
 
Figure 2-5. Schematic diagram of compression coated tablet form. 
 
Matsuo et al. used the outer shell as a protective barrier creating delayed release tablets 
(Matsuo et al., 1995). The in vitro dissolution of the tablets was monitored by UV/Vis 
spectroscopy and it was shown that the lag-time could be controlled by both particle 
size and amount of polymer in the outer shell. Ozeki et al. have also shown that it is 
possible to vary the lag-time by changing the thickness of the shell layer (Ozeki et al., 
2004). 
 
Ishino et al. have shown that rapid delayed release can be achieved by controlling the 
disintegration of the outer shell (Ishino et al., 1992), while Ueda et al. have used a 
spherical four layered formulation to achieve rapid drug release and programmed lag-
times (Ueda et al., 1994). These studies have both produced dissolution profiles 
demonstrating the delayed release mechanism and the ensuing controlled release 
thereafter.  
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Ordered release can be achieved by using a tablet-in-tablet system, in which there is a 
central core wrapped in an outer layer. This technique has been used for biphasic 
fast/slow release by Lopes et al. (Lopes et al., 2007) to develop a biphasic release 
system and study the effects of a combined fast release coat with controlled release 
core. Ibuprofen was used as the model drug for both sections of the tablet. HPMC and 
ethyl cellulose (EC) were used as the excipients in the controlled release core. The 
excipient for the outer section was microcrystalline cellulose, mixed with sodium 
croscarmellose as a superdisintegration component. The tablets were formed using a 
lightly modified version of standard compaction methods. The dissolution was 
monitored using UV/Vis spectroscopy. 
 
The shell structure of these tablets can be used as more than just a barrier to delay 
release. Indeed, Chan and Zhang. used hydroxypropyl cellulose and sodium alginate to 
coat freeze dried cells, protecting them from the acidic environment of the stomach and 
enhancing the efficiency of their delivery to the large intestine (Chan and Zhang, 2005). 
 
2.6.2 Multilayer and zero-order release tablets 
Standard monolithic tablets containing a uniformly distributed drug generally provide 
continuously diminishing release rates (Siepmann et al., 1999a, Siepmann et al., 
1999b). More complex tablet structures offer greater control and flexibility over the 
delivery of the drug in the patient and can create many different release regimes.  
 
Tablets with a multilayered structure offer an opportunity to modify release profiles. 
One example is bimodal release, while this pattern of release can be achieved using 
other tablet geometries such as core-in-cup tablets (Sirkiä et al., 1994), Streubel et al. 
used Hydroxypropyl Methylcellulose Acetate Succinate (HPMCAS) based tablets 
(Streubel et al., 2000b) for pH dependent bimodal release. 
 
The multilayer structure has been successfully applied to achieve biphasic delivery for 
the purpose of quick/slow release, which can simply be achieved by using one fast 
release layer and another controlled release matrix layer (Conte and Maggi, 1996). 
Uekama et al. used a double layer tablet for biphasic release of piretanide, with β-
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cyclodextrin being used in the fast layer and ethyl cellulose and hydroxypropyl 
methylcellulose (HPMC) being used in the slow release layer (Uekama et al., 1990). 
Maggi et al. used double layer tablets for biphasic release of two different drugs, in 
which the speed of release from the fast release layer was determined by a super 
disintegrant added to the layer (Maggi et al., 1999). 
 
Another common purpose of using multilayered tablets is to produce zero-order release 
tablets, which have the desirable property of exhibiting a constant release rate of drug 
(Chidambaram et al., 1998, Abdul and Poddar, 2004, Conte et al., 1993, Qiu et al., 
1998, Krishnaiah et al., 2002). These multilayer formulations employ barrier layers as a 
method for limiting the area of the tablet exposed to the dissolution medium. However, 
zero-order release can also be attained using monolithic tablets (Baveja et al., 1987). 
Baveja et al. used non-ionic HPMC and anionic sodium carboxymethylcellulose in a 
carefully controlled ratio with each other and the drug. This led to the swelling and 
expansion of the HPMC being balanced by the erosion of the gel layer, maintaining a 
constant diffusion length for the drug. Zero-order release has also been demonstrated 
using doughnut shaped tablets (Kim, 1995).  
 
Colombo et al. (Colombo et al., 1990) achieved a close to linear release profile by 
applying impermeable barrier coatings to the top and bottom face of HPMC based 
tablets to control the direction of swelling, restricting changes in the surface area for 
release. Further work found that manually applied film barriers could be replaced in 
favour of swellable HPMC barriers that would swell with the core maintaining the 
surface area of the exposed core (Conte et al., 1993). 
 
2.6.3 Analysis methods for structured tablets 
The dissolution of pharmaceutical tablets is often monitored using UV/Vis analysis 
which produces a profile of drug released over time. However, it is often important to 
understand how tablets behave during dissolution, particularly in the case of structured 
tablets. Therefore it can be advantageous to use imaging techniques to study their 
formation and dissolution. This has been done using a video camera to film layered 
tablets during the various stages of dissolution (Conte et al., 1993). However, this 
required the addition of coloured compounds to the dissolving matrix and photography 
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may not provide quantitative information regarding the concentrations of the 
components in a system.  
 
When studying tablet compaction and dissolution particularly of structured tablets, it is 
desirable to investigate the distribution of various components within the formulation, 
as this will influence the chemical and physical properties of the tablet (Chan et al., 
2003). Chemical imaging approaches such as FTIR, NIR and Raman imaging and 
mapping have been used for this (Chan et al., 2005, Clarke et al., 2001). Chemical 
imaging methodologies such as FTIR imaging have also been successfully applied to 
studying the dissolution of pharmaceuticals. FTIR imaging has been used to provide 
quantitative information regarding water ingress, component dissolution, polymer 
swelling as well as revealing phenomena such polymorphic transitions and salt 
formation (Kazarian and Chan, 2003, van der Weerd and Kazarian, 2005, Koenig, 
2002). A discussion of relevant pharmaceutical analysis approaches follows in Chapter 
3 and a discussion of infrared spectroscopy and imaging can be found in Chapter 4.  
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3 Analytical Methods for Pharmaceuticals 
 
3.1 Introduction 
Chapter 3 reviews relevant analytical approaches that have been applied to study the 
formation and dissolution of pharmaceutical formulations. The chapter starts with a 
discussion of established in vitro dissolution approaches for solid dosage forms. 
 
Section 3.3 introduces X-ray microtomography as a three dimensional imaging 
procedure used largely for analysis of static samples as well as covering MRI. Section 
3.4 covers the topic of visible optical imaging for studying tablet dissolution.  
 
Section 3.5 onwards then discusses the usage of spectroscopic techniques for 
investigating pharmaceutical formulations, including near-infrared spectroscopy 
including imaging and mapping. 
 
3.2 Tablet dissolution 
In vitro dissolution testing was originally used to investigate the amount and extent of 
drug release from solid dosage forms; but it is now used for studying many types of 
delivery forms (Siewert et al., 2003). Dissolution tests are used in the development of 
new products, determination of bioequivalence and quality control (Cohen et al., 1990). 
An important application is providing information on the dissolution properties of 
various candidate formulations, to find that which is most suitable for purpose. If the 
tests do not in some way reflect the in vivo performance then they may be irrelevant as a 
predictive tool (Löbenberg and Amidon, 2000). They are also used to establish in 
vitro/in vivo performance correlations and can be used in place of a large 
bioequivalence study (Dressman et al., 1998). As a result of this much work has been 
done to develop biologically relevant artificial dissolution media, such as Fed and 
Fasted States Simulated Intestinal Fluids (FeSSIF and FaSSIF) (Aiache et al., 1997) and 
other biorelevant dissolution media (Galia et al., 1998, Nicolaides et al., 1999, Wei and 
Löbenberg, 2006). For conventional solid oral dosage forms four different dissolution 
apparatuses are used: Basket, paddle, reciprocating cylinder and flow-through cell 
(Siewert et al., 2003). The most commonly used pieces of apparatus are the basket and 
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Figure 3-1. Schematic diagram of USP I (basket) and USP II (paddle) dissolution 
apparatus. 
 
The formulation is placed inside the basket or in the bottom of the flask for the paddle 
method and the chamber is filled with dissolution medium. The basket is then rotated 
and the concentration of the drug released into the dissolution medium is measured as a 
function of time. For these standard dissolution tests consistency of application is 
required for meaningful comparison, therefore there are very strict calibration settings, 
and modifications are made to the apparatus over time to help improve consistency 
(Beckett et al., 1996). 
 
The method by which the concentration of the drug in the dissolution medium is 
determined is UV/Vis spectroscopy. This makes use of radiation in the region of the 
electromagnetic spectrum between 190 and 900 nm. Much like other spectroscopic 
techniques such as infrared spectroscopy, the concentration of the component is 
determined via absorbance at a characteristic frequency of absorption. Using the Beer-
Lambert law, the absorbance is proportional to concentration of the species. However, 
as opposed to exciting molecular vibrations such as in infrared spectroscopy, UV/Vis 
spectroscopy is based on electronic transitions (Owen, 1996). 
 
UV/Vis spectroscopic analysis is generally used in pharmaceutical science to produce a 
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a plot of concentration of the component of interest in the dissolution medium as a 
function of time. This methodology is simple, effective and sensitive. However, 
dissolution analysis using UV/Vis spectroscopy with dissolution tests only provides 
information about the global dissolution rate of a sample and gives no information about 
the physical or chemical processes occurring within the sample (e.g. tablets).  
 
3.3 X-ray microtomography 
The bulk properties of a tablet, such as density and particle distribution are very 
important to dissolution properties of the formulation. X-ray microtomography provides 
a three dimensional non-destructive analytical approach with a wide range of 
applications, among which is the study oral dosage formulations (Stock, 2008). 
Previously, synchrotron sources of radiation were used to study particulate samples 
(Seidler et al., 2000, Richard et al., 2003). With the advent of portable 
microtomography equipment this is no longer necessary and successful application has 
been seen for the study of pharmaceutical formulations.  
 
The first application of X-ray microtomography to pharmaceuticals was performed by 
Farber et al. to study the morphology and porosity of granules (Farber et al., 2003). It 
was found to be less effective than mercury porosimetry for determining pore size, due 
to limited spatial resolution. X-ray microtomography still supplied valuable information 
concerning the morphology of the pores, and their spatial distribution and 
interconnectivity (Appoloni et al., 2002). Sinka et al. were able to extract precise 
measurements of localised density variations within a tablet matrix (Sinka et al., 2004). 
Busignies et al. studied the density distribution in compacted cylindrical tablets to find 
that density throughout the tablets was highly non-uniform (Busignies et al., 2006) as 
shown in Figure 3-2.  
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Figure 3-2. Images of tablets obtained from 2D reconstructed images showing uneven 
density throughout (Busignies et al., 2006). 
 
Figure 3-2 shows that the density is not uniform throughout the tablet. It was found that 
the tablet was denser at the edges than in the centre. This was attributed to friction at the 
wall during compaction of the tablet. X-ray tomography has also been used to study 
density distribution within structured tablets. Ozeki et al. used it to study the density 
distribution within dry coated tablets to determine the density of the core section (Ozeki 
et al., 2003). Yang and Fu studied the compaction and mixing of MCC particles, in 
order to deliver sufficient contrast in the images it was necessary to impregnate the 
particles of one of the materials with a high X-ray attenuation coefficient substance 
(lead acetate) (Yang and Fu, 2004). If there is a significant difference in density 
between the surrounding matrix and particles distributed within it, then X-ray 
microtomography can be used to distinguish the particles. This has been shown for 
citric acid particles (Hancock and Mullarney, 2005). X-ray microtomography has been 
used to study tablet dissolution by Karakosta et al. and clearly showed changes to the 
void structure within the tablet (Karakosta et al., 2006). However, the contrast of 
images between the polymer and the ingressing water was low and image acquisition 
required around 40 minutes. 
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Figure 3-3. Schematic diagram of X-ray tomography. 
 
A schematic representation of X-ray microtomography is shown in Figure 3-3. The X-
rays are emitted from the source and pass through the sample on the way to the detector 
which measures the intensity of the transmitted beam, creating a two dimensional 
shadow image. The greater the mass density of the material and the path length of the 
X-rays in the material, the greater the absorbance of X-rays will be (Sasov and Van, 
1998). The sample is then rotated in front of the source and two dimensional images are 
acquired from multiple angles. A Fourier analysis technique based on the Radon 
transform is used to compare the images from each rotational step and from this a three 
dimensional density map can be constructed (Hancock and Mullarney, 2005).  
 
 
Figure 3-4. Image showing good spatial resolution of 180-300 µm spheres using Skyscan 
1072 (Fu et al., 2006). 
 
As shown in Figure 3-4 the spatial resolution of X-ray microtomography can be very 
good, up to around 4 µm (Zeitler and Gladden, 2009). However, on smaller portable 
machines the spatial resolution is often much lower, around 50 - 80 µm (Kohout et al., 
2006).  
X-ray source Tablet Detector
X-ray 
source Ta let Detector
Rotating 
platform
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3.4 Imaging of tablet dissolution  
Imaging of tablet dissolution can help to improve the understanding of the physical and 
chemical mechanisms involved in tablet dissolution, and multiple approaches have been 
used to investigate these processes. Imaging methodologies are advantageous because 
they provide supplementary information about the tablet dissolution that would 
otherwise be unseen in the industry standard USP dissolution tests. In this section MRI 
and visible optical imaging will be discussed, although, numerous other approaches 
have been applied such as confocal laser scanning microscopy (Cutts et al., 1996) and 
cryo-SEM (Melia et al., 1993) but are outside scope of this review.  
 
Magnetic resonance imaging (MRI) is a three dimensional imaging approach and 
consequently has several advantages. A sample can be completely immersed in 
dissolution medium while a slice image through the sample is taken, whereas many 
other approaches require constraining of the sample in two dimensions. However, the 
chemical sensitivity of non-spectroscopic MRI is low. Quantification of drugs and their 
release from formulations is only possible through use of a marker such as fluorine 
(Fyfe and Blazek-Welsh, 2000). MRI images of pharmaceutical solids are generally not 
conducted directly; instead, the signal of the water interacting with a dissolving polymer 
is measured (Zeitler and Gladden, 2009), for example investigating the formation of the 
gel layer of a dissolving HPMC tablet (Rajabi-Siahboomi et al., 1994). MRI does have 
the advantage that it can be used in conjunction with the existing USP IV apparatus 
without major modification (Fyfe et al., 2000). 
 
Optical photography has been applied to study the dissolution of polymer based tablets. 
This is done through the addition of coloured drugs to the dissolving matrix; however, 
quantification of component concentration from the data gathered via this approach is 
not possible. Several groups have used this approach to determine the formation of 
fronts during dissolution. Colombo and co-workers, using buflomedil 
pyridoxalphosphate as a coloured drug defined three boundaries: 1) The glass transition 
boundary, where the gel matrix begins. 2) Drug diffusion boundary, the point at which 
the drug starts dissolving and diffusing. 3) The erosion boundary where the matrix 
completely breaks down due to erosion or dissolution (Bettini et al., 2001). Gao and 
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Meury defined somewhat different boundaries. 1) True penetration front, little or no 
swelling has occurred, but water has ingressed through pores. 2) Phase transition front, 
the glassy material becomes a transparent gel matrix. 3) Dissolution front, matrix has 
completely disappeared through erosion or dissolution (Gao and Meury, 1996). Visible 
optical imaging was used in conjunction with FTIR imaging by Kazarian  and van der 
Weerd (Kazarian and van der Weerd, 2008) (discussed further in Section 4.6.3), which 
confirmed the work by Gao and Meury. It is important to note that these optical imaging 
approaches display sharp fronts more clearly than FTIR imaging.  The fronts seen using 
these approaches are sharp, unlike the smooth gradients predicted by Fick’s law, or 
shown by FTIR imaging. This is indicative of the fact that they do not display 
quantitative data, rather they identify effects that occur at certain concentrations, such as 
changes in refractive index which reduces the scattering of light from the material 
(Kazarian and van der Weerd, 2008). This approach has also been applied to study the 
dissolution of structured tablets as shown in Figure 3-5 (Conte et al., 1993). 
 
 
Figure 3-5. Photographic image of cross-section of press coated tablet following four hours 
of dissolution (Conte et al., 1993). 
 
As shown in Figure 3-5, in order to obtain information concerning the internal processes 
of the tablet during dissolution it was necessary to remove the tablet from the 
dissolution medium in order to cross-section it. These images also provide little in the 
way of chemical information and the contrast between sections was poor. In order to 
improve contrast it was necessary to add coloured compound to sections of the matrix, 
as shown in Figure 3-6. 
 
Figure 3-6. Photographs taken in situ of dissolving multilayer tablets (Conte et al., 1993). 
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Melia and co-workers used a fluorescent dye (Congo Red) to study the early stages of 
gel formation in HPMC (Bajwa et al., 2006). The fluorescence of the dye selectively 
increased when bound to β-D-glucopyranosyl sequences. This allowed imaging of the 
structural changes of the hydrating polymer as the gel layer formed. It was found that 
upon contact with the dissolution medium, the medium was drawn into pores in the 
surface of the tablet. The morphology of the particles of HPMC then changed as they 
swelled in a columnar fashion, forming the gel layer. 
 
3.5 NIR spectroscopy 
As described in Section 4.1 the near-infrared (NIR) region of the electromagnetic 
spectrum lies between the visible region and the mid-infrared (MIR) region. Near-
infrared spectroscopy (NIRS) has gained significant popularity, especially within the 
pharmaceutical industry (McClure, 1994). This is because NIRS has several advantages 
over some other analytical techniques, it requires little or no sample preparation, remote 
measurements can be made using fibre optics, while chemical and physical properties of 
the sample can be predicted from one spectrum and it is relatively inexpensive (Reich, 
2005, Herkert et al., 2001, Roggo et al., 2007).  
 
MIR spectra usually contain well defined peaks that can be directly analysed using 
univariate analysis methods. However, NIR spectra often require multivariate 
processing using chemometric methodologies (Gendrin et al., 2008). This is due to the 
fact that the absorption bands of MIR and NIR spectroscopy have slightly different 
origins. The absorbance in MIR is a result of excitation of the fundamental vibrations 
within molecules. In NIR the bands are caused by combinations and overtones of –CH, 
–NH, –OH and –SH fundamental vibrations (Reich, 2005). Despite making the 
chemical information in NIRS slightly harder to elucidate, this does have certain 
advantages in sampling. As with MIR several sampling methodologies can be used, the 
most commonly used methods in NIR are transmission and diffuse reflectance. Due to 
the weaker absorbance of these overtones and combination bands, samples analysed 
using NIRS usually require little or no sample preparation (such as dilution), and 
samples can also be analysed through glass as it contains no X–H bonds. The detectors 
used do not require cooling, which make NIRS ideal for in-line analysis of industrial 
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pharmaceutical processes. As with MIR spectroscopy NIRS can be coupled with an 
FPA detector to provide chemical imaging capabilities (Koehler et al., 2002, Lewis et 
al., 2001). 
 
3.5.1 Multivariate analysis 
Univariate analysis uses one spectral band to produce chemical images and it is a simple 
and direct method for producing images. In systems with a large degree of overlap of 
the spectral bands, this method of analysis is not always possible and image artefacts 
can be induced (Chan et al., 2005). Rather than using a single band, multivariate 
analysis employs information from a range of spectral data. This allows the spectral 
properties and spectral distribution of components to be analysed. 
 
Principal component analysis (PCA) and partial least squares (PLS) are the two most 
commonly used algorithms (Gendrin et al., 2008). The aim of using PCA is to reduce 
the dimensionality of the data matrix. This is done by removing correlation between 
variables. The data produced in chemical imaging can be thought of as a three 
dimensional matrix, D, containing spatial data on two axes and spectral data on the third 
axis, na × mb × λc, where na and mb are the number of pixels in the x and y axes and λc 
represents the spectral data points. The data are then unfolded to form a two 
dimensional matrix X, such that X = i × λc, where i = na × mb. The data are then 
projected onto a new component subspace and the principal components known as 
loadings are calculated. The principal components are chosen such that the first explains 
as much of the data as possible, while the second explains as much of the remainder as 
possible while remaining orthogonal to the first. The data projections onto the principal 
components are known as scores. The first principal components normally describe the 
most important information, whereas the later components mostly describe noise. By 
rejecting these noisier components, the dimensionality is reduced. The data are then 
folded back into the same spatial arrangement as in matrix D, such that the loadings are 
in the correct spatial arrangement. While PCA is very useful for identifying 
components' differences from subtle spectral changes, it does not provide chemical 
information as the data produced are not spectra and the PCA loading will also describe 
negative values. 
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Factor Analysis (FA) is a similar approach to PCA, however, while PCA produces 
loading vectors, FA attempts to generate single component absorption spectra. 
Therefore, PCA is used to reduce the data into a smaller number of components and FA 
is used to determine what the components are which underpin the data. PLS is a 
different approach in which the aim is to establish a linear relationship between the 
spectral data of matrix X and a matrix Y containing reference data. This is done via a 
calibration step, using data for which the values of X and Y are well known. The data 
must then be validated using known values. The model can then be used for prediction, 
such as revealing the concentration of a component in each pixel of an image. 
 
Having processed the data the final step is to extract useful information from the 
distribution map displayed. This can be as simple as applying a rainbow colour scale 
showing the distribution of a component in which red is high and blue is low 
concentration, or showing how similar to one of the generated factors the data in a pixel 
may be. RGB colour analysis can be used in which one colour is assigned to each 
component to show their distributions simultaneously. Image binarization aims to 
clearly separate the component of interest from the rest of the material in a sample to 
produce an image showing where a component is and is not present within a two colour 
image. This methodology does lose any dynamic information as the data are presented 
in a purely binary fashion. This requires thresholding of the data, which often requires 
the user to determine where the threshold will be set (Hilden et al., 2008). 
 
3.5.2 Pharmaceutical applications of NIRS 
NIRS has a large range of applications within the pharmaceutical industry.  Analysis of 
intact solid dosage forms has largely focused on content determination (Chalus et al., 
2005, Trafford et al., 1999), hardness (Morisseau and Rhodes, 1997), coating thickness 
(Moes et al., 2008) and prediction of dissolution rates (Freitas et al., 2005). Component 
identification may even be performed through blister packs by using NIR in 
transmission as shown by Maesschalk and Van den Kerkhof when they used NIRS in 
conjunction with a PLS based chemometric method to verify whether tablets were 
placebos or not for clinical trial tablets (De Maesschalck and Van den Kerkhof, 2005). 
Polymorphism is more commonly studied using MIR and Raman spectroscopy, 
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although, NIRS has been shown to be applicable to study these phenomena as well, for 
example Blanco et al. studied the polymorphisms of miokamycin (Blanco et al., 2000). 
NIRS can be used for particle sizing of powders (Frake et al., 1998), whilst 
simultaneously providing chemical information. When NIR light scatters from diffusely 
reflecting materials, this can result in a non-uniform or offset baseline. One of the 
variables upon which these scattering effects are dependent is particle size. It has been 
seen that there is an inverse relationship between reflectance and mean particle size 
(O'Neil et al., 1998). Moffat and coworkers compared the results of Forward Angle 
Laser Light Scattering (FALLS) with NIRS and found that using relatively simple 
chemometrics it was possible to accurately measure the median particle size using 
NIRS. Good calibration was also achieved from both sieved and bulk samples (O'Neil et 
al., 1998). 
 
3.5.3 Pharmaceutical applications of NIR imaging 
NIR imaging also has great potential for studying pharmaceutical formulations. In an 
early application Koehler et al. used NIR imaging to show and quantify the distribution 
of API in a tablet using PCA (Koehler et al., 2002). This showed that the API was 
distributed in clumps. Least squares regression using pure component spectra allowed 
them to quantify the amount of drug in the sample (Koehler et al., 2002). This approach 
has applications in many facets of pharmaceutical science (Dubois and Kidder, 2010, 
Gendrin et al., 2008). 
 
An effective application of the imaging capabilities of NIR imaging has been seen in 
particle size analysis in solid dosage forms. Hilden et al. used NIR image analysis to 
determine the size and distribution of tartaric acid particles in a tablet matrix (Hilden et 
al., 2008). A principle component analysis was used for the separation of the tartaric 
acid particles from the surrounding matrix, by choosing the principle component 
spectrum which was most closely related to the difference between the tartaric acid 
spectrum and the excipient spectrum. Particles were then identified using contour 
delineation, a threshold was applied to create a binary image. It was found for this 
process that choice of a threshold level was non-trivial. When two particles lay in close 
proximity distinguishing between particles became difficult, and the results were very 
sensitive to the chosen threshold level as shown in Figure 3-7. A fine and coarse 
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threshold were chosen. When the contour level was set to fine, closely spaced large 
particles were well differentiated. Small particle fragments, which may have previously 
been part of the larger particle, which had fractured off and detached under compaction, 
were counted as individual particles. It also appeared that as a result of this thresholding 
some “real” particles were lost from the fine threshold level. When a coarse contour 
level was used large nearby particles were not well differentiated. 
 
Figure 3-7. Images showing particle distribution of tartaric acid using a fine contour level 
(left image) and coarse contour level (right image) (Hilden et al., 2008). 
 
The particles in powder batches were sized using laser light scattering which produces 
particle sizes as mean equivalent diameters. The mean equivalent diameter 
approximates the diameter of the particles to that of a circle which occupies the same 
area. This is a fast and simple measurement of the particle size as long as the particles 
are roughly spherical. However, powdered materials often have non-spherical particles. 
The particle sizes in the batches used experimentally are also often determined by 
particle sieving. Sieving could in theory let through a particle with a very wide aspect 
ratio, i.e. a very long, narrow particle, for which the equivalent spherical diameter 
would be very different from the sieve diameter. Sieve diameter is often better 
approximated using other sizing methods, such as Feret’s diameter (Walton, 1948).  
 
FT-NIR mapping has been combined with Raman mapping as a complementary 
technique to study heterogeneous pharmaceutical formulations (Clarke et al., 2001). 
Two samples were studied, one was used to verify the methodology, while the second 
was used to visualise the entire formulation. In the second formulation the drug and the 
inorganic binder were identified using Raman spectroscopy, while the diluent 
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disintegrant and cellulose derivative were identified using NIR spectroscopy. NIR and 
Raman maps were gathered from the same areas of the samples. The sampling aperture 
for NIR was set to 20 µm × 20 µm, while the spot size of the Raman laser was 5 µm. 
Therefore in order that the data could be overlaid, the X and Y direction step size was 
set to 20 µm for both. The data were used to identify tableting problems in the 
formulation, showing that the particle size and distribution of the binder was causing 
problems with tablets sticking to compaction punches. 
 
Overall, NIRS and NIR imaging have been shown to be powerful vibrational 
spectroscopic techniques for the study of pharmaceuticals. Chapter 4 continues the 
discussion of spectroscopic approaches introducing and discussing FTIR spectroscopy 
and imaging. 
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4 Mid-Infrared Spectroscopy  
 
Infrared spectroscopy has long been a useful analytical tool for studying pharmaceutical 
formulations. It has the potential to reveal much chemical information for both static 
samples and dynamic systems such as tablet dissolution. It provides complementary 
data to that obtained by conventional methods, such as the industry standard USP 
dissolution tests. These only produce a global dissolution profile, but do not provide any 
information concerning the internal processes within the sample. Therefore, a 
significant number of applications of FTIR spectroscopy have been developed to study 
such processes (Wartewig and Neubert, 2005).  
 
4.1 Introduction to infrared spectroscopy 
Infrared spectroscopy is the study of how radiation in the infrared region of the 
electromagnetic spectrum interacts with matter. It is a form of absorption spectroscopy 
and looks at the difference in the intensity of the light across a frequency range in the 
infrared region before and after interaction with the sample. 
 
The range of wavelengths defined as the infrared region lies between 800 and 3x10
5
 nm 
as shown in Figure 4-1. The unit of wavenumbers is commonly used in spectroscopy; it 
has the units of reciprocal distance (commonly cm
-1
). It is the inverse of the wavelength, 





The infrared region is split into three major regions, near-infrared, so called because it 
lies close to the visible region of the electromagnetic spectrum and is found between 
12000-4000 cm
-1
, then mid-infrared, which is found between 4000-400 cm
-1
, and far-
infrared which is found between 400-20 cm
-1
. The far-infrared region is in the low 
energy region and is used for studying rotational spectroscopy; the near-infrared is in 
the higher energy region and is used for studying molecular overtone and combination 
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Figure 4-1. Schematic diagram of the electromagnetic spectrum.  
 
The covalent bonds in molecules vibrate at characteristic frequencies. Absorbance of 
infrared light takes place when the frequency of the infrared light is the same as the 
natural frequency of vibration of the atoms in the molecule.  The different vibrations are 
referred to as vibrational modes. In a molecule with N atoms, the number of vibrational 
modes (vibrational degrees of freedom) for a linear molecule is given by 3N – 5 and for 
a non-linear molecule by 3N – 6. 
 
The vibrations for carbon dioxide are shown in Figure 4-2. These are all the possible 
vibrations of the carbon dioxide molecule. The two bending modes are the same but 
occur in different planes, therefore these vibrations are degenerate and absorb infrared 
light at the same frequency. 
 
Figure 4-2. Vibrational modes of carbon dioxide (Atkins and de Paula, 2002) 
 
Not all of these modes are infrared active, meaning infrared light will not excite every 
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mode to be infrared active the motion must be accompanied by a change in the dipole 
moment of the molecule. Therefore, the symmetric stretch is not infrared active.  
 
The frequency of vibration depends upon the force constant of the molecular bonds, the 
mass of the atom(s) attached and the type of the vibrational mode. Therefore, when a 
functional group is attached to a molecule, that group can be identified as it will absorb 
infrared light at a characteristic frequency. Many of these vibrations lie within the mid-
infrared region of the spectrum, which allows many compounds to be identified, making 
this region of the electromagnetic spectrum a powerful characterisation tool. 
 
4.1.1 Fourier Transform Infrared (FTIR) spectroscopy 
Before the advent of powerful desktop computers, a less computationally intensive 
method was required for acquiring spectra. This took the form of a dispersive grating 
spectrometer. These spectrometers used diffraction gratings to disperse the infrared light 
into a range of wavelengths and the detector measured the brightness of the radiation at 
each wavelength. Therefore, only a small portion of the beam was measured by the 
detector at any one time, this resulted in poor signal to noise or long acquisition times. 
 
Modern spectrometers no longer use this principle; instead they are Fourier Transform 
(FT) systems. The key component of any FT system is the interferometer, as shown in 
Figure 4-3, was first introduced by Albert Michelson in 1880. It was not employed in 
spectroscopy until much later, as the calculations required are computationally 
intensive. It was not until 1965 when Cooley and Tukey developed the Fast Fourier 
Transform algorithm that FTIR systems became commercially viable (Cooley and 
Tukey, 1965).  
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Figure 4-3. Schematic diagram of a Michelson interferometer.  
 
Infrared radiation is emitted from the source and travels towards the beamsplitter. At the 
beamsplitter, the beam is split in two, half proceeds to the fixed mirror, while half 
proceeds to the moving mirror. As the mirror moves a varying path distance is 
introduced to half of the beam, such that when the split beams recombine at the 
beamsplitter there is a phase difference between them. Therefore, the beams interfere 
with each other in an either constructive or destructive manner depending on the phase 
difference that has been introduced. The difference in phase is a function of the 
difference in optical path length. The results for a polychromatic and monochromatic 
source are shown in Figure 4-4. These are plotted as interferograms, which show the 
intensity of the signal at the detector with change in optical path. Figure 4-4 (b) shows a 
peak in intensity when the optical path difference is zero and fully constructive 
interference of the beams is seen, this is the centreburst. 
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The interferogram is a plot of beam intensity measured by the detector against path 
difference. Therefore, it is necessary to use the Fourier transform to convert this into a 
plot of infrared intensity against wavenumber as illustrated in Figure 4-5. In order to 
eliminate any instrumental or environmental influences on the spectral data gathered, a 
background scan must be gathered in an empty system which is then ratioed against 
data from the system gathered with the sample in place using Equation 4-1. This 
produces a result in terms of percentage transmittance (%T), and is a ratio of the 
intensity of the system with a sample in the beam (I) to the intensity of the system 
measured without a sample in the beam (I0). 
 
 






This transmittance can also be converted to absorbance (A), Equation 4-2 this is 
necessary for quantitative analysis. 
 
       
  





Figure 4-5. Conversion of interferogram into single beam spectrum using the Fourier 
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4.1.1.1 Advantages of FTIR spectroscopy 
One of the most important aspects of the performance of any spectrometer is its signal 
to noise ratio. Any spectrum will contain random points of noise. The signal to noise 
ratio, is the ratio of the magnitude of those noise peaks to real peak data.   
 
The dispersive systems reject a large amount of the light, whereas in an FTIR system all 
the light hits the detector at once so the detector sees the maximum amount of light 
throughout the whole scan. This is known as the throughput or Jacquinot advantage. 
The second advantage is due to the fact that all wavenumbers are detected at once, 
therefore if a system is set to scan for 10 minutes then an FTIR system will obtain data 
at all points for the whole 10 minutes, whereas in the dispersive system only a small 
amount of that time is spent observing the response at each wavenumber. Increased scan 
time will improve the signal to noise ratio, the relationship between number of scans 
and signal to noise ratio (SNR) is given by Equation 4-3.  
 
                      
 
 ⁄  Equation 4-3 
 
As the FTIR system can acquire more scans in a given period amount of time then it can 
achieve a significantly better signal to noise ratio. This is known as the multiplex or 
Fellgett advantage (Smith, 1996). 
 
4.1.2 Quantitative analysis 
FTIR spectroscopy is a well established technique for the acquisition of quantitative 
data (Wurster et al., 1993, Farinas et al., 1994). The transmitted intensity of infrared 
light through a sample is found to be dependent on: the concentration of the species, the 
path length of the radiation through the sample and the molar absorptivity of the sample. 
This is described in Equation 4-4 by the Beer-Lambert law, where ε is the molar 
absorptivity, l is the path length. 
       
     Equation 4-4 
 
       Equation 4-5 
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Based on Equation 4-2, the Beer-Lambert law becomes Equation 4-5. Assuming a 
constant path length, the absorbance (A) is proportional to the molar concentration (c) of 
the component. Therefore, if the molar absorptivity is known, or using samples of 
known concentrations to produce a calibration curve, it is possible to calculate the 
concentration of a component in a sample. 
 
4.1.3 Sampling methods 
Several different infrared sampling methodologies are commonly used; these are 
transmission, diffuse reflectance and attenuated total reflection. Diffuse reflectance 
based infrared spectroscopy uses diffusely scattered infrared light, and is often used 
when a sample scatters strongly but absorbs only weakly. It is often used for studying 
solid particulate samples as little preparation is required, however, solid samples require 
grinding and diluting with materials such as KBr which are non-absorbing. As the 
signal collected using this sampling approach is usually very low, long acquisition times 
are needed to produce an acceptable SNR. To compare the data between two samples 
reliably the particles in the sample need to be of similar size distribution. 
 
Transmission mode is the most well known form of infrared spectroscopy. A beam of 
infrared light passes through a sample as shown in Figure 4-6. Examination of the 
resulting radiation can determine which frequencies of infrared light have been 
absorbed. The advantages of this methodology are that the SNR is good and the 
accessories necessary are relatively cheap. It is also the most straightforward approach 
for quantitative analysis, as the path length of the beam in the sample is the same as the 
effective path length used in quantitative analysis (see Section 4.2.8). A disadvantage of 
this approach is that the sample must be thin enough to allow the radiation to pass 
through, but it must also be thick enough such that a reasonable amount of absorbance 
occurs. This can often require very careful sample preparation. A suitable thickness is 
usually between 5 and 20 μm for studies in the mid-infrared region. The form of the 
chosen sample is also an important factor, fluids are simple to prepare as cells with 
fixed path lengths can be used, whereas, working with solid samples is often non-trivial. 
Powders cause random reflections of the light as it passes through the sample, thus the 
beam can become too scattered or they will be too opaque for sufficient signal 
transmission. Solid samples will often require mixing with other non-absorbing 
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materials such as KBr to a concentration of around 0.2-0.5 wt% of the sample. The KBr 
and the sample are ground together and pressed into a disc.  
 
 
 Figure 4-6. Schematic diagram of transmission sampling. 
  
Attenuated Total Reflection (ATR) is a significantly more versatile sampling 
methodology which is described in detail by Harrick (Harrick, 1967). This technique 
relies on the principle of total internal reflection. A material with a high refractive index 
such as diamond which has a refractive index of 2.4 or zinc selenide, which has a 
similar value of refractive index, is often used in the form of an inverted prism. The 
sample is placed on the top surface of the crystal; the infrared radiation enters the 
crystal and approaches the top surface of the crystal at an angle greater than the critical 
angle. Although total internal reflection occurs at the interface between the crystal and 
the sample, the radiation does penetrate a few micrometers into the sample, in the form 
of an evanescent wave, where absorption of by sample attenuates the beam. This is 
illustrated in Figure 4-7. 
 
 
Figure 4-7. Diagram illustrating refraction below the critical angle and internal reflection 
above the critical angle, where n1 and n2 are the refractive indices of media 1 and 2, n1 > n2 








n1 – refractive index 
medium 1
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Figure 4-8. Exponential decay of evanescent field into the medium with lower refractive 
index. dp is the depth at which the field amplitude has decayed to 1/e of its initial value at 
the interface. 
 
The penetration depth of the evanescent wave into the next medium dp, which is defined 
as the distance in which the amplitude of the electric field falls to 1/e of its initial value 
at the surface, can be calculated using Equation 4-6, where θ is the angle of incidence, λ 
is the wavelength of light and n1 and n2 are the refractive indices of media 1 and 2. 
 
 
   
 





Equation 4-6  
       
The depth of penetration in Equation 4-6 is dependent on several factors listed above.  
Longer wavelengths have greater depth of penetration, the consequences of this will be 
discussed further in Chapter 7. The expected depth of penetration using common 
polymeric materials with refractive indices of around 1.5, is usually in the range 1 to 5 
μm when working in mid-IR (Gupper et al., 2002). 
 
To measure a sample in ATR mode, it must be placed on the surface of the crystal, 
therefore sample preparation can be very simple. The sample must be pressed onto the 
crystal with sufficient force to ensure comprehensive contact between the two media 
because of the shallow penetration depth of the evanescent wave. The crystal must be 
transparent to infrared radiation and have a high refractive index. Zinc selenide crystals 
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relatively cheaply. Diamond is another option however; it is expensive and absorbs 
certain frequencies of infrared radiation, especially at high temperatures. The main 
advantages of diamond are that it is able to endure high pressures, its chemical 
resistance and it is exceptionally hard making it scratch resistant. 
  
A general perception about ATR spectroscopy is that a high level of force is required to 
achieve a good contact between sample and ATR crystal, which is often not the case. 
Adequate contact can be achieved with liquid samples simply by covering the top of the 
crystal with the sample, although, when working with polymeric materials, some 
compaction force is required to achieve sufficient contact. The required force can be 
minimised as flat surfaces help facilitate the contact, while malleable samples require 
minimum force in compaction. When working with some pharmaceutical polymeric 
materials in dissolution experiments, the formation of a gel upon contact of the 
polymeric sample with water greatly improves the contact of the polymer (van der 
Weerd and Kazarian, 2004b). Although the compaction force used for compacting 
tablets of the ATR crystal is significantly lower than in industrial tablet presses, the 
image data obtained using these in situ compaction methods show good contact for 
pharmaceutical formulations. This demonstrates that the force used to compact tablets in 
situ is sufficient to achieve good contact. Nevertheless, while compaction with a 
diamond as an ATR crystal is not an issue, it can be harder to achieve a satisfactory 
compaction on some other crystals, such as zinc selenide, without incurring damage to 
the crystal. 
 
4.2 FTIR spectroscopic imaging 
Conventional FTIR spectrometers are single detector devices. One spectrum is obtained 
which averages information from the total measured volume of the sample, no spatial 
information is acquired. Previously, image production was only possible using mapping 
techniques, which involved gathering spectral data in a grid pattern from localised areas 
of the sample to build up a spatially resolved map of the system. This was advanced 
with the introduction of linear array detectors which gather a line of data at a time, and 
move across the sample. Focal Plane Array (FPA) detectors use a grid array of detectors 
which collect spatially resolved spectral information from all regions of the sample 
simultaneously. When acquiring the image, each detector gathers a full spectrum with 
 Chapter 4: Mid-Infrared Spectroscopy 
 
- 81 - 
 
every scan, and therefore every point is measured at the same time. The FPA detector 
can be used in conjunction with a standard interferometer and source. As a 64 × 64 
system records 4096 spectra with each scan, a large amount of data are produced. In 
early systems, to reduce the computationally intensive nature of this process, step scan 
mode was implemented, where the moving mirror changed position in discrete steps. 
This allowed the computer time to process the data. With modern, more powerful 
systems and better detectors, continuous scan mode is used, in which the mirror moves 
smoothly and continuously. This gathers data much more rapidly. 
 
Today FPA detectors are available in a number of sizes. The most commonly used sizes 
range from 32 × 32 up to 256 × 256 pixels. In this thesis two detectors are used, both 
with 64 × 64 pixel arrays. The earlier model used a detector with a pixel size of 60 µm × 
60 µm, producing an unmagnified image size of 4 mm × 4 mm, though these had 
relatively slow response times. The newer versions of the detectors have a pixel size of 
approximately 40 µm × 40 µm producing an unmagnified image size of 2.6 mm × 2.6 
mm. 
 
4.2.1 Introduction to spectroscopic imaging 
The subject chosen for this description of the imaging process is a model 
pharmaceutical tablet consisting of caffeine and hydroxypropyl methylcellulose 
(HPMC), a cellulose based polymer. A schematic diagram of the imaging process is 
presented in Figure 4-9. 
 
Figure 4-9. Schematic diagram showing the collection of spectra using an FPA detector to 
produce images showing the distribution of two different components in the sample. 
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Each pixel in the grid collects a full infrared spectrum, with a spectral range of 4000 to 
900 cm
-1
. The concentration of a component is proportional to its absorbance as stated 
by the Beer Lambert law. The absorbance of a particular spectral band can be calculated 
by integrating the area under a spectral band. By plotting the absorbance values of a 
component spatially it is possible to generate a relative concentration map. A band must 
be found for each material which is well-separated from the bands of other materials for 
univariate image analysis. For this reason the band highlighted between 2750 and 3000 
cm
-1
 was chosen for HPMC and the band between 1670 and 1730 cm
-1
 was chosen for 
caffeine in Figure 4-9. By plotting the values of intergrated absorbance in a grid 
matching that of the detector array (taking into account the aspect ratio of the images 
obtained with macro ATR using an inverted prism) concentration maps of HPMC and 
caffeine within the tablet can be constructed as shown in Figure 4-9. 
 
The two images generated in Figure 4-9 represent the same spatial region. One plots the 
distribution of the absorbance of the corresponding band of caffeine, the other plots the 
distribution of the absorbance of HPMC and hence they show their corresponding 
distribution within the imaged area of the sample.  Red and pink domains correspond to 
regions of high concentration, whereas blue domains correspond to regions of low 
concentration. It can be seen that these images are complementary, i.e. where there is a 
high concentration region of caffeine there is a relatively lower concentration region of 
HPMC. There are some regions where low concentration in registered for both, this is 
most likely a void within the tablet structure, or an impurity.  
 
4.2.2 Transmission FTIR imaging 
Spectroscopic imaging can be performed in both transmission and ATR modes, 
however, as explained in Section 4.1.3, transmission requires significantly more sample 
preparation. 
 
As transmission measurements apply through the whole the sample, in imaging mode 
only an average through the thickness of the sample is seen (Kazarian and Chan, 2006). 
This can have some significant effects when studying heterogeneous samples. A large 
particle seen in an image may in fact not be a large particle, but instead consist of two 
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separate particles at different depths that slightly overlap in the path of the beam as 
shown in Figure 4-10. Therefore the sample thickness should be less than the domain 




Figure 4-10. Schematic diagram showing the effect of “averaging” through the sample 
when imaging in transmission. (a) Front view of sample showing overlapping particles, (b) 
sample at an angle showing separate particles, (c) side view of sample. (d) and (e) 
transmission images of (a) and (c) respectively. 
 
 
4.2.3 ATR-FTIR imaging 
ATR imaging with visible light can be demonstrated by pressing a finger against a glass 
of water, the parts of the finger print in contact with the glass can be seen, the remainder 
of the light, in the areas of the valleys in the fingerprint, undergoes total internal 
reflection. At the points where there is contact between the skin and the glass this total 
internal reflection is destroyed and thus the finger print is visible. This effect was 
demonstrated by Harrick, through the use of a prism (Harrick, 1967). The finger was 
pressed against the surface of the prism and the light focused onto a photo film, 
producing an image of the fingerprint. In the ATR-FTIR imaging approach used in this 
thesis, rather than focusing visible light onto a photo film, infrared light will be focused 
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Figure 4-11. Effect of probing depth in ATR imaging on imaged particle size. 
 
ATR imaging is a surface technique and usually does not suffer from the “averaging” 
issue seen in transmission; however, there are some considerations that must be made as 
the spectroscopic data obtained are sampled from the surface layer of the sample. The 
probing depth is around several micrometers, however, the individual particles in most 
powder based pharmaceutical formulations are much larger than this. Therefore, a 
relatively small fraction of total volume is imaged and only “the tip of the iceberg” may 
be seen. This effect is demonstrated in Figure 4-11 where, although the particles all 
have the same maximum diameter, there are some much smaller domains visible. These 
smaller visible domains are actually a small fraction of a much larger particle, of which, 
a large part lies outside the ATR field of view. Nevertheless, both transmission and 
ATR mode have uses and an appropriate choice must be made based on the analytical 
requirements as they differ on many aspects such as spatial resolution, field of view and 
the possibility of leaving artefacts (Chan et al., 2003, Sommer et al., 2001).  
 
4.2.4 Spatial resolution 
The spatial resolution of an ATR system is limited by the wavelength of the radiation 
being used, the pixel size of the detector and the numerical aperture of the objective 
being used. The resolution is determined by diffraction, when light enters a slit, 
diffraction occurs; the diffraction pattern is shown in Figure 4-12. This is described by 
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          Equation 4-8 
 
Where r is the distance between two adjacent point that are just resolved, λ is the 
wavelength of the radiation, NA is the numerical aperture of the system, defined in 
Equation 4-8, with n being the refractive index of the imaging medium between the 
objective and the sample and θ being half the angular aperture. 
 
 
Figure 4-12. Schematic diagram of the diffraction pattern of light. 
 
In order to resolve two points completely from each other, the separation required is a 
minimum of 2r. In practice this cannot be achieved due to practical imperfections such 
as optical aberrations within the system. A microscope is required to realise the highest 
spatial resolution that can be achieved in infrared, which Chan and Kazarian found to be 
about 4 µm using light of wavelength 6 µm. In the case of a diamond Golden Gate™ 
accessory, 13 μm is the demonstrated spatial resolution (Chan and Kazarian, 2003). 
However, careful alignment of the optical systems is required to achieve the maximum 
spatial resolutions, as due to optical aberrations in the system and throughput issues the 
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4.2.5 Acquisition of ATR-FTIR images 
Before the advent of FPA detectors various mapping techniques were applied in order to 
obtain image data. Many of these involved translation of the crystal under the sample, 
although this could result in smearing of the sample and physical damage, reducing the 
quality of the image data. Separating the sample from the ATR crystal between each 
measurement and moving to the next point greatly increased the time required to 
acquire the mapping data. Various attempts have been made to overcome these issues, 
Esaki et al. developed a V-shaped hexagonal crystal which can be moved with the 
sample in place to gather mapping data without damage to the sample (Esaki et al., 
1993a). This crystal was able to map an area of ca. 2 mm × 7 mm. As this required a 
custom designed crystal it is not as widely available as hemispherical crystals (Esaki et 
al., 1993b). The use of a germanium hemisphere for non-destructive mapping of soft 
materials has been demonstrated by Lewis et al. (Lewis and Sommer, 2000). However, 
this still remained a relatively slow method of acquisition.  
 
Linear array imaging systems make use of a linear array of pixels as opposed to a single 
element detector system or full grid like an FPA (Patterson and Havrilla, 2006). This 
system has some advantages, as the spectral range of the detector is greater, being able 
to go down to 700 cm
-1
, and a flexible imaging size, whereas the image size produced 
by the FPA is usually determined by the size of the FPA detector and the optics being 
used. However, there are disadvantages, as the inability to capture all the data 
simultaneously is a limitation when studying dynamic systems, while the spatial 
resolution and depth of penetration are not consistent across the imaging area. It has 
been shown by Patterson et al. that a combination of using an FPA with a translating 
ATR crystal it is possible to image a larger field of view (Patterson et al., 2007). 
However, there are limitations to this approach in the size of the area measured and the 
spatial resolution of the data. Kazarian and Chan have employed an imaging and 
mapping combination through which a large field of view can be imaged without 
sacrificing spatial resolution (Chan and Kazarian, 2008). However, this approach, as 
with all mapping approaches, is generally limited to the investigation of static or steady 
state systems. 
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4.2.6 Macro ATR-FTIR imaging 
In this thesis the imaging data are predominantly acquired in macro mode using a 
diamond Golden Gate™ ATR-FTIR accessory from Specac, ltd. The internal optics are 
shown schematically in Figure 4-13. Based on the detector used and version of the 
accessory used the image size produced can range from ca. 570 µm × 530 µm to 1140 
µm × 820 µm.   
 
Figure 4-13. Schematic diagram of the internal optics of Golden Gate™ 
 
As can be seen from the diagram in Figure 4-13 the beam of infrared radiation 
undergoes total internal reflection at the interface of the ATR crystal with the sample. 
The angle at which the beam arrives at the interface is ca. 45˚; therefore as opposed to 
being imaged with a circular beam, the sample area is imaged by an elliptical beam. As 
the angle is ca. 45˚ the resulting ratio of the height of the image to the width of the 
image is approximately 1:2
1/2
 as shown in Figure 4-14, this aspect ratio must be taken 
into account when recording and displaying the images.  
 
 
Figure 4-14. (a) Schematic presentation showing the elliptical imaging area resulting in 
image stretching. (b) Resulting change in imaging aspect ratio (Chan and Kazarian, 2003). 
 
A diamond ATR crystal is used for several reasons. When working in ATR 
spectroscopy it is important to have a crystal with a high refractive index, which at 2.4 
for diamond is relatively high.  Diamond is also very hard, which is a very useful 
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between the sample and the crystal (Kazarian et al., 1999, Everall and Bibby, 1997).  
The hardness of the crystal also facilitates the in situ study of materials under high 
pressure (Flichy et al., 2002, Kazarian and Martirosyan, 2002). The diamond ATR 
accessory was not specifically designed for imaging, however, it has been shown to be 
capable of the acquisition of imaging data (Kazarian and Chan, 2004, Chan and 
Kazarian, 2003). As described previously the angle of incidence of the beam led to an 
elongated aspect ratio. The introduction of the Imaging Golden Gate™ (Specac, UK), 
minimised this effect as it was designed specifically for imaging purposes. The imaging 
accessory incorporates a set of corrective optics which consists of a wedge-shaped 
prism, which corrects the orientation of the focal plane and the anamorphic 
magnification of the imaged sample (Poulter and Thomson, 2004).  
 
Attaining the highest spatial resolution is often of significant importance, though this 
will come at the expense of the size of the field of view leading to imaged areas that are 
rather small (e.g. ca. 64 µm × 64 µm when using a microscope). Using a ZnSe crystal 
with no magnifying optics, such as the Oil Analyser from Specac, can produce an image 
size of 2.6 mm × 3.6 mm. This is the same size as the detector with the aspect ratio of 
the beam taken into account. Accessories with optics which allow for a variable angle of 
incidence are also available (Chan and Kazarian, 2007a). For studies in which a larger 
field of view (FOV) is required it is possible to use a large ZnSe imaging prism with 
custom designed expanded optics. The experimental apparatus is analogous to that of a 
standard Golden Gate™, however concave lenses are also inserted which expand the 
beam (Chan and Kazarian, 2006a). The schematic for this system is shown in Figure 
4-15. The area imaged by this accessory is ca. 15.4 mm × 21.5 mm; this enlarged FOV 
facilitates the measurement of multiple samples simultaneously, as the samples can be 
easily deposited directly on the surface of the crystal within the imaged area. This has 
been applied to acquire data from more than a hundred static samples in one image, 
while the dissolution of five samples has been studied simultaneously (Chan and 
Kazarian, 2006a). A disadvantage of imaging with an expanded FOV is a decrease of 
the spatial resolution. As the beam is expanded the projected area for each pixel in the 
detector increases, the beam expansion also leads to a reduction in the numerical 
aperture (NA) of the system. Thus, expanded field of view imaging cannot be used to 
obtain data concerning smaller features of the studied samples and therefore is only 
applied to situations for which an enlarged area of interest is necessary. 
 Chapter 4: Mid-Infrared Spectroscopy 
 
- 89 - 
 
 
Figure 4-15. Schematic diagram of optics for expanded field of view accessory. 
 
4.2.7 Micro FTIR imaging  
Micro FTIR imaging employs an imaging system in conjunction with microscope optics 
to gather spectra from very localised regions (Sommer et al., 2001). This has an 
application in the analysis of heterogeneous samples with small domain sizes, and can 
be performed in both transmission and ATR modes. In practice the achievable spatial 
resolution of microspectroscopic mapping is limited to around 10-15 μm, which can be 
accounted for by the low throughput of the IR beam with small aperture sizes, though 
this can be improved by the use of a synchrotron (Dumas et al., 2004, Carr, 2001, Briki 
et al., 2000, Bantignies et al., 2000). This has allowed the collection of chemical maps 
of hair showing the medulla region (Briki et al., 2000, Dumas and Miller, 2003). 
However, despite the use of a 3 μm aperture, the fingerprint region has a wavelength of 
6-11 μm resulting in spectra that would be “contaminated” by the spectral information 
from the surrounding materials because of diffraction. 
 
As shown by Equation 4-7 the Rayleigh criterion is partially dependent upon the 
numerical aperture of the system. Therefore, by using an ATR crystal which has a much 
higher refractive index than air, it is possible to drastically improve the spatial 
resolution of the system. Chan and Kazarian were able to obtain a resolution of 4 μm 
using infrared light of wavelength 6 μm (Chan and Kazarian, 2003). 
 
The increased spatial resolution has led to improved detection limits when looking for 
trace amounts of materials (Chan and Kazarian, 2006b).  This is particularly useful 
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4.2.8 Quantitative analysis  
With the introduction of the FPA detector quantitative analysis can now be performed in 
imaging mode. This has been demonstrated with pharmaceutical tablets consisting of 
HPMC as the polymer matrix and niacinamide as a model drug (van der Weerd and 
Kazarian, 2004a). Concentration profiles were created using the partial least squares 
method to quantify the components. From these dissolution profiles it was possible to 
obtain a global view of the dissolution and link it to the physical processes occurring in 
the dissolving tablet for determination of the mechanism of dissolution.  
 
FTIR imaging has also been applied to study in situ experiments concerning polymer 
interdiffusion using poly(vinylpyrrolidone) (PVP) and poly(ethylene glycol) (PEG) 
under high pressure CO2 (Fleming et al., 2006). FTIR-ATR imaging is also being 
applied to aid the development quantitative models for drug dissolution as proposed by 
Jia and Williams (Jia and Williams, 2007) and now applied by Kimber et al. (Kimber et 
al., 2011). This is significant, since for real systems and those with complex granule 
structures, it is important to have experimental examples as case studies for validation 
and improving the accuracy of the model. It is also essential to understand what the 
effects of digitization may be in terms of introducing errors into the predicted behaviour 
of a system. Imaging can also be applied to quantitatively study the effects of 
contaminants in formulations (Roggo et al., 2005). 
 
Quantitative analysis is based on the Beer-Lambert law shown in Equation 4-5. In 
transmission, the radiation passes straight through the sample and so the path length is 
merely the thickness of the sample. In ATR mode, due to the fact that the radiation 
interacts with the sample via the evanescence wave, the effective path length (de) is 
used. For non-polarised light this is calculated using Equation 4-9 (Chan and Kazarian, 
2007a), where θ is the angle of incidence, n1 is the refractive index of the crystal and n2 
is the refractive index of the sample. 
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When performing quantitative studies it is important to note that even when analysing a 
homogeneous sample the absorbance may not always be homogeneous throughout the 
whole imaged area of the sample. Depending on the accessory used, the angle of 
incidence may not always be uniform across the imaging surface of the crystal (Wessel 
et al., 2006). This will have the effect of changing the effective path length across the 
imaged area and consequently the absorbance, despite a uniform distribution of the 
sample. Therefore, it is very important to ensure correct optical alignment of the system 
for imaging studies. It should also be noted that the mean angle of incidence is heavily 
dependent upon the alignment of each individual system and so may not match the 
specification of the manufacturer (Flichy et al., 2002). More sophisticated methods such 
as parallel factor analysis (PARAFAC) and multi-linear partial least squares (N-PLS) 
can be used to determine the amount of drug in a formulation as well (Matero et al., 
2007). 
 
4.2.9 Detection limits of ATR-FTIR imaging  
When analysing samples with potentially very low concentrations of a component the 
sensitivity levels of the imaging approaches are very important. A high sensitivity 
means components with very low concentrations may be detected within the sample. 
 
Conventional spectroscopy using a single element detector gathers one spectrum from a 
relatively large area, whereas in imaging, data are gathered from many very localised 
points in the sample. In heterogeneous samples this can lead to a significant increase in 
detection sensitivity, depending on the size of the sampling area, particle size, number 
of pixels in the array detector and the spatial resolution of the image. The sensitivity 
levels of conventional FTIR spectroscopy and FTIR spectroscopic imaging were 
compared for a model tablet made of polymer and drug. In this model system the 
detection limit for the drug was found to be 0.35 wt% for the conventional 
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spectrometer. When using imaging drug material was found in a sample containing 
0.075 wt% of drug (Chan and Kazarian, 2006b).  
 
Ricci et al. used micro ATR-FTIR imaging in combination with desorption electrospray 
ionization linear ion-trap mass spectrometry (DESI MS) to analyse counterfeit 
artesunate anitimalarial tablets (Ricci et al., 2007b). Micro ATR-FTIR imaging located 
and identified the domains of drug while DESI MS facilitated high-sensitivity drug 
detection. 
 
Macro ATR-FTIR imaging was also used in conjunction with spatially offset Raman 
spectroscopy (SORS) (Ricci et al., 2007a).  SORS was able to acquire Raman spectra of 
the tablets within their packaging materials. SORS identified the bulk of the 
constituents of the tablets and macro ATR-FTIR spectroscopic imaging revealed the 
spatial distribution of the drug and other components across the surface of the tablets 
and was able to detect drug concentrations below, the threshold for detection when 
using the SORS technique (Ricci et al., 2007a). 
 
4.3 Applications of FTIR spectroscopy 
FTIR spectroscopy is well suited to the study of polymorphism of drugs. The ability to 
distinguish between polymorphic forms is crucial to the pharmaceutical industry as each 
polymorphic form can be individually patented. Therefore, pharmaceutical companies 
must find all possible the polymorphs of the drugs they have developed otherwise 
competitors can use the same drug in another crystalline form as in the case of Cefdinir 
(Cabri et al., 2007).  
 
The polymorphic state of the drug can have a large effect on the dissolution properties 
of a formulation. The amorphous form of a drug typically exhibits a much higher 
solubility than the crystalline forms. Moreover controlling the crystalline state of the 
API has significant implications in ensuring the safety and efficacy of the formulation. 
 
Infrared spectra are highly sensitive to polymorphic changes in a compound. 
Polymorphic transitions will manifest in several forms of spectral change. Upon a 
transition from an amorphous state to a crystalline structure, the peaks in the spectrum 
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of the compound become sharper and more defined. A more quantifiable difference 
comes in the form of a peak shift, for example amorphous ibuprofen has a carbonyl 
peak at 1730 cm
-1
, whereas the carbonyl peak in the crystalline form shifts to ca. 1710 
cm
-1
, because during crystallization hydrogen bonds will form between the drug 
molecules  (Kazarian and Chan, 2003). 
 
This sensitivity has led to the creation of many assays for classifying the crystallinity of 
a compound (Bugay et al., 1996, Kamat et al., 1988, Sarver et al., 1998, Agatonovic-
Kustrin et al., 1999, Hartauer et al., 1992). For example, sulfamethoxazole has two 
distinct polymorphic forms, and, when studied in diffuse reflectance mode, distinct 
spectra can be identified which correspond to the different forms. However, in using 
diffuse reflectance mode, homogeneous samples must be used for validation and 
calibration, while particle size must remain consistent for all components. 
 
Inhomogeneous calibration and validation samples can give incorrect values for IR 
absorption leading to errors in prediction, while variation in particle size can change the 
diffuse reflecting properties of a sample. However, an accuracy of 4% is readily 
achievable when quantifying the crystallinity of a sample. 
 
When preparing pharmaceutical formulations numerous methods may be used for 
embedding the drug within the polymer bulk. Solvent impregnation has been shown to 
be practical in preparing samples for which a molecularly dispersed and homogeneous 
distribution of the drug within the polymer is required. This can be done via particle 
formation by antisolvent precipitation, aerosolisation and rapid expansion of 
supercritical fluids (Alessi et al., 1996, Benedetti et al., 1997, Yeo et al., 1993). 
Kazarian and Martirosyan (Kazarian and Martirosyan, 2002) have applied ATR-FTIR 
spectroscopy to study the procedure of supercritical fluid drug impregrnation using PVP 
as the polymer and ibuprofen as a model drug. It was shown that this process is capable 
of molecularly dispersing the drug in the polymer matrix (the drug is dissolved in 
polymer matrix at the molecular level). This was revealed by the shift of the carbonyl 
peak of ibuprofen from 1710 cm
-1
 to 1727 cm
-1
 within the PVP, indicating that the 
intermolecular bonds between drug molecules had been broken. This study also 
demonstrated the ability of ATR-FTIR spectroscopy to reveal specific interactions 
between the C=O groups of the PVP and CO2. ATR-FTIR spectroscopy using a 
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diamond crystal is particularly suited to this work as it is much stronger than other 
applicable materials such as zinc selenide, and thus it can endure the high pressures 
required to work with supercritical carbon dioxide (Kazarian et al., 1999). 
 
4.4 General applications of FTIR imaging 
With modern FPA detectors an image can easily be attained in as little as 10 seconds. In 
recent work, through careful optimisation of the imaging parameters, it was possible to 
acquire full FTIR images in a scanning time of 50 ms with a temporal resolution of 120 
ms (Chan et al., 2011). Mapping methods which are not strictly imaging are also 
commonly used. The use of linear array detectors for the chemical mapping of 
polymeric materials (Zhou et al., 2009) and pharmaceutical samples (Pajander et al., 
2008) has recently been demonstrated. Pajander et al. used mapping to study the 
dissolution of starch acetate tablets. As the mapping process required a significant 
amount of time, the samples were freeze dried prior to imaging (Pajander et al., 2008). 
 
Since Mid-FTIR imaging was first introduced in 1995 (Lewis et al., 1995), the 
technique has been applied to study many different systems from all facets of science. 
One of the most popular areas of application has been in the field of polymeric materials 
(Bhargava et al., 1998, Oh and Koenig, 1998), studying samples such as polymeric 
blends (Gupper et al., 2002, Wilhelm et al., 2005) and multilayer films (Chernev et al., 
2008) and their degradation (Nagle et al., 2010) as well as in situ diffusion and 
dissolution (Ribar et al., 2001, Snively and Koenig, 1999, Gupper et al., 2004). 
Recently this approach has found application in biomedical science (Salzer et al., 2000, 
Camacho et al., 2001), investigating samples including the imaging of live cancer cells 
(Kuimova et al., 2009), arteries (Palombo et al., Colley et al., 2004), proteins (Steiner et 
al., 2007) blood cells (Sommer et al., 2001) and stem cells (Randle et al., 2007). The 
approach has also been used to study drug diffusion through skin (Andanson et al., 
2009) and in forensics (Ricci et al., 2007c). The ability of imaging to measure a large 
area simultaneously allows studies of many samples at once in high-throughput analysis 
(Snively et al., 2001, Kubanek et al., 2004, Chan and Kazarian, 2005), and applications 
in microfluidics (Kazarian, 2007) (Chan et al., 2011). 
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While this thesis will investigate the application of ATR imaging to pharmaceuticals, 
transmission imaging has been successfully applied to many materials (Artyushkova et 
al., 2001, Koenig and Bobiak, 2007, Miller-Chou and Koenig, 2003), including the 
study of pharmaceutical formulations (Rafferty and Koenig, 2002, Koenig, 2002). This 
will be further discussed in more detail below. 
 
4.5 Pharmaceutical applications of FTIR imaging 
 
4.5.1 Imaging of compacted pharmaceutical tablets 
ATR-FTIR imaging is a useful tool for studying pharmaceutical tablets, as little or no 
preparation of the sample is required, and much valuable spectroscopic information can 
be extracted from imaging studies of these formulations. The minimal sample 
preparation is a useful property of the ATR methodology. While ATR-FTIR imaging 
allows for the study of many aspects of the tablets, the most important property of 
imaging is being able to assess the spatial distribution of different components within 
the sample (van der Weerd et al., 2004, van der Weerd and Kazarian, 2005, Chan et al., 
2005).  By taking several images of a sample, changes in the distribution can be studied, 
e.g. when undergoing compaction the positions of particles within the tablet rearrange, 
followed by the particles crumbling, the voids within the material then collapse 
resulting in a harder denser material (Duberg and Nystrom, 1985). This process can be 
studied in situ using ATR-FTIR imaging (Wray et al., 2008, Elkhider et al., 2007).  
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A custom designed compaction cell has been developed to work in conjunction with a 
diamond ATR crystal and Golden Gate™ accessory that allows for in situ compaction 
of the  pharmaceutical powders into model tablets (Chan et al., 2005). The operation of 
this cell is shown in Figure 4-16. 
 
The brass cell is bolted into place over the diamond plating; the powder mixture is then 
poured into the hole in the cell, the cylindrical punch is then placed into the hole on top 
of the powder before the armature is lowered. A torque screwdriver is then used to wind 
down a compaction plating from the armature of the Golden Gate
TM
 accessory onto the 
punch compacting the powder. Diamond is employed for this approach because when 
working with compaction only hard ATR crystals can be used. The feasibility of using 
this methodology for imaging tablet compaction has already been shown for model 
tablets consisting of starch and caffeine (Chan et al., 2003).  
 
4.5.2 Micro ATR-FTIR imaging  
Macro imaging, such as that using the Golden Gate™, is useful when a large field of 
view is required. However, sometimes it is necessary to investigate samples on a 
smaller scale in order to resolve details of smaller features. Micro-ATR imaging can be 
used to study compacted pharmaceutical tablets; however, it is not possible to perform 
in situ compaction on these samples so they have to be prepared ex situ. Micro-ATR 
imaging produces an image with a size of approximately 50 x 50 μm2. This has been 
demonstrated by Chan and Kazarian using model formulations consisting of caffeine, 
starch and HPMC as shown in Figure 4-17 (Chan and Kazarian, 2003). 
 
 
Figure 4-17. Micro ATR-FTIR images showing the distribution of caffeine starch and 
HPMC in a model tablet (Chan and Kazarian, 2003). 
Caffeine Starch HPMC
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Figure 4-17 shows that the distributions of starch and HPMC are complementary, 
demonstrating the ability of micro ATR-FTIR imaging to spatially separate different 
chemical domains within a mixture on the micrometer scale. The quality of these 
images also shows that good contact was made between the micro-ATR crystal and the 
sample. The large particle seen in the caffeine image is approximately 10 μm in 
diameter; this would not have been visible using macro ATR imaging, demonstrating 
the effectiveness of being able to image samples on a much smaller scale. The smaller 
caffeine particles in the image only have a diameter of the order of 2-3 μm, despite this 
being very close to the limits of the spatial resolution of the system, they still clearly 
visible. 
 
The manufacture of pharmaceutical solid dosage forms mixes drug compounds which 
are typically hydrophobic into hydrophilic polymer matrices in order to enhance the 
dissolution properties of the API. Therefore, during storage and manufacture these 
formulations may well absorb water from the atmosphere. This sorption of water can 
manifest itself in the form of undesirable effects on the dissolution and therapeutic 
properties of the formulation, hindering the bioavailability of the API. The sorption of 
water into the polymer powder can alter its compaction properties, which can then have 
an effect on the particle morphology within the formed tablet (Yoshinari et al., 2003). 
This has led to interest in studying the uptake of water into pharmaceutical formulations 
(Aso et al., 2002, Crowley and Zografi, 2002, De Brabander et al., 2003). 
 
The application of conventional FTIR spectroscopy can only give an overall value of 
the quantity water absorbed into the sample; however, it is unable to display any 
heterogeneity of water sorption into different domains of the tablet. Previous studies 
have used solely polymer based formulations, whereas Kazarian and Martirosyan have 
shown that the composition of the formulation can affect the availability for water 
sorption (Kazarian and Martirosyan, 2002). FTIR imaging has been applied to study the 
heterogeneous distribution of water in pharmaceutical formulations. A controlled 
humidity cell was combined with FTIR imaging in transmission mode to study water 
sorption into different domains of the sample in situ as shown in Figure 4-18 (Chan and 
Kazarian, 2004b). 
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Figure 4-18. Schematic diagram of controlled humidity in FTIR transmission imaging 
mode (Chan and Kazarian, 2004b). 
 
The tablets used consisted of polyethylene glycol and griseofulvin. The relative 
humidity was varied between 0.5 and 90% and the temperature maintained at 25
°
C. 
Images were produced to show the distribution of griseofulvin, PEG and water 




Figure 4-19. FTIR images of the PEG-griseofulvin mixture exposed to different relative 
humidities. The left (a) middle (b) and right (c) columns show the distribution of 
griseofulvin, PEG, and water, respectively. Adapted from (Chan and Kazarian, 2004b). 
 
The work demonstrated that the water preferentially absorbed into the domains of the 
hydrophilic PEG, rather than the drug. It was also able to reveal that there was a 
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significant increase in the amount of water adsorbed in the formulation above a relative 
humidity of 70%, but no effect was seen on the spatial distribution of the components. 
 
As described previously, humidity can affect the compaction properties of tablets. The 
controlled humidity approach has been applied to study the compaction of 
pharmaceutical formulations in  ATR mode (Elkhider et al., 2007). Tablets consisting of 
ibuprofen and HPMC were exposed to relative humidities between 0 and 80% before 
being compacted into tablets. Results of this work are shown in Figure 4-20. 
 
These data in Figure 4-20 show that at the same compaction pressure the sample 
exposed to the higher humidity shows a greater level of infrared absorbance of the 
corresponding components in the measured spectra. This is due to an increased density 
of the tablet resulting from a greater degree of compaction, showing increasing the 
humidity had a significant lubricating effect upon the formulation. FTIR imaging has 
demonstrated the ability to reveal information about the properties of compacted tablets. 
These data were quantitatively analysed via extraction of the absorbance values of the 
corresponding spectral bands, from which histograms were produced showing the range 




Figure 4-20. a) Image showing FTIR results for compaction of HPMC at 120 MPa and 
60% RH with histogram showing the number of pixels at a particular absorbance level b) 
Image showing FTIR results for compaction of HPMC at 120 MPa and 80% RH with 
histogram showing the number of pixels at a particular absorbance level FTIR Imaging of 
Tablet Dissolution. Adapted from (Elkhider et al., 2007). 
 
The combination of macro ATR-FTIR imaging with a controlled environment accessory 
also allowed analysis of the stratum corneum, which is the uppermost layer of the skin, 
under controlled humidity (Chan and Kazarian, 2007b). The heterogeneous distribution 
of water in the stratum corneum was analysed with the aid of a multivariate approach. It 
(a)    Integralvalues
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has also been shown that ATR-FTIR imaging provides information on the swelling of 
the stratum corneum as a function of humidity. This approach was also used to image 
the penetration of liquid ethanol into the skin (Chan and Kazarian, 2007b) and showed 
good potential for studying the transdermal delivery of drugs (Andanson et al., 2009, 
Boncheva et al., 2008). 
 
4.6 FTIR imaging of dissolution processes 
FTIR imaging has been applied successfully to study many relevant processes, such as: 
pH effects on tablet dissolution (van der Weerd and Kazarian, 2005), polymer behaviour 
under tablet dissolution (van der Weerd and Kazarian, 2004b), effects of the initial 
sample parameters on tablet dissolution (van der Weerd and Kazarian, 2004a, Kazarian 
et al., 2005), and the occurrence of polymorphic transitions (Kazarian and Chan, 2003, 
Chan and Kazarian, 2004a). 
 
4.6.1 Transmission imaging of dissolution 
Koenig and co-workers used FTIR imaging to analyse the dissolution of drug delivery 
formulations in transmission mode (Coutts-Lendon et al., 2003). Formulations 
consisting of testosterone as the API and poly(ethylene oxide) (PEO) as the polymer 
matrix were used. This technique was able to demonstrate the dissolution of the API 
from the hydrophilic matrix as shown in Figure 4-21. 
 
This work was challenging due to the strong infrared absorption of water in the mid-
infrared region. This necessitated the use of deuterated water as well as a very thin 
spacer, thus restricting investigation to very thin samples (ca. 10 m). These samples 
did not fully represent real tablets as with the application of such thin spacer, the tablets 
had a very small thickness.  
 
 Chapter 4: Mid-Infrared Spectroscopy 
 
- 101 - 
 
 
Figure 4-21. FTIR imaging of formulation dissolution in transmission (Coutts-Lendon et 
al., 2003). The arrows point to the polymer and drug dissolution fronts. Time is given 
below each pair of images in minutes:seconds.  
 
4.6.2 ATR imaging of static dissolution 
ATR imaging has the advantages that the path length is independent of the sample 
thickness and that the depth of penetration of the infrared light into the sample is rather 
small. Therefore, the dissolution, in water based media, of thicker tablets which more 
closely approximate real world samples can be studied, as opposed to thin artificially 
prepared samples. 
 
The possibility of using macro ATR-FTIR imaging to examine the dissolution of 
polymer/drug formulations in contact with water was first demonstrated in a study by 
Kazarian and Chan (Kazarian and Chan, 2003). The macro ATR-FTIR imaging 
approach, developed in that work, allowed them to simultaneously study the spatial 
distribution of both polymer and drug in contact with water as a function of time. The 
most important finding in that study was that crystallization of the initially molecularly 
dispersed drug occurred upon contact with the dissolution medium. This was important 
because crystallization slows overall drug dissolution. These phenomena would not be 
detected by the conventional dissolution tests and demonstrated that ATR-FTIR 
imaging can provide important insight into the mechanisms of drug release. The study 
also demonstrated that the ATR-FTIR imaging approach can study the dissolution of 
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inclusion complexes of ibuprofen with cyclodextrins which prevented drug 
crystallization (Kazarian and Chan, 2003). 
 
Another example of ATR-FTIR imaging of dissolution involved formulations of 
nifedipine in PEG (Chan and Kazarian, 2004a). Different amounts of crystalline 
nifedipine were dissolved in molten PEG (MW = 8000) at 70 
°
C to produce samples of 
5, 10 and 20 % drug. The samples were allowed to cool and solidify before being 
powdered. The powder was then transferred to the surface of the ZnSe ATR crystal 
which was heated to 60 
°
C to re-melt the formulation. The sample was then covered 
with a glass slide, using a spacer to create a space in which a sample of uniform 
thickness could form. The sample was then allowed to cool further before the addition 




Figure 4-22. Dissolution of nifedipine and PEG. Top row shows drug dissolution, bottom 
row shows the polymer dissolution (Chan and Kazarian, 2004a). 
 
The results show that there was a change in the morphology of the drug as it 
recrystallized. This occurred within the polymer matrix upon contact with water, but 
FTIR imaging shows that this happened in regions in which the water had not yet 
reached. This suggested that water vapour had ingressed through microchannels in the 
formulation initiating crystallisation; therefore the concentration was below the limit of 
the measurement equipment. This demonstrated a different trigger for crystallization 
compared to ibuprofen which exhibits crystallization on direct contact with the 
500 μm
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dissolution medium (Kazarian and Chan, 2003). The data also showed that an increase 
in the drug loading led to much increased crystallization at the same conditions. This 
work utilised the potential of FTIR imaging to reveal more information about the 
dissolution of pharmaceutical formulations (Chan and Kazarian, 2004a). 
 
4.6.3 Flow-through dissolution studied with FTIR imaging 
In order to study flowing dissolution using ATR imaging a refinement of the simple 
compaction cell was employed. The cell was developed such that the tablet could be 
compacted in situ as shown in Figure 4-23, and the dissolution medium could flow 
through the cell without the need to move the sample. The construction is similar to the 
standard compaction cell; however, surrounding the punch is a retractable metal bolt 
which is raised after compaction creating a chamber through which the dissolution 
medium flows as shown in Figure 4-23 (van der Weerd et al., 2004). 
 
 
Figure 4-23. Schematic representation of the flow dissolution cell combined with ATR 
accessory. 
 
The dissolution cell has a similar experimental set up to that of the compaction cell as 
shown in Figure 4-16. It is bolted into place over the diamond plating, the only 
difference being the off-centre punch hole and the retractable bolt. There are also flow 
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This equipment is particularly useful for studying the dissolution of model 
pharmaceutical tablets, as it brings the spatially resolved chemical specificity of FTIR 
spectroscopic imaging to flow processes. It allows for the study of the ingress of water 
into the tablet, the formation of polymer gel layers and ultimately the dissolution of the 
drug itself. By taking images at regular time intervals, time-resolved chemical 
information of the dissolution can be obtained. The dissolution cell was also designed 
with the punch aligned slightly off centre relative to the diamond, such that the tablet 
only covers half the face of the imaged area. This sets the interface between the tablet 
and the dissolution medium as the centreline of the image, while also providing space 
for any potential gelation and expansion or dissolution of the polymer to be observed. 
 
 
Figure 4-24. FTIR images showing dissolution of tablet containing HPMC and caffeine 
(van der Weerd et al., 2004). 
 
Figure 4-24 reveals the extent of the information that can be obtained using this method. 
The sample was a model tablet consisting of HPMC and caffeine (van der Weerd et al., 
2004). The caffeine and HPMC are shown to have only covered half of the image as 
expected. It can also be seen that the images were complementary; there are two circular 
domains of low concentration in the HPMC image, which are matched by the positions 
of two domains of higher concentration in the caffeine image. Water was shown to have 
filled the empty space on the unoccupied side of the interface, as this image was taken 
shortly after dissolution commenced and water had not yet started to ingress into the 
bulk. 
 
The in situ compaction and dissolution cell is used in conjunction with the diamond 
Golden Gate
TM
 ATR acessory producing images that are 1 mm
2
 or smaller. These 
images were obtained with a high spatial resolution (ca. 15 m) which is useful for 
studying crystallisation and small changes in the structure of the tablet. This FOV only 
500 μm
HPMC Caffeine Water
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facilitates the study of a relatively small area of small tablets, however, sometimes it is 
necessary to have a larger field of view  to study larger areas of tablets, and the 
processes of dissolution that occur a larger distance from the original boundary of the 
tablet (Chan et al., 2003, Kazarian and Chan, 2003). For this a larger ATR crystal must 
be used. ZnSe is suitable for this purpose, but it is not as hard as diamond and so 
compaction cannot be performed in situ. Therefore, the tablets must be compacted ex 
situ and then dissolution studied in situ. This creates the possibility of leakage of the 
dissolution medium into the interface between the sample and the surface of the cell if 
care is not taken.  In the compaction and dissolution cell, as the formulation is 
compacted onto the diamond, leakage is very unlikely (van der Weerd et al., 2004), the 
swelling of polymers such as HPMC further helps to prevent this ingress (van der 
Weerd and Kazarian, 2004b). When using  the ZnSe crystal the sample can be formed in 
situ if the polymer has a low melting point, and this has been used to study the 
dissolution of PEG based formulations (Chan et al., 2005). A schematic diagram of the 
ZnSe dissolution cell can be seen in Figure 4-25. 
 
 
Figure 4-25. Schematic diagram showing the ZnSe tablet dissolution cell (Kazarian et al., 
2005). 
 
A recent example of the application of ATR-FTIR imaging to dissolution and drug 
release is the simultaneous FTIR imaging and visible optical photography of an HPMC 
based tablet (Kazarian and van der Weerd, 2008).  A custom designed cell was built, 
which was attached to the standard diamond ATR accessory and had a transparent 
window for visual observation of the top surface. The tablet was compacted ex situ and 
then placed between a diamond crystal and the window.  The cell had pipes built in to 
the sides, which allowed the dissolution medium to flow through the chamber inside the 
cell.  Thus, visible images were acquired using a CCD camera from the top surface of 
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the tablet simultaneously with ATR-FTIR images measured from the bottom surface 
during the dissolution of the tablet. This combined approach allowed the study of the 
moving fronts observed during dissolution. The assignment of the fronts had been a 
contentious issue as different explanations for the fronts were provided. Consequently, 
this new imaging approach was applied to a previously studied system which consisted 
of a coloured drug (buflomedil pyridoxal phosphate) and HPMC (Kazarian and van der 
Weerd, 2008). Previous assignment of the dissolution fronts for this tablet based on 
optical photography was not convincing because photography does not provide a 
quantitative value for concentrations of the drug, polymer and water. Effects such as 
changes in the materials’ refractive indices due to intake of water and gel formation will 
change the scattering properties of the medium, which can affect the interpretation of 
the visible imaging data. The ATR-FTIR imaging approach provided reliable 
interpretation of varying concentration of the components across the system. These were 
then compared with the appearances of the fronts in visible photography. The three 
fronts observed in the dissolution of the studied tablets were assigned to: true water 
penetration, total gelification of HPMC and the erosion front (Kazarian and van der 
Weerd, 2008). Significantly, due to the information provided by ATR-FTIR imaging the 
front assignment was seen to be different to those postulated by Melia et al., Colombo 
et al. (Melia et al., 1992, Bettini et al., 2001), and instead was in line with that 
postulated but Gao and Meury (Gao and Meury, 1996). This assignment of the fronts is 
crucially important for understanding the mechanism of drug release in HPMC based 
tablets. This understanding may help in the designing of new and better drug delivery 
products. That Perspex cell also provides the opportunity to study samples which cannot 
be compacted in situ. As it is Perspex, alignment of the sample relative the imaging 
crystal can be viewed and controlled as the cell is bolted into place, while it is capable 
of working with samples which are not necessarily cylindrical tablets with flat surfaces 
(Velasco et al., 2011). 
 
4.6.4 ATR-FTIR imaging for high-throughput analysis 
Imaging in macro ATR mode is a very useful tool for high-throughput technology, 
especially applied to pharmaceutical formulations. This fast screening of many samples 
could drastically reduce the time required to investigate a range of formulations. 
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Chan and Kazarian used a micro-drop system to deposit a range of over 100 
formulations directly onto the surface of the ATR crystal. Formulations with different 
compositions were created by varying the number of drops dispensed from each head to 
the same point in the sample (Chan and Kazarian, 2005). A controlled humidity cell was 
used to control the environment, studying the performance of all samples under uniform 
conditions simultaneously (Chan and Kazarian, 2005). The micro-drop system had 2 
dispenser heads, the first was loaded with the drug sample (nifedipine or  ibuprofen) and 
the second was loaded with pure PEG. ATR-FTIR images showing an array of samples 




Figure 4-26. Images showing the distribution of (a) PEG and (b) ibuprofen in an array of 
samples. Adapted from (Chan and Kazarian, 2005). 
 
High through put analysis was also used to investigate the effects of temperature on the 
stability of formulations. A range of stable formulations was found along with evidence 
that hydrogen bonding between ibuprofen and the polymer results in improved stability 
of the formulations at higher temperatures (Chan and Kazarian, 2006d). The use of a 
multi-channel grid facilitated studying the dissolution of several formulations 
simultaneously (Chan and Kazarian, 2006a), while high throughput analysis using  
macro ATR-FTIR imaging was applied to study protein crystallisation (Chan et al., 
2009). 
 
25 wt % 
0 wt% 
100 wt % 
0 wt % 
1 mm 
(a) (b) 
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4.7 Summary  
The applications presented here have illustrated the potential of FTIR imaging for  
studying pharmaceutical formulations. The use of an FPA detector facilitates the 
acquisition of both spatial and spectral information with a short measurement time. 
 
Macro and micro ATR imaging allow for studies to be carried out at a range of fields of 
view.  ATR-FTIR imaging is not necessarily a destructive technique, therefore samples 
can be extracted and reanalysed using complementary techniques to support the 
investigation of the sample. Although the dissolution procedures are obviously 
destructive, other analysis techniques, such as UV/Vis spectroscopy or visible optical 
analysis, can be used in conjunction. 
 
FTIR imaging is a valuable analytical tool for the studying pharmaceutical and has clear 
advantages over the standard pharmaceutical analysis tools such as the USP dissolution 
tests, as it reveals information about the physical and chemical processes occurring 
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5 Experimental Apparatus  
  
5.1 Introduction 
In the work described in this thesis a number of different experimental apparatuses in 
various configurations were used. This chapter contains a general description of the 
major pieces of equipment and tools used and their applications. 
 
Table 5-1 and Table 5-2 also contain a summary of the properties of the various optical 
arrangements used for FTIR imaging throughout the work. Particular experimental 
modifications and specifications are detailed as appropriate in each chapter. 
 
5.2 FTIR imaging 
 
 
Figure 5-1. Photograph of Bruker FTIR imaging system including a) IFS 66 spectrometer, 
b) microscope, c) macro chamber (large sample accessory), d) a diamond Golden Gate™ 
ATR accessory. 
 
The data presented in this thesis were primarily acquired using two continuous scan 
FTIR imaging systems from Bruker (Germany). One system used an IFS 66 
spectrometer connected to an external microscope and macro chamber (shown in Figure 
5-1). The other used an Equinox 55 connected directly to an external macro chamber. 
Some measurements were also acquired using an imaging system from Varian Inc now 
part of Agilent Technologies, USA. The measurements on the Varian system made use 
of both the microscope optics (UMA 600) and the Large Sample Accessory. The IFS 66 
spectrometer shown in Figure 5-1 is a conventional spectrometer and contains a single 
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(MCT) detector. The source was a silicon carbide Globar source and the interferometer 
used a germanium coated potassium bromide beamsplitter. When acquiring data using 
the microscope (both imaging and non-imaging), the source and interferometer of the 
spectrometer unit were utilised and the beam was directed out of a port on the right of 
the spectrometer, through a light box and into the microscope. In order to gather 
imaging data using the macro chamber, the beam was directed to bypass the microscope 
optics and passed into the macro chamber. The FPA detector was then incorporated into 
these external sections where needed. The FTIR imaging data were all gathered using 
FPA detectors with 64 × 64 pixel arrays (Santa Barbara Focalplane, USA), which 
acquired 4096 spectra simultaneously. A range of different optical arrangements and 
FPA detectors were used over the course of the work. The general properties of each 
arrangement are displayed in Table 5-2 and will be detailed as appropriate throughout 
the thesis. As the FPA detectors are MCT based detectors, they require cooling with 
liquid nitrogen to operate. Proper safety procedures for the handling of cryogenic 
materials were followed, such as the wearing of appropriate protective clothing and the 
usage of the correct transportation vessels. 
 
5.2.1 Acquisition process 
When acquiring data it is important to ensure that the system has been configured 
correctly. The important aspects of image acquisition are outlined below. 
 
5.2.1.1 Co-addition of scans 
As a standard 64 × 64 FPA detector records 4096 spectra simultaneously, then a large 
amount of data are produced. In the first application of these detectors this meant using 
the FTIR spectrometer in step scan mode to allow the computing hardware time to 
gather the data. With the advent of faster FPA detectors and more powerful computers 
the system can be run in continuous scan mode, such that the mirror in the 
interferometer moves in a smooth continuous fashion rather than moving in discrete 
steps. In order to improve the SNR several scans are co-added. For studying static 
systems fast measurement time is not necessary, therefore hundreds of scans can be co-
added to improve the SNR. However, for dynamic systems such as dissolution 
measurements acquisition time is very important. An image with good spectral quality 
can be gathered in fewer than ten scans, however, for the work in this thesis normally 
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20 to 32 scans were co-added depending on the requirements of the system being 
studied and the performance of the equipment being used. The older FPA detectors with 
a pixel size of 60 µm × 60 µm had a significantly slower measurement performance 
than the newer FPAs with 40 µm × 40 µm pixels. 
 
5.2.1.2 Spectral resolution 
An important aspect of any dataset is the spectral resolution: the number of data points 
which make up the spectrum. On the imaging systems used in this work, spectral 
resolution was typically set to 8 cm
-1
, although it was possible to gather data at higher 
and lower resolutions. In order to gather data at higher resolutions the mirror in the 
interferometer must move through a greater distance. This requires a longer acquisition 
time and generates larger datasets. 
 
5.2.1.3 Spectral range 
The spectral range for FPAs when working in mid-infrared was generally set to 4000 
cm
-1
 to 900 cm
-1
. The FPA detectors have a cut-off below 900 cm
-1
 meaning no 
measurements are possible in the region lower than this wavenumber. However, 
depending on the coating of the window in the Dewar holding the FPA it was possible 
to extend the spectral range into the near-infrared above 4000 cm
-1
. When working with 
the prototype imaging Golden Gate
TM
, the spectral range was limited to the fingerprint 
region (2000 – 900 cm-1) as the coating on the lenses of the internal optics did not allow 
wavenumbers above 2000 cm
-1
 to pass through. Reducing the spectral range will also 
decrease the measurement time as the there will be fewer points in the resulting 
interferogram. However, a suitable low pass filter is required to prevent spectral 
artefacts. 
 
5.2.1.4 Gain and frame rate 
The intensity of the infrared radiation at the detector is often below the maximum 
available given the dynamic range of the analogue to digital converter (ADC). In order 
to maximise the dynamic range of the system, the electronic gain can be set such that 
the maximum intensity of the centreburst is close to the top of the dynamic range, 
without exceeding it. At the “wings” of the centreburst, the intensity is much lower, 
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therefore increasing the gain maximises the number of discrete levels used upon 
analogue to digital conversion. This can significantly increase the SNR of the spectra 
produced (Bhargava et al., 2001). 
 
The signal measured by the detector can be increased by decreasing the framerate, this 
increases the exposure time. The greater the exposure time, the higher the intensity of 
the signal measured and the better the SNR. However, increasing the exposure time too 
much will result in increased temporal smearing of the data, as the mirror of the 
interferometer will have moved a significant distance during the exposure time. This 
will add more noise to the data, which would need to be rectified by slowing the scan 
speed. 
 
5.2.1.5 Sample alignment 
The imaging FOV is usually smaller than the surface area of the ATR crystal. When 
dealing with dissolving tablets it is important to ensure that the FOV is aligned with the 
region of interest of the dissolving tablet. As the diameter of the imaging area for the 
diamond is approximately 500 µm across, it is important to check that the sample has 
been positioned correctly. Sample position may be checked through acquisition of an 
image however, if the sample position is incorrect then the sample position must be 
adjusted and another image recorded in order to check this. Fine adjustment of the 
sample position can be a fairly lengthy process using this methodology, therefore a 




Figure 5-2. Live images showing intensity of light falling on FPA detector, where white is 
high intensity and black is low. a) no sample on ATR crystal b) sample positioned to half 
cover imaging area. 
a) No sample b) Sample in lower half of image
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This is most simply done using the live scan, which shows the intensity of the IR light 
reaching each pixel of the FPA detector. The first item to note in Figure 5-2a is that the 
illumination is heterogeneous. This is due to several factors; the first is that the Globar 
source provides a heterogeneous distribution of radiation; the second is that the 
sensitivity of each pixel varies slightly and the third is that the optics of the system does 
not provide a completely even distribution of radiation across the imaging area. In 
Figure 5-2b it can be seen that while the overall distribution of intensity is very similar 
to that in Figure 5-2a there is a darker red region in the lower part of the image. This 
darker region denotes an area in which something is in contact with the crystal, slightly 
attenuating the IR signal. By using the live scan in this way it is possible to ensure the 
sample has been positioned correctly before acquisition of any image data.  
 
5.2.2 Macro chamber 
The macro chamber or large sample accessory was used for achieving fields of view 
(FOV) with dimensions ranging from approximately 0.5 mm to 4 mm depending on the 
accessory used (though larger FOVs may be achieved using other optical 
configurations). For these measurements the IR beam was directed from the source in 
the spectrometer through to the macro chamber using a series of motorised mirrors. The 
macro chamber serves as a housing device for a range of spectroscopic accessories, 
which can be exchanged depending on the application. The accessories in combination 
with the FPA produce a different FOV and spatial resolution, and depending on the 
crystal within the accessory, can be used in conjunction with custom designed cells for 
compaction and dissolution of samples. The work in this thesis mainly used a Golden 
Gate™ diamond ATR accessory (Specac Ltd, UK) (Figure 5-3) which was originally 
designed for supercritical fluid analysis, the internal optics for this are presented in 
Figure 4-13. As shown in Figure 5-3c this accessory has a set of threaded holes around 
the diamond plating, by which cells for dissolution and compaction may be affixed. In 
the middle of the armature of the gate a threaded bolt can be seen. This bolt was used to 
press down the punch in the in situ compaction cells. A range of anvils could also be 
attached to the bottom, which were used to press the sample onto the ATR crystal, in 
the absence of a compaction cell. 
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Figure 5-3. Photographs showing the Golden Gate™ accessory in a) closed and b) open 
positions. Image c) shows the diamond in the centre surrounded by the circular tungsten 
carbide plating and the screw holes, by which accessories can be affixed. 
 
5.3 Data acquisition 
The data acquired in this thesis were gathered using the ATR approach, for which the 
sampling procedure is relatively simple. The sample must be placed in contact with the 
crystal. In order to produce reliable and repeatable data, good contact between the 
sample and the crystal must be achieved. This is not an issue with liquid, wet or 
relatively soft samples, whereas in the case of hard or fragile samples achieving good 
contact can be more difficult. For samples with low melting points, contact may be 
improved by heating the measuring surface until the bottom of the sample softens 
slightly. In the case of samples where this is not possible, a set of in situ compaction and 
dissolution cells have been designed which help to press the sample onto the crystal. 
 
5.3.1 Compaction cell 
In order to study in situ tablet compaction on the diamond ATR accessory, a 
compaction cell was used as shown in Figure 5-4a (Elkhider et al., 2007). The cell was 
mounted on the accessory and the constituent powders of the tablet were poured into the 
cell. A punch (Figure 5-4b) was then inserted into the cell and the armature of the 
Golden Gate™ accessory was lowered. The anvil was then brought into contact with the 
top of the punch and a torque screwdriver was used to control the amount of compaction 
force applied to the sample. The force used in the formation of tablets using this 
methodology was up to an order of magnitude smaller than that usually used in 
a) b) c)
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industry; nonetheless this formed tablets with a good structural integrity. The torque 
screwdriver (Figure 5-4c) was calibrated to produce a known compaction force on the 
sample. The range of the compression force applied on the diamond ranged from ca. 




Figure 5-4. Photographs showing a) compaction cell with screw fixings at corners, b) 
punch which is inserted into the central hole and c) torque screwdriver, the first 
application of this cell was described by Elkhider et al. (Elkhider et al., 2007). 
 
 
5.3.2 Compaction and dissolution cell 
The compaction and dissolution cell allows for compaction and dissolution of a tablet to 
be studied in situ (van der Weerd et al., 2004). The compaction and dissolution cell 
bolts onto the diamond ATR accessory in much the same way as the standard 
compaction cell. However, in order to allow flowing dissolution to occur, it had pipes to 
allow dissolution medium to flow both into and out of a central chamber. The 
dissolution chamber was created by a central bolt which could be partially lifted out of 
the central chamber exposing the tablet to the dissolution medium. The bolt was only 
lifted for dissolution, during compaction the bolt remained down, as in the down 
position it served as the compaction chamber for the tablet. The compaction of the tablet 
was off-centre from the middle of the diamond crystal, such that when imaged half of 
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Figure 5-5. Photographs of compaction and dissolution cell, a) cell showing flow pipes 
attached to side of cell and b) lifting bolt containing compaction chamber and screw 
thread. The application of this cell was described by van der Weerd et al. (van der Weerd 
et al., 2004). 
 
5.3.3 Visible optical dissolution cell 
A transparent dissolution cell has been designed, such that the dissolution of samples 
may be studied using a video camera while simultaneously acquiring FTIR images 
(Kazarian and van der Weerd, 2008). The cell consists of a rectangular section of 
Poly(methyl methacrylate) (PMMA), with flow holes drilled through it to allow the 
flow of dissolution medium. The sample is placed on the diamond ATR crystal and a 
rubber O-ring is placed around the sample. The dissolution cell is then bolted into place 
on top of the sample, sealing against the O-ring to create a chamber for dissolution. As 
the bottom of the cell is a flat piece of PMMA, this cell has the advantage that it may be 
used with samples that cannot be formed inside the standard compaction/dissolution 
cell. This is particularly useful when careful alignment of the system is required as the 
position of the sample may be monitored by the operator at all times.  
 
 
Figure 5-6. Photograph of visible optical dissolution cell. The cell is affixed by the four 
screws in the corners, the pipes can be seen passing through the PMMA into the chamber 
created by the rubber ring between the cell and the diamond plating. The tablet can be 
seen dissolving within the chamber. This was first described by van der Weerd et al. (van 
der Weerd and Kazarian, 2004b). 
a) b)
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Figure 5-7. Photographs of a Varian microscope system a) Infrared microscope, b) micro 
ATR objective, c) Germanium ATR crystal.  
 
For analysis of some static samples a high spatial resolution was required. In this case it 
was necessary to use the FTIR microscope (Figure 5-7) which produced images with a 
field of view of 64 µm × 64 µm with a spatial resolution of 4 µm. The area of interest of 
the sample was located using visible microscopy, before switching to infrared. The 
microscope used a germanium crystal which was attached to a removable mounting 
(Figure 5-7c), which was moved into position when taking measurements (Figure 5-7b). 
The crystal was held in place and the sample was lifted into contact with the crystal, 
with sufficient force to achieve adequate contact. Compaction cannot be conducted in 
situ when using a microscope objective, therefore samples are prepared ex situ before 
measurement in the microscope system. The micro ATR system as of yet has not been 
used for studying dissolution.  
 
5.3.5 Properties of ATR crystals 
As discussed in Section 5.2.2 the majority of the FTIR imaging measurements in this 
thesis were conducted using diamond ATR accessories; although zinc selenide and 
germanium ATR crystals were also used. The zinc selenide was large and facilitated the 
acquisition of data with a larger FOV, while the microscope was fitted with the 
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zinc selenide crystals can be grown relatively easily, zinc selenide is brittle and 
susceptible to acidic and basic erosion. The general properties of the materials used in 
this work for ATR crystals are summarised in Table 5-1. 
 
Table 5-1. Properties of ATR crystals. 
 
 
5.4 Conventional FTIR spectroscopy 
 
 
Figure 5-8. Photographs of portable FTIR spectrometer a) Bruker Alpha-P spectrometer, 
b) ATR diamond and anvil. 
 
In order to obtain spectra of the components which were used in a sample, the pure 
forms of the components were measured using a conventional (non-imaging) ATR-
FTIR spectrometer before sample preparation. In order to ensure a good comparison 
could be made between the spectra extracted from the imaging datasets and the 
conventionally acquired spectra, both were measured at the same spectral resolution, 










Zinc Selenide (ZnSe) 2.4 20000 - 500
Insoluble in water, however is 
brittle, easily scratched and is 
attacked by acids and bases
Germanium (Ge) 4 5500 - 870
Insoluble in water, however is 
brittle and easily scratched
Diamond (C) 2.4
4500 - 2500, 
1650 - <200
Very hard, can withstand high 
pressure
a) b)
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Two spectrometers were used for this, a Bruker Vector 22 and a Bruker Alpha-P, which 
is shown in Figure 5-8a. The Vector 22 used a standard Golden Gate™ ATR accessory. 
The Alpha-P system was a portable spectrometer and used a lever to lower the anvil 
onto the sample pressing against the ATR crystal to ensure good contact. The detectors 
for these systems were able to operate at room temperature as they used deuterated 
triglycine sulphate (DTGS) detectors. 
 
5.5 X-ray microtomography 
 
 
Figure 5-9. Photograph of Skyscan 1074 portable X-ray microtomograph 
 
X-ray microtomography was used as a complementary technique for sample analysis 
Figure 5-9. This was done using a Skyscan 1074 Portable X-ray microtomograph 
(Skyscan, Belgium). The data were captured using the Skyscan 1074 data capture 
software, which recorded the data as greyscale transmission images with a resolution of 
720 × 576 pixels. These two dimensional images were reconstructed into three 
dimensional data using the Skyscan Dataviewer program. Unless otherwise stated, the 
step scan angle was set to 0.9º and the sample was rotated through 360º. The exposure 
time was set to 2 ms, and each image extracted was an average of 10 frames. 
 
 
Figure 5-10. Photograph of interior of X-ray microtomograph showing, a) plinth, b) 
sample and modelling clay, c) detector. 
a
c b
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The interior of the microtomograph contained a rotating plinth, on which the samples to 
be measured were positioned as shown in Figure 5-10a. They were fixed in place using 
a small amount of modelling clay (Figure 5-10b), the platform was then adjusted to the 
correct height ensuring the sample was in the middle of the detector’s field of view 
(Figure 5-10c).  
 
5.6 UV/Vis spectroscopy 
In order to measure the amount of drug dissolved into dissolution media it was 
necessary to connect a UV/Vis spectrometer to the effluent stream of the dissolution cell 
as shown in Figure 5-11 (van der Weerd and Kazarian, 2004a).  
 
 
Figure 5-11. Schematic diagram of UV/Vis flow system.  
 
It was not possible to simply connect the UV/Vis detector directly to the effluent stream 
as there was very large pressure drop across the detector used. This would have resulted 
in the system being very susceptible to leakages. Therefore the dissolution system was 
separated into two sections. In the first section dissolution medium was drawn out of 
Reservoir 1 and was pumped through the dissolution cell at atmospheric pressure and 
into Reservoir 2. In the second section dissolution medium was drawn out of Reservoir 
2 and pumped via Pump 2 through the UV/Vis spectrometer into the effluent tank. 
Reservoir 2 employed a small vial suspended above and within a larger beaker. The 
residence time of the fluid in the vial was approximately 2 minutes for a flow rate 
through Pump 1 of 1 ml/min. Pump 2 was run at 90% of the flow rate of Pump 1, such 
that the vial constantly overflowed into the beaker. This was designed so Reservoir 2 
never ran dry, while there was only a small amount of averaging of the concentration in 







































Reservoir 1 Reservoir 2 Effluent tank
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The UV/Vis detector was also used in a single pump configuration, as shown in Figure 
5-12, in which the dissolution medium was continually recirculated. This system was 
used for the work comparing the dissolution performance of the FTIR flow cell system 
to the USP dissolution apparatus in Chapter 7. This was because in the two pump 
system the tablet is constantly dissolving in fresh dissolution medium, whereas in the 
USP dissolution apparatus the tablet dissolves in a bath, the recirculating system more 




Figure 5-12. Schematic diagram of single pump UV/Vis flow system. 
 
In the configuration shown in Figure 5-12, the UV/Vis spectrometer was positioned 
after the pump and before the dissolution cell. There were two reasons for this; there 
was a large pressure drop across the spectrometer, while the flow cell was susceptible to 
leaks when operating at high pressure. This system was designed to measure the 
concentration of the bulk of the fluid in the reservoir. If the spectrometer had been 
placed after the dissolution cell, the spectrometer would have measured the bulk 
concentration plus the material which had just been dissolved. 
 
These pumping systems were capable of achieving a flow rate of 9.99 ml/min. Pump 1 
was a Merck-Hitachi L-6200 (Hitachi, Japan) and Pump 2 was a Kontron 320 (Kontron, 
USA), both systems were originally used for high pressure chromatography. The 
detector used was a Kontron 332 UV/Vis detector; the wavelength used for analysis will 
be specified in each chapter containing UV/Vis data where appropriate. 
 
5.7 Hardware properties 
Table 5-2 contains a summary of the imaging and experimental capabilities of the 
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5.8 Materials and samples 
The materials used throughout this thesis were model pharmaceutical powders and were 
therefore potentially harmful. Powders were all handled while wearing appropriate 








Macro or Micro imaging approach Macro Imaging Micro Imaging
ATR crystal type Diamond Zinc Selenide Germanium
Spectrometer type Bruker: IFS 66 Bruker: Equinox Bruker: Equinox Varian: 670 FT-IR Varian: 7000 FT-IR
Accessory Non-imaging Prototype imaging (CO*) Prototype imaging (no CO*) Oil Analyser 10x micro ATR objective
Detector pixel size (µm) 60 40 40 40 40
Spatial Resolution (µm) (approx) 20-30 15 15-20 40 4
Field of view (µm x µm)** 800 × 1100 500 × 550 500 × 700 1800 × 2500 64 × 64
In situ compaction capable Yes Yes Yes No No
Suitability for studying dissolution Yes Yes Yes Yes No
Combination with UV/vis detector Yes Yes Yes Yes No
* Corrective Optics (CO) incorporated into imaging Golden Gate™ creating an aspect ratio close to 1:1
** FOV size calculated based on using a 64 × 64 pixel detector 
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6 Compaction of Pharmaceutical Tablets with Different 
Polymer Matrices studied by FTIR Imaging and X-ray 
Tomography 
 
This chapter presents the application of ATR-FTIR spectroscopic imaging to study the 
compaction of model pharmaceutical formulations. As discussed in the literature 
review, the spatial and chemical specificity of this imaging approach have been 
exploited to analyse the distribution of different components in various formulations. 
ATR-FTIR imaging is a surface analysis methodology which analyses a relatively thin 
(a few micrometers thick) surface layer of the sample, therefore when studying 
pharmaceutical formulations it is important to understand the relationship between the 
data gathered at the surface layer and the bulk properties of the formulation. 
 
6.1 Compaction of model tablets made of different polymer matrices 
 
6.1.1 Introduction 
The first section of this chapter sees ATR-FTIR imaging applied to study the 
compaction of model caffeine tablets made of two different commonly used polymer 
matrices, microcrystalline cellulose (MCC), hydroxypropyl methylcellulose (HPMC) 
and lactose (Reier and Shangraw, 1966, Bolhuis and Armstrong, 2006, Wu et al., 2005). 
The effective performance of a tablet depends upon the composition and the 
manufacturing process. The important parts of the process are the choice of the polymer 
matrix, the processing of the components and then the compression of the powder into a 
tablet. 
 
While conventional attenuated total reflection spectroscopy has previously been used to 
study the surface layers of compacted tablets (Planinsek et al., 2006), imaging can 
reveal the distribution of different components at the surface layer of the tablet matrix 
(Chan et al., 2003, Chan et al., 2005). 
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As the penetration depth of the infrared radiation into the sample is relatively shallow, 
good contact between the sample and the ATR crystal is required. Good contact can be 
defined as a region in which band intensities remain constant across a homogenous 
sample (Buffeteau et al., 1996). Uniform contact usually requires a liquid or smooth 
sample. Particle based pharmaceutical powders therefore do not provide uniform 
contact and so a compaction force must be applied to ensure good contact for non-ideal 
samples (Zhao et al., 1987). When a tablet is compacted, initially the positions of 
particles rearrange. The particles crumble, and the voids then collapse into harder denser 
material. Elastic and plastic deformation, is followed by particle fragmentation, the 
particles then rearrange further into a closer packing structure reducing the volume 
(Duberg and Nystrom, 1985, Duberg and Nyström, 1986), thereby improving contact 
with the ATR crystal. Therefore, during compaction, not only can relocation and 





6.1.2.1 Sample preparation 
Tablets made of four different components were investigated in this study: caffeine 
(model drug) and three common excipients (HPMC, microcrystalline cellulose (MCC), 
and lactose) for the tablet matrix. HPMC was supplied by Colorcon. Microcrystalline 
cellulose and lactose were supplied by Merck Sharp & Dohme.  The powders were 
sieved into a selection of particle size ranges.  For the excipients, particles with size 
below 90 µm were used, while the drug particles were sieved to a size of 90-125 µm. 
Drug/polymer matrix mixtures were created by mixing an accurately weighed amount 
of drug and polymer in a small vial. The powder mixtures were blended together in a 
vial with a flat bottom with a spatula that was approximately as wide as the inner 
diameter of the vial. This ensured that any powder at the edges of the vial would 
become mixed in as well. Following mixing, the powders were compacted directly on 
the diamond surface where the ATR-FTIR image was measured.   
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6.1.2.2 FTIR spectroscopic imaging 
The IFS 66 spectrometer was used in conjunction with the macro sample chamber to 
accommodate the diamond Golden Gate
TM
 ATR accessory.  FTIR images were acquired 
with a 64 × 64 FPA detector with 8 cm
-1
 spectral resolution and 32 scans co-addition. 
This is described in Column 1 of Table 5-2. All images shown are 1100 µm × 780 µm.     
 
6.1.2.3 Compaction 
Compaction of the powder mixture was performed using a custom designed compaction 
cell. The cell, which was integrated with the diamond Golden Gate
TM
 ATR accessory, 
was the same cell described in Section 5.3.1.  The compaction force was controlled 
using a torque wrench. Following compaction, the force on the tablet was not released 
until the image data had been captured.    
 
6.1.3 Results and discussion 
The composition of each component was varied systematically to facilitate an 
understanding of the effect made by each individual component.  The drug loading was 
varied between 10 and 30 weight percent (wt%) and the other components were varied 
accordingly. A full range of tablet compositions were tested, with concentration varied 
by 10 wt% at each step. The data presented here are representative and convey the 
major results. The presented formulations are given in Table 6-1. 
 
Table 6-1. Tablet formulations  
 
 Lactose HPMC MCC 
10 wt% 
Caffeine 
Tablet 1.1 - - 
20 wt% 
Caffeine 
Tablet 1.2 Tablet 2.2 Tablet 3.2 
 
The strength of the diamond allowed the compaction and the imaging measurement to 
be performed in situ, thus providing a means to study the effect of pressure on tablet 
compaction without the need for removal of the tablet from its die. Therefore the same 
tablet could be studied at several different levels of compression force, while at the 
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same time ensuring a good contact between the ATR crystal and the tablet surface 
which is important in ATR-FTIR measurement. The range of the compression force 
applied on the diamond ranged from ca. 270 – 850 N which is corresponded to ca. 50 – 
120 MPa for a 3 mm diameter tablet.  
 
In order to obtain a good contact between the tablet and the surface of the diamond, a 
minimum force of 610 N (86 MPa) was required as shown by the poor contact in Figure 
6-1 at 40 MPa. Nevertheless, measurements were taken from 370 N to assess the effect 
of increasing pressure on the formation of the tablets. Images of the tablet were then 
taken at compression forces of 610 N (86 MPa) to 850 N (120 MPa) at 120 N intervals, 
these pressures were relatively mild when compared to those used in industry because 
the maximum torque that can be applied by the torque wrench used was limited.  
Further improvement to the compaction cell with a stronger press with calibrated 
pressure is possible and could be investigated in future developments.   
   
The absorption bands at 1562 – 1518 cm-1, 1153 – 1127 cm-1, 3007 – 2774 cm-1 and 
1118 – 1088 cm-1 were used to generate images showing the distribution of caffeine, 
lactose, HPMC and MCC respectively. The images of the same substance all share the 






Figure 6-1. An image showing the relative surface changes in caffeine and lactose content 
of the surface layer of the tablet with increasing pressure for a 10 wt% drug loading of 
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Between the two sets of images shown in Figure 6-1 and Figure 6-2, the caffeine 
concentration is doubled from 10 wt% to 20 wt%. This is reflected by the increasing 
intensity and area occupied by the caffeine for the tablet with a higher caffeine 
concentration. The caffeine (top row) and lactose (bottom row) images are not totally 
complementary as in some areas the images show low concentration for both 
components.  This is an indication of the presence of a large void in the tablet and as 
expected there is a greater presence of voids at the surface of the tablet at low 
compaction pressures. For example, by comparing the images of caffeine and lactose 
shown in Figure 6-1 at 40 MPa there are large areas of the image in which there is no 
presence of either component.  
 
This in situ compaction study provides an opportunity to obtain a series of chemical 
images representing the distribution of different chemical components from the same 
area of a tablet when compaction pressures are increased.  The effect of pressure on the 
distribution of different components can be studied.  When the compaction pressure 
increases, the absorptions of caffeine and lactose also increase due to the reduction of 
voids in the tablet and at the surface of the ATR crystal and better contact of the with 
the crystal tablet is achieved.  However, there was not much change in the distribution 
of the two components analysed which is expected since lactose is a low fragmentation 
propensity material (Bolhuis and Armstrong, 2006). This can be clearly observed by the 
increase in absorption of all tablet components in the series of images shown in Figure 
6-1 and Figure 6-2.  
 
There is also a much greater percentage change in the apparent concentration of lactose 
across the image range. The caffeine images in Figure 6-1 and Figure 6-2 are almost 
stable above 95 MPa, however there is a noticeable increase in absorbance for lactose 
even between the images for 112 and 120 MPa. This indicates that lactose continued to 
move within the matrix with increasing compaction force, and that, were the 
compaction force to be increased further changes in the matrix would continue to be 
seen in the images. 
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Figure 6-2. An image showing the relative surface changes in Caffeine and lactose content 
of the surface layer of the tablet with increasing pressure for a 20 wt% drug loading of 
caffeine (tablet 1.2). The images size is 1100 µm × 780 µm. 
 
The images of caffeine and lactose remained not completely complementary even when 
the pressure reached 120 MPa.  This made the assessment of drug homogeneity in the 
tablet more challenging.  While this accessory was not originally designed for imaging 
purposes or for compaction studies, modifications to enable the study of tablet 
compaction were made to the apparatus.  A higher compression force would further 
eliminate voids, such that the images would become complementary. While this was not 
possible with the existing equipment, the opportunity for modification to allow this 
exists in potential further work.   
 
Nevertheless, comparing the tablet that contains more caffeine (20 wt%) to the tablet 
with less caffeine (10 wt%), Figure 6-2 which presents the result of the tablet with a 
greater loading of caffeine appears to give a stronger average lactose absorption than 
Figure 6-1 even though the lactose is actually in lower concentration in that tablet. This 
was due to a greater void reduction which must be as a result of higher caffeine 
concentration.  A previous study has shown a similar effect when a small amount of 
magnesium stearate, which is a known lubricant, was added to the formulation of a 
HPMC tablet (Chan et al., 2005). This suggests that the caffeine acts as a lubricant for 
the lactose making it more compactable. It is therefore possible to apply this approach 




40 86 95 103 112 120 Pressure (MPa) 
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vice versa.  This is very important to the pharmaceutical industry because the final 
density of the tablet, which can be a strong function of its dissolution properties, may be 
affected by the lubrication of the powders during compaction. 
 
The imaged area has a width of approximately 500 µm. Drug particles of 90-125 µm in 
size (largest particles from sieving) would be expected to occupy approximately 1/5 the 
width of the image at their maximum width. In Figure 6-1 and Figure 6-2 the largest 
particles are almost exactly this size which indicates the particle size of caffeine used 
for this tablet coincides with the maximum domain size of the caffeine. These data show 
that it may be possible to use FTIR imaging to obtain particle size information from 





Figure 6-3. An image showing the relative surface changes in caffeine and HPMC content 
of the surface layer of the tablet with increasing pressure for a 20 wt% drug loading of 
caffeine (tablet 2.2). The images size is 1100 µm × 780 µm. 
 
Figure 6-3 and Figure 6-4 illustrate the polymer (80 wt%) and drug (20 wt%) 
distribution in the tablet with polymer matrices of HPMC and microcrystalline 
cellulose. The drug and polymer images from these tablets are more complementary 
than those shown in Figure 6-1 and Figure 6-2 even for those compacted with low 
compaction pressure (40 MPa) suggesting that these polymers have very good 
compaction properties (Bolhuis and Armstrong, 2006). This results in the appearance of 
larger drug domains.   
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As in Figure 6-1 and Figure 6-2 there is a greater percentage change in the apparent 
concentration of microcrystalline cellulose and HPMC across the image range in Figure 
6-3 and Figure 6-4. The caffeine images stabilise with pressure quite rapidly, however 
the bulk of the polymer matrix continues to improve in contact even up to the maximum 





Figure 6-4. An image showing the relative surface changes in caffeine and MCC content of 
the surface layer of the tablet with increasing pressure for a 20 wt% drug loading of 
caffeine (tablet 3.2). The images size is 1100 µm × 780 µm. 
 
Comparing the relative increase in absorbance of drug and polymer based on the change 
in the colour in the images, the relationship between compression force and the tablet 
density can be visualised immediately. However, this comparison is clearer when the 
absorbance is plotted as histograms which are presented in Figure 6-5.   
 
The same approach has been previously used to assess the homogeneity of 
pharmaceutical formulations (Coutts-Lendon et al., 2003, Chan and Kazarian, 2004a).  
The histogram on the right hand side of Figure 6-5 shows that the absorbance of HPMC 
increased more with pressure than that of MCC.  A previous study (Picker, 2004) has 
shown that HPMC exhibits a greater slope of porosity (density) over pressure than MCC 
which is consistent with the result shown.   
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Figure 6-5. Top two histograms showing change in apparent caffeine (left) and HPMC 
(right) absorption with increasing pressure (MPa, as indicated in the right-top corner of 
each graph) for tablet 2.2. Bottom two histograms showing change in apparent caffeine 
(left) and MCC (right) absorption with increasing pressure for tablet 3.2. 
 
The histogram on the left hand side of Figure 6-5 reveals that a higher absorbance of 
caffeine can be observed when MCC was used as the polymer matrix.  The absorbance 
of caffeine is more sensitive to the compression force and the distribution of absorbance 
is wider for the tablet with MCC.  This demonstrates that the employed approach can 
reveal the effects of different types of polymer matrices on the distribution and the 
relative density of drug and polymer on the tablet.   
 
6.1.4 Conclusions 
In this part of the chapter it has been shown that during tablet formation, lactose 
compaction can be enhanced by the presence of caffeine particles. This has important 
implications for the pharmaceutical industry as the integrity of a tablet can have an 
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important influence over its dissolution properties. Statistical analysis of the data 
obtained with in situ spectroscopic imaging for compaction of HPMC and MCC has 
shown that the polymers have very good compaction properties, whilst also 
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Spectroscopic chemical imaging allows a high resolution two-dimensional “chemical 
image” to be created. The infrared radiation penetrates up to several micrometers into 
the sample. The chemical images are obtained from a thin surface layer of the tablet. 
There are several advantages to this. The sampling region where the data are gathered is 
very well defined; there is no averaging through the sample as there would be when 
imaging using the transmission approach. The sampling methodology can be applied to 
a range of samples types that might be more complicated to study using other sampling 
approaches, such as transmission, which for tablet studies would necessitate 
microtoming of the samples in order to achieve the required thinness (this is more 
clearly illustrated in Figure 4-10). As the diamond ATR crystal is hard, the compaction 
of the tablets can be studied in situ, while the short penetration depth of the evanescent 
wave facilitates dissolution studies as seen in Section 4.6. Most importantly for the 
work in this chapter, ATR-FTIR imaging is non-destructive allowing the samples to be 
reanalysed using complementary analytical techniques. 
 
In order to verify the usage of data from this surface layer analysis approach, a 
complementary technique was used to analyse the samples in conjunction with ATR-
FTIR imaging. X-ray microtomography, which is a more penetrative technique, was 
chosen. As it uses X-rays which pass through the sample, a three-dimensional image of 
the sample can be generated, showing the density distribution within the tablet. The 
results obtained were compared to ATR-FTIR images obtained from the thin surface 
layer of the tablet. As X-ray microtomography can only distinguish different samples 
based on density differences, it cannot distinguish between the different chemical 
compounds in a tablet as clearly as FTIR imaging. In order to ensure clear 
differentiation of the components in the tablets it was necessary to select components 
which had significantly different densities, in this case caffeine and microcrystalline 
cellulose were used. The results of this work show that X-ray tomography can be used 
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in conjunction with FTIR spectroscopic imaging to produce a density map that verifies 




6.2.2.1 X-ray microtomography 
The X-ray data were acquired using a Skyscan 1074 Portable X-ray Microtomograph. 
The data were collected using the Skyscan 1074 data capture software, and were 
reconstructed using the Dataviewer program. The step scan angle was set to 0.9° and the 
tablet was rotated through 360°. The exposure time was set to 2 milliseconds and each 
extracted image was an average of 10 frames. 
 
6.2.2.2 Sample preparation 
The tablet samples were blended and compacted using the same methodology as 
described in Section 6.1.2.3. The density of caffeine crystals is 1.23 g/cm
3
 and the 
density of microcrystalline cellulose is 1.58 g/cm
3
 (IPCS, 1998, Sun, 2005). Upon 
exposure to a damp atmospheric environment MCC will absorb water influencing the 
final density of the compacted tablets (Sun, 2005). Therefore the samples were stored in 
a stable low humidity environment until usage. 
 
6.2.3 Results and discussion 
 
6.2.3.1 FTIR imaging and particle size 
The effect of particle size on the measured domain size of caffeine on the compacted 
tablet was also investigated.  Caffeine with particle sizes of 100-125 m and 125-150 
m were mixed with MCC at 30 wt% and compacted into tablets with 120 MPa of 
compaction pressure.  Examples of the distributions of caffeine at the surface of the 
compacted tablets are shown in Figure 6-6.   
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Figure 6-6. An image showing the relative surface changes in caffeine content of the 
surface layer of the tablet with increasing particle size for a 30% drug loading of caffeine 
and a 70% loading of MCC. The images size is 1100 µm × 780 µm. 
 
The maximum domain size of caffeine shown in Figure 6-6 varied according to the 
particle size of the drug used.  However, there are many domains of caffeine shown in 
each of the images that are smaller than the particle size of caffeine used.   This is 
possibly due to the fact that some of the caffeine particles may have fragmented during 
the process of compaction despite the relatively mild pressure used.  Another possibility 
is that since the evanescent wave of the IR radiation (one of the features of ATR 
measurement) only probes into the sample for a few micrometers (Harrick, 1967), then 
the full size of the domains of caffeine may only be revealed with more penetrative 
measurements. The smaller particles seen in the images are most likely merely the tips 
of relatively unfragmented particles.  This is more clearly illustrated in Figure 4-11. The 
image illustrates how particles, which all have the same diameter, with a tablet matrix 
can present significantly different sizes in the resulting ATR image. In Figure 4-11 the 
measured particle size is dependent on the point of intersection of the particle with the 
surface of the tablet. In a real system the varying measured particle size would be 
produced by the non-spherical nature of the particles, or the degree of deformation of 
the particles at the surface of the tablet.  
 
The images in Figure 6-6 also display some domains of caffeine which appear to be 
larger in one dimension that the stated particle size. There are several possible reasons 
for this, the most likely is post sieving agglomeration, such that either in the sieve pan 
or during the subsequent mixing and compaction procedures, two particles either adhere 
to one another or arrive in very close proximity to one another in the final tablet matrix, 
100 – 125 μm 125 – 150 μm 
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appearing as one larger particle in the final image. Sieving selects particles based on a 
two-dimensional projection of the shape, therefore particles which posess an aspect ratio 
significantly greater than 1 may fall though the sieve on their smallest diameter but 
present in the images with their larger diameter visible. 
 
6.2.3.2 Comparison with X-ray data 
 X-ray microtomography was used as a complementary method to construct three 
dimensional spatially resolved images of materials of different density. Following the in 
situ compaction of the tablet and acquisition of an ATR-FTIR image, the tablet was 
retrieved and imaged using the X-ray microtomographic approach. The data are 





Figure 6-7. Images showing the data obtained with ATR-FTIR spectroscopic imaging 
which are compared with images from X-ray tomography. The top set of images shows the 
results for the 100-125μm particle size. The bottom set shows the data for the 125-150μm 
particle size. The FTIR data are shown on the right hand side, the key area of the X-ray 
tomography is shown in the middle, and the FTIR is layered over the X-ray data for 
comparison on the left hand side. The FTIR images are 1100 µm × 780 µm in size. 
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The images in Figure 6-7 show X-ray images extracted from the surface layer of the 
tablet overlaid with the ATR-FTIR images for comparison. The X-ray 
microtomography images were able to distinguish the caffeine particles based on the 
density difference between HPMC and caffeine. The image shown in Figure 6-7 reveals 
large caffeine particles (150-200 µm) embedded in the tablet which are not shown in the 
ATR-FTIR images. However, due to the limited spatial resolution of the X-ray 
microtomograph used in this study (ca. 80 micrometers (Kohout et al., 2006)), the 
smaller particles of caffeine are not shown clearly and it is probable that these larger 
particles were either a collection of smaller particles which averaged to appear as one 
large domain or were slightly beyond the penetration depth of the ATR images. 
 
It was possible to compare the two sets of results by directly overlaying the two images 
from the FTIR-ATR approach and X-ray microtomography approach based on the 
pattern of the distribution of caffeine in the tablet.  The results are shown in Figure 6-7.   
The distribution of caffeine did not match exactly due to the fact that the two methods 
have different sampling volumes and spatial resolutions.  However, the similarity 
between the two caffeine distribution patterns suggests the results are showing the same 




Figure 6-8. Coronal, sagittal and transverse cross sections through tablet with caffeine 
particle size 100-125μm. The particles of caffeine distributed in the sagittal and transverse 
planes are circled in red. 
 
1mm
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As ATR imaging is a surface layer analysis technique, when studying samples of any 
thickness, such as pharmaceutical tablets, it is important to understand whether the 
image seen at the surface is representative of what may be found in the bulk of the 
sample. It is illustrated in Figure 4-11 that the measured particle diameter may be less 
than the maximum diameter of the particle, however if the distribution of particles 
throughout the tablet matrix is relatively even and similar to that found at the imaging 
surface, then the ATR data can be seen as representative of the tablet as a whole. The 
image in Figure 6-8 is a significant result in conjunction with the data in Figure 6-7, as 
it shows the distribution of caffeine through the depth of the tablet. As would be 
expected, there was a relatively even distribution, as particles can be seen at all depths, 
indicating that as long as one is aware of the assumptions being made regarding particle 
size etc., the data seen at the surface of the tablet can be applied to the bulk of the tablet. 
This result helps to validate an assumption that must be made when using ATR-FTIR 
spectroscopic imaging to study pharmaceutical tablets. 
 
This is the first time that X-ray microtomography has been used in combination with 
ATR-FTIR imaging. As X-ray microtomography relies on the density difference 
between the drug and the polymer in order to distinguish between the two substances, it 
would be challenging to analyse a multi-component system containing more than two 
substances.  Based on the success of this combination of X-ray microtomography with 
ATR-FTIR imaging, a feasible future study would be to explore the possibility of 
assigning the presence of different components to the colour scale in the X-ray 
tomography image based on the result obtained from the comparison between the ATR-
FTIR imaging and X-ray microtomography for a 3D-multicomponent analysis.   
 
6.2.4 Conclusions 
The work showed that data obtained with ATR-FTIR imaging can give a good 
indication of the particle size being investigated. However, the validity of this 
information is limited by the relatively short penetration depth of the infrared light into 
the sample. Therefore, more penetrative supplementary techniques must be used to fully 
determine this parameter of a system. 
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It was also shown that X-ray tomography can be used in conjunction with FTIR 
imaging to produce a density map of the tablets that verifies the data from the FTIR 
imaging. However, as it is only a density map, this technique relies on a system 
containing only two different species with distinctly different densities and may be too 
limited for complex mixtures such as those found in commercial tablet formulations. 
 
This chapter has described an investigation in to studying particle distribution within 
compacted tablet matrices using FTIR imaging. This work is continued in Chapter 7 
which evaluates the possibility of obtaining quantitative information from the FTIR 
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ATR-FTIR imaging has been shown to be highly applicable to pharmaceutical 
formulations. It is an excellent approach for studying physical phenomena during 
dissolution, such as drug crystallization (Kazarian and Chan, 2003). Its application to 
achieving quantitative data from dissolution tests has also been shown (van der Weerd 
and Kazarian, 2004a). However, the application of this approach to gathering 
quantitative data regarding particle size and component loading from dry tablet matrices 
is less established.  
 
Three factors were studied: An assessment of the ability to determine the relative 
concentration of a component from FTIR images, particle size analysis and statistical 
analysis of the data to determine the number of images required for the mean of these 
parameters to satisfy required confidence levels. 
 
Similar analyses have been performed with spectroscopic techniques previously; 
however, this has mostly been with NIR spectroscopy (Clarke, 2004, Hilden et al., 
2008, Lyon et al., 2002, Clarke et al., 2001). While surface analysis of binary mixtures 
of powders to quantify the appearance of components at the surface layer has been 
conducted using ATR-FTIR spectroscopy (Planinsek et al., 2006), there has been no 
application of imaging to similar studies. The application of ATR-FTIR imaging to 
spherical objects has been investigated (Everall et al., 2009), which could be seen as an 
analogous system to tablet particulates. However, the spheres studied were intact glassy 
samples, whereas pharmaceutical powders undergo deformation and fracture during 
compaction. 
 
The work presented here aims to investigate how changes in particle size affect the 
measured values of component area fraction that may be extracted from the FTIR 
imaging data, whether particle size can be determined from ATR-FTIR images and 
finally what is a statistically significant amount of data. 
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7.2 Materials and methods 
 
7.2.1 Sample preparation 
For these model tablets acetaminophen (paracetamol) and caffeine were chosen as the 
two components for these binary samples as they had similar Young’s moduli (Duncan-
Hewitt and Weatherly, 1989, Roberts et al., 1991), densities (Haisa et al., 1976, 
Duncan-Hewitt and Grant, 1986, Roberts et al., 1991) and indentation hardnesses 
(Duncan-Hewitt and Weatherly, 1989, Jetzer et al., 1985), whilst being 
spectroscopically distinct. The similarities in these mechanical properties result in the 
deformation behaviour of the two components being similar (Jain, 1999). Therefore, 
changes in the compaction behaviour seen in the FTIR images were largely due to the 
desired control variable of particle size. 
 
The two components were ground and sieved. Caffeine was sieved to the size range 90-
125 µm, while paracetamol was sieved to six size ranges, <75 µm, 75-90 µm, 90-125 
µm, 125-150 µm, 150-180 µm, >180 µm. Tablet formulations were blended with a 20 
wt% loading of paracetamol and each tablet used 10 mg of powder. Tablets were 
compacted in situ using the same compaction cell described in Section 4.5.1 to a 
pressure of 120 MPa. 40 tablets were compacted for each size interval. The 
formulations used are shown in Table 7-1. 
 
Table 7-1. Formulations studied for compaction 
  Batch 1 Batch 2 Batch 3 Batch 4 Batch 5 Batch 6 
Paracetamol 
 
Loading (wt%) 20 20 20 20 20 20 
Particle Size (µm) <75 75-90 90-125 125-150 150-180 >180 
Caffeine 
 
Loading (wt%) 80 80 80 80 80 80 
Particle Size (µm) 90-125 90-125 90-125 90-125 90-125 90-125 
 
7.2.2 Particle analysis 
To ensure correct sieving size and investigate particle shape visible light microscopy 
and X-ray microtomography were used. 
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7.2.2.1  X-ray microtomography 
Samples were measured using the Skyscan 1074 X-ray microtomography described in 
Chapter 5. The step scan angle was set to 0.9° and the tablet was rotated through 360°. 
The exposure time was set to 2 milliseconds and each extracted image was an average 
of 10 frames. 
 
7.2.3 FTIR imaging 
Images were acquired in the macro chamber of the Bruker Equinox FTIR imaging 
system described in Column 3 of Table 5-2. The accessory used was the diamond ATR 
accessory (Prototype Imaging Golden Gate™ without the correcting mirror). The 
condenser lens of the ATR accessory was modified with the addition of an aperture 
which modified the average angle of incidence of the system to 47º (Chan et al., 2008, 
Kazarian and Chan, 2010). This minimised any possible gradient in absorbance across 
the imaging area caused by possible non-uniform depth of penetration.  
 
7.3 Results and discussion 
 
7.3.1 Particle size investigation 
The first step in analysis was to study the size and shapes of the particles following 
sieving, as the particles were unlikely to be spherical and this would have a significant 
effect on measurement of the particle diameter. Therefore, the particles were scanned in 
three dimensions using X-ray microtomography. 
 
7.3.1.1  X-ray data 
The paracetamol particles shown in Figure 7-1 were scattered in a dispersed fashion on 
a flat surface before being imaged. This allowed for an approximate analysis of particle 
shape and size in three dimensions. 
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Figure 7-1. Coronal, Sagittal and Axial views of paracetamol particles in the size range 
180-150 µm. The profile line marks out the density profile from which Figure 7-2 was 
generated.  
 
Figure 7-1 clearly shows that the particles were highly non spherical. As a result the 
importance of choosing the correct diameter for measurement is seen in Figure 7-2. 
 
 
Figure 7-2. Intensity profile through three particles sieved to 150-180 µm as highlighted in 
Figure 7-1. The red and blue lines mark out the 10% intensity cut-off for two of the 
particles. The y-axis represents the intensity of radiation falling on the detector. 
 
The data in Figure 7-2 illustrate the importance of choosing the correct diameter to 
measure when sizing the particle. This profile approximately cut through the middle of 
all three particles; however, the results are significantly different. The smaller particle 
had a measured diameter of 157 µm, while the larger particle had a measured diameter 
of 310 µm. This is not a truly fair comparison as the spatial resolution of the equipment 
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A consistent sizing methodology was needed which reflected the method by which the 
particles were separated into their size categories and the methodology by which the 
particle size data were acquired from the FTIR images. In this case the particles were to 
be sized using image analysis. There are many examples of methods by which to size 
particles from imaging data, such as chord size (Heath et al., 2002), equivalent circle 
diameter (Kobayashi et al., 1997), Martin diameter, Krumbein diameter (Yasuo, 1996) 
and Feret’s diameter (Walton, 1948). Feret’s diameter is often used in sieve analysis. In 
this case the minimum Feret diameter will be used as illustrated in Figure 7-3. The Feret 
diameter serves as an approximation of the smallest gap through which the particle can 
fit and therefore is similar to the sieve diameter. 
 
Figure 7-3. Illustration of Feret’s diameter on non spherical particle. XF, min represents the 
minimum Feret diameter, which is the smallest distance between two parallel lines which 
are tangential to the surface of the particle and do not intersect with any part of it. XF, max 
is the maximum Feret diameter which represents the largest distance between two parallel 
lines which are tangential to the surface of the particle and do not intersect with any part 
of it. 
 
7.3.1.2  Microscopy data 
Images of particles were obtained on a visible microscope. In order to size these 
particles, image processing was required to produce binary image data. The data were 
imported into the imageJ image processing software. The images were then converted to 
greyscale and the threshold was set to 10% of the maximum intensity. Auto 
thresholding was available; but it was found that the resulting particle size was very 
sensitive to small changes in the threshold value. Particles with holes resulting from the 
thresholding process were filled. Small particles less than 10 µm in diameter were 
discarded from analysis. This process is summarised in Figure 7-4. 
XF, min
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Figure 7-4. Image processing of microscope data in imageJ of particle size category 150-
180 µm.  
 
Following this image processing the particles were then sized using the Feret’s diameter 
algorithm built in to imageJ. The results are shown in Figure 7-5. 
 
 
Figure 7-5. Correlation between sieved size category and the resulting minimum Feret 
diameter for visible optical microscope data. The diagonal line is x=y. The categories on 
the x-axis are plotted in the centre of the size range. 
 
Figure 7-5 shows a very good correlation between the sieved sizes and those calculated 
by the minimum Feret diameter. It can be seen that there is a slight bias towards the 
values of the Feret diameter being high. This is probably a result of the fact that the 
holes in the sieve are square. Therefore, a sieve with 125 µm spacing has a diagonal of 
177 µm allowing larger particles to fall through. It has been shown previously that this 
leads to two dimensional image analysis producing an over estimate of particle diameter 
(Fritts, 1937). 
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7.3.2 Parameters for FTIR image preparation 
When performing quantitative analysis of samples using ATR-FTIR spectroscopy, 
choice of the characterisitic band used for analysis is a significant factor. This has been 
shown to change the measured size of glassy hard spheres in ATR-FTIR imaging 
(Everall et al., 2009). As shown by Equation 7-1 the depth of penetration, dp, of the 
evanescent wave is dependent on wavelength . 
 
 
    
   ⁄






Where λ is the wavelength of radiation, n1 is the refractive index of the ATR crystal, n21 
is the ratio of the refractive index in the sample medium to the refractive index of the 
ATR crystal and θ is the angle of incidence of the infrared beam. In the case of air as the 
adjacent medium n2 = 1 and Equation 7-1 becomes Equation 7-2 . 
 
 
    
 
     






dp is considered here as the point at which the field has decayed to 1/e times the value at 
z = 0 (the surface of the ATR crystal). The work in this chapter will be done based upon 
the depth at which the intensity has fallen to 10% of its value at z = 0 as the threshold 
value in image processing will be set to 10%. This will be denoted as dt and has been 
shown to have a value of 1.15 dp (Everall et al., 2009). The geometry of this calculation 
for the apparent size of a sphere in ideal conditions using hard spheres is shown in 
Figure 7-6. 
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Figure 7-6. Diagram showing how the depth of penetration of the evanescent wave (dx) 
affects the perceived radius (S) of as sphere with radius (rs). Adapted from (Everall et al., 
2009). 
 
Figure 7-6 shows the relationship between the actual radius of a sphere (rs) and the 
apparent radius of a sphere (S) when measured in ATR mode. dx is the depth of 
penetration and in this case can represent either dp or dt. S can be calculated using 
Pythagoras as shown in Equation 7-3. 
 
      
         
  
  ⁄
 Equation 7-3 
 
 
Figure 7-7. Comparison of the spectra of caffeine and paracetamol. The boxes highlight 
the possible ranges that could be used for univariate analysis. ● Caffeine: range 1721 - 
1684 cm
-1
 centre at 1694 cm
-1
 ● Paracetamol: range 1513 - 1486 cm-1 centre at 1504 cm-1 ● 
Caffeine: range 1300 - 1274 cm
-1
 centre at 1285 cm
-1
 ● Paracetamol: range 1122 - 1091 
cm
-1




Figure 7-7 highlights four possible characteristic bands of paracetamol and caffeine 
which could be used for image generation, spread throughout the spectral range. Each of 
these bands will exhibit a different mean depth of penetration. For consistency it was 
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penetration with as little discrepancy as possible. The theoretical case for hard spheres 
was calculated using Equation 7-2 and Equation 7-3 the data are presented in Figure 
7-8. The colours of the lines in Figure 7-8 correspond to the colours used to highlight 
the bands in Figure 7-7. 
 
Figure 7-8. Comparison of measured diameter and true diameter for hard spheres.  The 
wavenumbers of the centre of the bands above are shown in the legend. The dashed lines 
are caffeine bands, the solid lines are paracetamol bands. 
 
Figure 7-8 shows an almost 25% discrepancy in the measured size across the spectral 
range. It is clear that the caffeine and paracetamol bands with the closest result for 
measured size are the bands at 1694 cm
-1
 and 1504 cm
-1
. Therefore these bands were 
used for analysis of the data. 
 
7.3.3 Analysis of component area fraction 
The paracetamol and caffeine were mixed in a 20:80 mass ratio. Therefore if all the 
compaction properties of the two components were equal, the ratio of the surface areas 
occupied by the components in the imaged area should have been approximately 20:80. 
The ATR-FTIR images of the compacted tablets were processed in the same manner as 
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Figure 7-9. Image processing from colour FTIR image to black and white threshold 
images for particle analysis. The size of the images is 500 µm × 700 µm. 
A randomly selected image from each size batch shown in Table 7-1 is shown in Figure 
7-10. From this presented dataset it appears as through the percentage of the image area 
in which paracetmol was present was higher at lower particle size, while also there 
appears to have been a large amount of particle agglomeration, despite thorough mixing, 
at lower particle size. 
 
 
Figure 7-10. ATR-FTIR images of caffeine and paracetamol following extraction and 
thresholding of the data for each size category of paracetamol. The size of the images is 
500 µm × 700 µm. 
 
As there were 40 images measured for each size interval, the mean value for each 
dataset of 40 images was calculated and the results are shown in Figure 7-11. It can be 
seen from Figure 7-11 that the measured fraction of the imaging area covered by 
paracetamol was not consistent across the range of size intervals studied. When the 
sieved particle size of paracetamol was in the 90-125 µm size range, i.e. the same size 
as the caffeine particles, then the area faction was very close to 20% indicating that the 
inconsistency in measured area across the range was due to differences in particle size. 
Paracetamol
125-90  µm
Colour FTIR data Greyscale FTIR 
data
Black and white 
FTIR data
<75 µm 75-90 µm 90-125 µm 125-150 µm 150-180 µm >180 µm
paracetamol
caffeine
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The data showed a strong trend of exhibiting higher than expected surface area when 
paracetamol particle size was small and a lower than expected surface area when the 
particle size was large. 
 
Figure 7-11. Plot of sieved particle size of paracetamol against measured area fraction the 
image covered by paracetamol for each size interval. Error bars were generated based on 
the standard deviation of each dataset. 
 
The data showing the area fraction of the images covered by caffeine showed the 
opposite trend to that for paracetamol as shown in Figure 7-12. The area fraction 
occupied in the imaging data by paracetamol increased with increasing particle size of 
paracetamol, i.e. as the caffeine particle size became smaller relative to the particle size 
of the paracetamol. Also plotted in Figure 7-12 is the summation of the caffeine and 
paracetamol surface area contributions at each size interval.  
 
In the case of a perfect system with no void space this should be equal to 1 at each size 
interval. In this case the average value was around 0.97, and although there was some 
variation between points the overall trend across the range was flat. This indicated that 
the integration ranges used for processing the FTIR images were relatively unaffected 
by spectral influences from the other component. The value of 0.97 does not suggest a 
void fraction of 3%, indeed it is probably slightly larger than this at the surface as the 
spatial resolution in the x and y directions is at best around 15 µm, therefore increasing 
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Figure 7-12. Plot of sieved particle size of paracetamol against measured area fraction of 
caffeine for each size interval. The graph also shows the summation of the values for 
caffeine and paracetamol. Error bars for caffeine were generated based on the standard 
deviation of each dataset. Error bars for the total are based on the larger error bar from 
either the caffeine or the paracetamol data. 
 
The reason for this discrepancy across the range is most likely due to the fact that ATR-
FTIR imaging measures at the surface layer of the sample. The smaller particles pack in 
around the larger particles. A series of many thin cross sections measured through the 
bulk of the tablet would still produce an 80:20 surface area ratio of the particles. 
However, due to the spaces between larger particles at the surface any smaller particles 
would pack in between the larger particles present producing an over estimate of surface 




Figure 7-13. Arrangement of particles at surface of ATR crystal before compaction. 
 
The arrangement of particles would then lead to the smaller particles deforming under 
the large particles following compaction. This would lead to a greater overestimate of 
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Figure 7-14. Schematic of compaction of particles of different size on an ATR crystal 
showing image data before and after compaction. 
 
These data show that ATR-FTIR imaging can give an approximation of component 
loading in a formulation with some caveats. When gathering these data one must be 
aware of the size of the particles involved and their properties under compaction. As 
ATR-FTIR imaging is a surface layer approach the data are susceptible to changes in 
these properties. However, if these are understood then it may be possible to draw 
meaningful conclusions from these data as long as one is aware of the assumptions 
being made. 
 
7.3.4  Statistical testing of data 
When analysing image data it is very important to understand whether or not the data 
truly represent the overall characteristics of the sample. ATR-FTIR imaging with a 
diamond crystal has good spatial resolution and can be used to study the compaction of 
tablets in situ; however it images a relatively small area of the sample. 
 
For the dissolution studies reported previously (Kazarian and Chan, 2003, van der 
Weerd et al., 2004) and seen elsewhere in this thesis, absolute statistical significance is 
less of an issue. These studies investigate the application of FTIR imaging to study 
physical phenomena such as crystallization, salt formation or mechanisms of drug 
release. As these are model formulations, the absolute values obtained are less important 
as they provide proof of concept and key mechanistic information. In the case of 
determining component concentration or particle size the absolute values are important, 
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Ideally there would be an infinitely large test dataset from which values for many 
different samples could be extracted. In practice this is not possible. Therefore, a 
relatively large dataset must be obtained and the data can be analysed carefully. 
 
It is possible  to follow the mean and standard deviation as a series of data samples are 
taken; when the inclusion of several further data points leaves these quantities 
unaffected, one can be confident that a good approximation to these values has been 
obtained. However, this entails human judgement and is very dependent upon the nature 
of the samples taken and especially upon the order in which the data are supplied. 
 
It is more useful to have a statistically rigorous value for how many samples to take in 
each case. An asymptotic approximation to such a number can be derived from a single 
dataset using the technique of bootstrap resampling (Adèr, 2008). Here, the dataset is 
randomly resampled to simulate a larger dataset; it can then be seen how many samples 
are necessary to calculate a good approximation to the mean. A set of scripts was 
written to determine how many samples must be taken to obtain an estimated value of 
the mean with 95% confidence for a variety of confidence intervals. The process used 
for this is outlined in Figure 7-15. 
 
 
Figure 7-15. Simplified flow chart showing data processing methodology used for 
establishing statistical significance for each size batch. The blue and green boxes represent 
subroutines which are detailed in Figure 7-16. 
 
Figure 7-15 presents the basic outline of the script used to determine a sample size 
which produces statistically relevant data. There were three inputs to the process. The 
confidence level (CL) which was set at 95%. The confidence interval (CI*) which was 
set to 20, 10 or 5% of the mean values presented in Figure 7-12 and Figure 7-11. Finally 
the raw surface area values for each size batch as defined in Table 7-1, where Xi is one 
of size batch 1 to 6. These data were then passed to the Confidence Testing (CT) 
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were a sufficient number of data points (images) used to achieve a 95% confidence that 
the mean value was within the chosen confidence interval (CI*). This process was 
repeated 50 times. The number of images required for each of the 50 repeats was then 
passed to the second subroutine which calculated their means and standard deviations. 
Assuming a normal distribution of values, 95% of all measurements should fall within 
two standard deviations of the mean, 97.5% of measurements will satisfy the required 
confidence level.  
 
The subroutine “CT” shown in Figure 7-16 details the confidence testing section of the 
script. As gathering thousands of images would have been an unfeasibly lengthy 
process, 40 images of data were used. In this subroutine the data were randomly 
resampled to simulate an infinitely large dataset. The first step read a surface area value 
from dataset Xi into a new set Yn. The point standard deviation and mean of Yn were then 
calculated. Based on this the confidence interval for a confidence level of 95% was 
calculated. If this value was greater than the chosen confidence interval CI* then the 
first loop was followed. This added another image to the set Yn, increasing the value of 
the number of images used (Pn) by one. This was repeated until confidence interval was 
less than CI*. Once this condition had been satisfied the process was repeated until 
n=50, i.e. there were 50 Y datasets each with a number of images required until the CI ≤ 
CI*. The number of images required for each Y was then printed. 
 
The subroutine “Mean + 2 Standard Deviations” shown in Figure 7-16 was the final 
step of the script. This subroutine read the values Pn for the number of images required 
for each n in subroutine “CT”. The mean and standard deviation (   and stdev    ) of 
these values were then calculated. The number of images required was then defined as 
   + 2*stdev    , finishing the script. This process was then repeated in triplicate for 
each size batch for both caffeine and paracetamol, for 5, 10 and 20% confidence 
intervals. 
 
 Chapter 7: Methodologies for Statistical Analysis of Pharmaceutical Formulations 
 
- 158 - 
 
 
Figure 7-16. Flow diagrams detailing the subroutines “CT” and “Mean + 2 Standard 
Deviations” as presented in Figure 7-15. 
 
The data presented in Figure 7-17 show an example set of the confidence interval 
testing outlined in subroutine “CT” in Figure 7-16. The graph shows data for 20 
different repeats of loop n. It can be seen that as the data were selected randomly, some 
measurements settle rapidly, requiring only a couple of images to achieve the desired 
confidence interval, whereas some required as many as 20 images. The sample mean 
was 10 images, with a standard deviation of 4.85, therefore these data would suggest 
that gathering 20 images would suffice. 
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Figure 7-17. Graph showing example data for 125-90 µm particle size of change in 
confidence level with increasing number of imaged sampled for a confidence level of 95%. 
The graph shows 20 repeats of the data settling to the required confidence interval. 
 
The data summarising the number of images needed to satisfy the required confidence 
level for paracetamol are presented in Figure 7-18. Within each confidence interval the 
values are relatively consistent across the range of particle sizes tested. Using a 20% 
confidence interval required just 8 to 10 images and a 10% confidence interval 20 to 25 
images. However, satisfying a 5% confidence interval was much more expensive in 
terms of number of images required, with around 60 images required on average. This 
also shows that repeating the confidence tests in subroutine “CT” 50 times was 
sufficient as the 3 repeats for each data point in Figure 7-18 are almost all overlapped. 
 
 
Figure 7-18. Graph showing the number of images determined for achieving statistical 
significance for the surface area of paracetamol at each particle size of paracetamol. Each 
point was repeated 3 times. The data points are plotted in the middle of the size range for 
paracetamol.  
 
Figure 7-19 replots the data as presented in Figure 7-18, but for the surface area of 
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paracetamol seen in Figure 7-18. Only around 10 images were required for a 20% 
confidence interval, while 25 were required for a 10% confidence interval. 5% was 
again much more expensive, requiring around 70 images. There is one significant 
difference, the data for a paracetamol size of >180 µm present a discontinuity with the 
rest of the data. This is most likely due to the fact that the particles of >180 µm were 
significantly larger than 180 µm, and presented as only one particle in each image. 
Therefore although the percentage variation in paracetamol surface area was relatively 
consistent, the variation in caffeine area was much smaller as the area percentage of 
paracetamol was only around 8%. 
 
 
Figure 7-19. Graph showing the number of images determined for achieving statistical 
significance for the surface area of caffeine at each particle size of paracetamol. Each 
point was repeated 3 times. The data points are plotted in the middle of the size range for 
paracetamol. 
 
These data have shown that it is possible to gather information that can be considered as 
satisfying a 95% confidence level with an interval of 10% and 20% of the sample mean, 
using the macro diamond ATR accessory in relatively few images. As seen in Figure 
7-18 and Figure 7-19, this is highly dependent on the confidence interval chosen.  
 
The data presented here are for a model system containing paracetamol and caffeine 
sieved to controlled particle sizes. Therefore, the absolute values cannot simply be 
transposed to other formulations which may be studied. However, these are two 
relatively typical pharmaceutical ingredients and serve as a model formulation. More 
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7.3.5 Particle size analysis 
In Section 7.2.2 the Feret diameter was used for analysis of the diameter of 
uncompacted particles. In this section Feret’s diameter was used for analysis of the 
diameter of particles within a compacted tablet matrix. The same thresholding process 
as seen in Section 7.2.2 was applied. A particle was defined as an individual domain of 
paracetamol. There were a certain number of small particles which were probably a 
result of small fragments of original particles breaking off during mixing and 
compaction of the powders. Particles below 10 µm in size were discarded. Only the size 
of the paracetamol particles were analysed as it was only a 20 wt% loading, therefore 
the caffeine mostly presented as a continuous phase as seen in Figure 7-10. 
 
The first results of the particle size analysis are presented in Figure 7-20, which plots 
measured particle size against the sieved particle size of paracetamol. Rather than 
presenting as a straight line with a positive gradient as may be expected, the graph 
exhibits a clear “U” shape. On the high end of the graph the data behaves as expected, 
but on the low end the measured particle size increases. This effect can be seen in 
Figure 7-10, with a smaller particle size there were a greater number of paracetamol 
particles present at the surface of the ATR crystal which led to overlap at the edges of 
the particles. Therefore, these data were very sensitive to the threshold used and ratio of 
particle sizes, and to the loading of the two components in the formulation. 
 
 
Figure 7-20. Graph showing measured particle size against sieved particle size for caffeine 
across all size batches. The data were all thresholded to 10% and the loading of 
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The other issue with this analysis method was that it was largely automatic following 
initial establishment of the threshold levels. The data were not interpreted in any way so 
although it may appear as though there were clearly a large number of well separated 
particles in the colour images in Figure 7-9, when processed the separate particles may 
merge. The reason for this is that the colour images have a greater dynamic range than 
those in greyscale, making them easier to interpret by eye. However, it was necessary to 
convert to greyscale for the image processing and apply a blanket threshold. In order to 
try and improve the particle sizing a second set of batches was prepared, with a 10 wt% 
loading of paracetamol as opposed to a 20 wt%, while a 20 percent threshold was 
applied which may have made maximum particle size slightly smaller. The cut off for 
smaller particles was raised to 15 µm. The data for this are presented in Figure 7-21. 
These data show a trend much closer to the positive gradient that would be expected. 
Although the higher threshold level may have reduced the mean size of the particles, the 
increased cut-off size maintained the mean value across the size batches as 




Figure 7-21. Particle size analysis in formulations with 10 wt% loading of paracetamol, 
thresholding value of 20% and particle size cut-off of 15 µm. 
 
 
These data were then run through the statistical analysis script described in Section 
7.3.4 in order to determine how many particles and images were needed to satisfy a 
95% confidence level with a 10% confidence interval. These data are presented in 
Figure 7-22. The data presented there show that the number of particles required was 
fairly consistent through the size batches except for the largest  size batch, although this 
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required increased with paracetamol particle size as there were fewer particles contained 
within the imaged area, although for most particle sizes only a few images were needed. 
 
 
Figure 7-22. Graph showing the number of particles and images required to achieve 




Importantly these data show that relatively standard particle analysis methods can be 
applied to extract information from compacted pharmaceutical formulations using ATR-
FTIR images. However, this methodology was very sensitive to the parameters of the 
processing methodology employed. The sensitivity of this approach to changes in 
particle size was also not very high. Ideally Figure 7-21 would have presented as close 
to x=y, however, the gradient of the line was only around 0.12. This was almost 
identical to the average gradient of the lines presented in Figure 7-8 for the case of hard 
spheres. The data in Figure 7-21 do have a positive offset of around 10 µm, most 
probably due to particle deformation under compaction. However, it does show that the 
approach is applicable when the user is aware of the properties of the analysis system. 
 
7.4 Conclusions 
The work presented in this chapter has covered three aspects of compacted tablet 
analysis. The first stage was studying the effect on the observed surface area fraction of 
a component in ATR-FTIR images with changing particle size. It was found for the two 
component model system studied here, that when the particle size of paracetamol was 
the same as the size of the bulk caffeine particles that the observed surface area fraction 
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the paracetamol particle size was smaller than that of caffeine the surface area fraction 
of paracetamol was larger than the bulk volume fraction and when the particle size of 
paracetamol was larger than that of caffeine the surface area was an underestimate 
compared to the bulk volume fraction. 
 
The second part of the chapter dealt with investigating how much data was required to 
achieve a set confidence level. It was found that for these model samples it was found 
that 10 – 20 images was sufficient to gather surface area coverage in 2D imaging data to 
within a small confidence interval, while only a few images were needed for 
determination of particle size. 
 
The final section investigated the application of this approach for assessing particle size 
within compacted matrices using FTIR imaging. It was found that this is possible; 
however, it was very sensitive to the parameters of the sample and analysis 
methodology. However, through the use of more advanced particle identification 
techniques this should become more feasible. 









APPLICATION OF FTIR IMAGING TO 
STUDY THE EFFECTS OF MODIFYING 
THE pH MICROENVIRONMENT ON 
THE DISSOLUTION OF IBUPROFEN 
FROM HPMC MATRICES
 Chapter 8: Application of FTIR Imaging to Study the Effects of Modifying the pH 
Microenvironment on the Dissolution of Ibuprofen from HPMC Matrices 
 
- 166 - 
 
8 Application of FTIR Imaging to Study the Effects of 
Modifying the pH Microenvironment on the Dissolution 
of Ibuprofen from HPMC Matrices 
 
8.1 Introduction 
The work in this chapter investigates the effects of modifying the pH in the tablet 
microenvironment on the dissolution of ibuprofen, studied with FTIR spectroscopic 
imaging. Previous work on the dissolution of ibuprofen using FTIR imaging was used 
to study polymer/drug interactions while the formulations were in contact with aqueous 
media (Kazarian and Chan, 2003). That work showed that while polyethylene glycol 
could be used to maintain the ibuprofen in a molecularly dispersed state when dry, the 
ibuprofen would form crystalline deposits as the water soluble polymer dissolved. 
These crystalline deposits can irritate the lining of the gut causing stomach ulcers, 
(Lanza et al., 1979) and as ibuprofen is one of the most commonly taken drugs in the 
world, these side can effects pose significant problems. 
 
Previous work by Kazarian and Chan using FTIR imaging has demonstrated that this 
approach is fully capable of monitoring the crystallisation of the drug (Kazarian and 
Chan, 2003). The next logical step is to use this methodology to investigate ways to 
control and mitigate these issues. Several approaches have been used to enhance and 
control the release of ibuprofen. Ibuprofen can be dispersed in water soluble polymers 
such a polyethylene glycol (PEG) (Najib and Salem, 1987) or form complexes with 
cyclodextrins (Mura et al., 1998). While these methods do enhance dissolution of the 
drug, their effects are relatively small in magnitude compared to those of pH change and 
as in the case of PEG particularly, become ineffective once the polymer has dissolved, 
causing the drug to recrystallise.  
 
As ibuprofen is a weak acid, the solubility will increase above the pKa of the drug 
(Levis et al., 2003) therefore by adding alkaline compounds to the tablet matrix it 
should be possible to increase the rate of dissolution, or by adding acidic compounds 
retard the dissolution rate. At high pH ibuprofen can react with the basic compounds to 
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form salts which can have both positive and negative effects on the dissolution 
performance of the drug. 
 
The aims of the research reported in this chapter are to study and understand the effects 
of adding pH active compounds to mechanically mixed HPMC and ibuprofen tablet 
matrices. The gelling of the HPMC layer provided controlled release of the ibuprofen 
from the tablet, while manipulating the local pH within the tablet controlled the physical 




8.2.1 Sample preparation 
Sodium biphthalate powder, designed to produce a buffer of pH 4 when dissolved in 
aqueous media and sodium carbonate and sodium bicarbonate powders blended to 
produce a pH 10 buffer when dissolved in aqueous media were supplied by Sigma 
Aldrich. Citric acid and calcium hydroxide were both supplied by VWR International. 
HPMC K4M was used as the bulk excipient for the tablets and was supplied by 
Colorcon. The powders were sieved to 90-125 µm in diameter to ensure particle size 
consistency. The formulations presented here were mixed to have a 10 wt% loading of 
drug, 10 wt% loading of pH modifying compound, with the remainder consisting of 
HPMC. In the case of the formulations containing basic modifier compounds molar 
loadings are important due to possible interactions between the species. In each tablet 
there were 4.85×10
-5
 moles of ibuprofen. In the calcium hydroxide tablets there were 
1.75×10
-4
 moles of pH modifier and in the sodium carbonate based tablets there were 
5×10
-5
 moles of both sodium carbonate and bicarbonate. Ibuprofen was supplied by 
Whitehall International. 
 
8.2.2 FTIR spectroscopy 
An Alpha T FTIR spectrometer (Bruker, UK), as detailed in Section 5.4, was used to 
measure the ATR–FTIR spectra with a single element detector and a spectral resolution 
of 8 cm
–1
 and 32 co-added scans. 
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8.2.3 FTIR spectroscopic imaging 
The work in this chapter used a 64 × 64 FPA to acquire the images at a spectral 
resolution of 8 cm
-1
, with 20 co-added scans for each image. The non-imaging 
Supercritical Fluid Analyser accessory with a diamond ATR crystal was used (Specac 
Ltd., UK) as detailed in Column 1 of Table 5-2. Acquisition of each image required 
approximately 2 minutes. All images shown are 1100 µm × 780 µm. The tablets were 
positioned such that they half covered the imaging area, allowing the ingress of water to 
the matrix and swelling at the tablet edge to be imaged. 
 
8.2.4 Compaction and dissolution 
The in situ dissolution/compaction cell as described by van der Weerd and Kazarian 
(van der Weerd et al., 2004) was used for in situ compaction and dissolution of the 
tablet. The compaction force was applied using a torque wrench and the compression 
force applied to the sample on the diamond was 850 N which corresponded to 120 MPa 
for the 3 mm diameter tablet used. The dissolution medium used was deionised water 
and the flow rate was set to 60 ml/h. Each experiment was run for 3 hours. Water was 
used as the dissolution medium, rather than phosphate buffer in order to isolate the 
effects of pH modifiers added to the matrix. 
 
8.2.5 Visible optical procedure 
Visible optical video analysis was used, similarly to that introduced previously 
(Kazarian and van der Weerd, 2008), to study retention of the pH modifying compounds 
in the matrix during dissolution. A transparent Perspex dissolution cell was used, as 
schematically shown in Figure 8-1a. The tablets were compacted using the same method 
as before, however they were then removed from the compaction cell, and placed on the 
measuring surface of the diamond crystal with the Perspex dissolution cell bolted into 
place on top. The CCD video camera was mounted above the system as shown in Figure 
8-1b to capture visible optical images of the dissolution. Images were captured every 10 
minutes at a resolution of 720 × 576 pixels and an image size of 6 mm × 4.5 mm. As the 
pH control compounds were the same colour as the rest of the tablet, universal indicator 
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(supplied by VWR, UK) was added to the dissolution medium, which in a basic 










Figure 8-1. (a) Schematic of Perspex dissolution cell showing a top down view. The sample 
is placed half covering the top surface of the ATR diamond crystal. (b) Schematic of the 
optical dissolution assembly. The camera is mounted above the dissolution cell looking 
down on the sample, which is sandwiched between the Perspex cover and the diamond. 
 
8.3 Results and discussion 
 
8.3.1 Imaging of tablet dissolution 
The first set of images in Figure 8-2 show the changing distributions of the three major 
components (water, HMPC and ibuprofen) over time following contact between the side 
of the tablet and the dissolution medium. This was the control tablet which contained no 
pH modifying compounds. The characteristic spectral band used for analysis of the free 
acid ibuprofen was the carbonyl band in the range 1740 - 1670 cm
-1
, the band used to 
plot the distribution of the HPMC was in the range 1162 - 945 cm
-1
 and the band used to 
plot the distribution of water was in the range 3800 - 3000 cm
-1










Screw hole(a) (b) 
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Figure 8-2. Overview of dissolution data for main tablet constituents. The top row shows 
the ingress of water with time, while the expansion and gelation of HPMC can be seen in 
the middle row and the distribution of the ibuprofen can be seen in the bottom row of 
images as a function of time. No pH modifier compounds were used in this tablet. The 
images are 1100 µm × 780 µm. 
 
The data shown in Figure 8-2 served as a control experiment which was performed with 
no pH modification to illustrate the poor dissolution of ibuprofen from this type of 
formulation in a neutral pH tablet microenvironment and aqueous media. The data 
clearly differentiate all components of the system simultaneously in situ. 
Some domains of drug did dissolve, although there was also a significant amount of 
recrystallisation. Region (a) in Figure 8-2 (10 minute image in row 3) is a domain of 
depositing crystalline ibuprofen. Where the crystalline deposits formed on the surface of 
the imaging diamond, a corresponding region of low concentration of HPMC or water 
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Figure 8-3. Spectra showing a comparison of the spectrum of crystalline ibuprofen and a 
spectrum extracted from domains of crystallising ibuprofen in Figure 8-2. The spectrum 
of crystalline ibuprofen is shown to have the peak of the carbonyl band located at 1705 
cm
–1
, whereas the crystallizing spectrum has a shoulder located at 1705 cm
-1
 
corresponding to the presence of some crystalline material (the broad band at ca. 1640 
cm
-1
 corresponds to the bending mode of water).  
 
The spectrum of pure crystalline ibuprofen shown in Figure 8-3 was used as a reference 
and the spectrum of crystallising ibuprofen was extracted from region (a) of the 
ibuprofen image at 10 minutes in Figure 8-2. The reference spectrum of crystalline 
ibuprofen displays a prominent carbonyl band which is positioned at ca. 1705 cm
-1
. This 
has been validated in previous work as corresponding to the crystalline form (Kazarian 
and Chan, 2003). The spectrum of crystallising ibuprofen, extracted from the ten minute 
image of row 3 of Figure 8-2, shows a small band at around 1705 cm
-1
 which can be 
assigned to the carbonyl of depositing crystalline ibuprofen. In Figure 8-2 this cloudy 
region becomes more defined over time and is still present after 180 minutes of 
dissolution. 
 
8.3.2 Comparison of evenly loaded formulations 
Figure 8-4 presents data for tablets each with a 10 wt% loading of ibuprofen and a 10 
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Figure 8-4. Figure showing ibuprofen (in free acid form) dissolution performance for 
tablets with 10 wt% loadings of pH modifying compounds and ibuprofen. Row 1: 10 wt% 
loading of calcium hydroxide; Row 2: 10 wt% loading of citric acid; Row 3: 10 wt% 
loading of sodium carbonate based modifier; Row 4: 10 wt% loading of sodium 
biphthalate. These images were generated based on the carbonyl band of ibuprofen 1740 - 
1670 cm
-1
. The images are 1100 µm × 780 µm. 
 
Initially the data presented in Figure 8-4 appear to show that the compounds with basic 
pH modifiers exhibited faster dissolution of the ibuprofen than those with acidic pH 
modifiers. Indeed the presence of crystalline ibuprofen in the basic tablets was almost 
completely diminished after 180 minutes. In the acidic tablets there was a large presence 
of crystalline ibuprofen after 180 minutes of dissolution.  
 
The effects of using HPMC as the polymer are also apparent in Figure 8-4. 
Translocation of the particles with the swelling matrix is seen to some extent in all of 
the images. Indeed in row 3 of Figure 8-4 there was a slight increase in the overall 
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HPMC polymer moving drug particles from deeper within the tablet matrix into the 
imaging field of view. 
 
8.3.2.1 Dissolution profiles based on FTIR spectroscopic imaging 
In order to summarise the dissolution of the ibuprofen domains seen in Figure 8-4 a 
mass balance was performed on the imaging data. The processing method for these data 
is illustrated in Figure 8-5.  
 
 
Figure 8-5. Data processing of absorbance values for ibuprofen dissolution from tablet 
loaded with basic buffer. 
 
 The absorbance values for the ibuprofen integration for each pixel were extracted from 
the imaging datasets for each time step and arranged in size order, pixel 1 to 4096. 
These were then plotted as seen in Figure 8-5. The large positive values correspond to 
pixels displaying part of an ibuprofen domain. A significant fraction of the values are 
close to zero in value as the tablet only half covers the imaging area. The negative 
values could be caused either by contaminants which produce a negative value when 
integrated for ibuprofen, which is unlikely as none were found in the images, or they are 
a result of non-uniform illumination of the detector. These values are erroneous and 
were discarded from the data processing. The remaining data were then averaged for 
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each dissolution test. This produced a mass balance over time for the amount of 




































Figure 8-6. Graph showing the fraction of ibuprofen in free acid form remaining in the 
image at each time-step from Figure 8-4 and Figure 8-2. These graphs use eight data 
points in each line. The time-steps are dry, 0, 10, 40, 80, 120, 150 and 180 minutes. The dry 
measurement and the time zero reading are both plotted at t = 0, therefore each line has 
two data points for 0 minutes. The data presented here are an average of three runs, error 
bars are based on the standard deviation. 
 
The basic tablet formulations in Figure 8-6 showed a faster rate of removal of the free 
acid of ibuprofen from the dissolving matrices than those with the acidic additives. The 
magnitude of the difference between the acidic formulations is small because the 
solubility of ibuprofen in aqueous media plateaus below pH 4, as this is below the pKa 
of ibuprofen (Levis et al., 2003). Therefore, the decrease in pH from the sodium 
biphthalate to citric acid was unlikely to have altered the dissolution of the ibuprofen 
significantly. The dissolution performance of the control formulations was between the 
acidic and basic formulations although notably closer to the acid modified tablets. 
 
It can be seen that for some of the formulations the maximum amount of ibuprofen is 
seen at the 10 minute time point. This is a result of the fact that contact between the 
sample and the ATR diamond improves upon wetting of the formulations. This leads to 
an increase in absorbance by the ibuprofen in the tablet matrix. 
 
The magnitude of the error bars in the early stages of dissolution of the basic 
formulations was much larger than in the latter parts. This was a result of the increased 
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rate of disappearance of the free acid form in the basic conditions. It is proposed that the 
basic environment of the mechanically mixed tablet enhanced the dissolution rate of the 
ibuprofen; such that when a domain of drug was wetted it dissolved relatively quickly, 
causing the fraction of ibuprofen remaining to drop rapidly between the two time steps, 
resulting in greater variation between experimental repeats. This is shown in row 3 of 
Figure 8-4 as large domains of ibuprofen were seen to have dissolved rapidly. 
 
Conversely, the smaller error bars seen for the tablets containing the acidic pH 
modification compounds demonstrated that the acidic modification worked effectively. 
The presence of these compounds retarded the rate of dissolution of the ibuprofen. 
Therefore ibuprofen domains dissolved slowly, resulting in less variation between 
repeats. 
 
8.3.2.2 Formation of calcium salt during dissolution 
In previous studies of the dissolution of formulations containing ibuprofen using FTIR 
spectroscopic imaging, a large degree of recrystallisation of ibuprofen was observed 
(Chan and Kazarian, 2006c). In these formulations the addition of calcium hydroxide 
apparently prevented this as the ibuprofen appeared to dissolve well over the course of 
180 minutes (Figure 8-4, row 1). However, ibuprofen is a weak acid and will form salts 
at high pH (Kararli et al., 1989). 
 
In order to investigate the formation of this salt, super saturated solutions of ibuprofen 
and calcium hydroxide were prepared. As seen in Figure 8-7 these took the form of fine 
particulate suspensions. The pH of the calcium hydroxide based suspension was around 
12 while the ibuprofen solution registered around pH 5. The two suspensions were then 
mixed and almost immediately formed the ibuprofen Ca
2+
 salt seen in the third image in 
Figure 8-7. The particulates in this suspension were much larger and were very 
insoluble, even in the presence of a very large amount of excess dissolution medium 
which agrees with data found in the literature (Levis et al., 2003). 
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Figure 8-7. Laboratory prepared suspensions of calcium hydroxide, ibuprofen and the 
ibuprofen Ca
2+
 salt. The particulates in the calcium hydroxide and ibuprofen suspensions 
are very fine, whereas the particulates in the ibuprofen salt are much larger 
 
Following formation of this salt, it was extracted and analysed using conventional FTIR 
spectroscopy. The results showing the spectral changes associated with this reaction are 
given in Figure 8-8. The formation of the salt is characterised by the removal of the 
carbonyl and the appearance of the carboxylate band at 1550 cm
-1
. These spectral 
changes were similar to those which occur during the formation of the magnesium salt 
(Kararli et al., 1989). The images of ibuprofen dissolution in Figure 8-4 were generated 
based on the carbonyl of the crystalline ibuprofen. As this was replaced by the 
carboxylate carbonyl at 1550 cm
-1
 these images presented an apparently increased 




Figure 8-8. Comparison of the spectra of ibuprofen, calcium hydroxide, HPMC and the 
calcium salt of ibuprofen in the range 1800 cm
-1
 to 1300 cm
-1
. The carbonyl of the 
crystalline ibuprofen can be seen at 1705 cm
-1
 whereas in the spectrum for the calcium salt 
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Figure 8-9. ATR-FTIR images showing the formation of the calcium salt of ibuprofen with 
water ingress in ibuprofen tablet with 10 wt% loading of ibuprofen and calcium 
hydroxide. Image size is 1100 µm × 780 µm. The water images were generated based on 
the intensity of the ν(OH) band at 3800 - 3000 cm-1, the salt images on the carboxylate 
band at 1580 - 1545 cm
-1




The data in row 1 of Figure 8-9 show the presence of the calcium salt in the dissolving 
tablet loaded with calcium hydroxide from Figure 8-4 row 1. During the course of the 
dissolution there was a great deal of salt precipitation within the tablet matrix. This was 
therefore an unsuitable formulation for modifying the release of the drug, despite the 
apparently increased dissolution rate shown in Figure 8-4.  
 
The spectra in Figure 8-10 were chosen to illustrate the conversion of the ibuprofen into 
the calcium salt within the matrix. The spectrum given in Figure 8-10a was extracted 
from the top edge of the area covered by the salt, while the spectrum given in Figure 
8-10b was extracted from within the matrix where the salt was still forming. The 
spectrum given in Figure 8-10b clearly exhibits the carboxylate peak at 1550 cm
-1
 
(shown by box), although the bands are not as sharp or as well defined at those seen in 
Figure 8-8. This is most likely because there was still a large presence of unreacted 
ibuprofen present as evidenced by the presence of the crystalline carbonyl at around 
1705 cm
-1
 seen in the spectrum given in Figure 8-10c. There was also still a large 
amount of HPMC present in this spectrum, shown by the contribution of the of the 
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C-O-C stretching band presented in the spectrum given in Figure 8-10d at 1058 cm
-1
. 
This evidence suggests that within the matrix the crystalline salt was still forming at the 
time of extraction of the spectrum given in Figure 8-10b. The spectrum given in Figure 
8-10a has much sharper more defined peaks, while there is almost no presence of the 
original ibuprofen carbonyl at 1705 cm
-1
, the contribution from the C-O-C band of the 
HPMC is also much reduced relative to the spectrum given in Figure 8-10b. This 
suggests that the extracted the spectrum given in Figure 8-10a was from a much purer 








Figure 8-10. Spectra from Figure 8-9 and comparative pure spectra a) spectrum extracted 
from point (a) in Figure 8-9, b) spectrum extracted from point (b) in Figure 8-9, c) 
spectrum extracted from pure, dry domain of ibuprofen in Figure 8-9, d) extracted 
spectrum of pure dry HPMC from Figure 8-9. 
 
These data suggest that the ingress of water initiated the formation of the salt crystals 
within the matrix. While the effect of water to increase the rate of this kind of 
interaction has been seen before (Wright and Carstensen, 1986), the images in Figure 
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The images in the middle row of Figure 8-9, which show the presence of both the salt 
and the crystalline ibuprofen, were generated using the range 1440-1390 cm
-1
 in which 
both the ibuprofen and the salt present bands. Due to differences in the shape of the 
band between the two species, this row of images presents the distribution of the two 
components only qualitatively. While the salt did primarily form around the initially 
present ibuprofen crystals, these domains went on to form seed points around which 
more of the calcium salt crystallised. The insoluble salt forming around these nucleation 
points remained present in the images for the full three hours of the experiment. Over 
the course of the dissolution, the amount of salt increased, indicating dissolved 
ibuprofen was reacting with the calcium hydroxide forming an insoluble layer on the 
diamond. 
 
8.3.2.3 Formation of sodium salt during dissolution 
The formulation containing the sodium carbonate based pH modifier also formed an 
ibuprofen salt during dissolution (Figure 8-11). As the modifying compound in this case 
was sodium based, this was less of an issue for as the sodium salt was soluble. A 
secondary product of the reaction between the carbonates in the pH modifying 
compounds and the ibuprofen would have been the production of carbon dioxide. The 
volume produced would have been small relative to the total volume of the swollen 
matrix, and due to the buoyancy of the bubbles formed they would have floated to the 
top of the matrix. As a result there is no evidence of this in the images in Figure 8-4. 
 
The spectrum shown in Figure 8-11 extracted from the salt deposit seen in the images 
above. Based on the position of the band at 1550 cm
-1





, the salt formed as expected was sodium ibuprofen dihydrate (Lee and Wang, 
2009). The sodium salt of ibuprofen is significantly more soluble than the calcium salt 
and so this aids in the dissolution of the ibuprofen. This is highlighted in Figure 8-11 as 
the salt only appears to a slight degree in the middle of the dissolution before rapidly 
dissolving. 
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Figure 8-11. Formation of sodium salt during dissolution of tablet with 10 wt% loading of 
basic buffer, with extracted spectrum of salt (a). These images were generated based on 
the intensity of the carboxylate band at 1550 cm
-1
. The images are 1100 µm × 780 µm. 
 
As the sodium salt was highly soluble the images produced using univariate analysis, 
seen in Figure 8-11, do not show a clear image of the salt. Therefore following 
identification of the presence of the sodium salt, the data were analysed using factor 
analysis.  By using factor analysis it was possible to check whether any other as yet 
undetected species had formed during dissolution. The first step was to process the data 
to produce factors. Factors were produced which corresponded to the HPMC, water, 
ibuprofen and the sodium salt of ibuprofen. The factors for ibuprofen and the sodium 
salt are presented in Figure 8-12. 
  
Figure 8-12. Factors extracted from dissolution of tablet loaded with pH 10 buffer. (a) 
Factor corresponding to crystalline ibuprofen – the large band at 1700 cm-1 corresponds to 
the carbonyl of crystalline ibuprofen. (b) Factor corresponding to sodium ibuprofenate – 
the band at 1540 cm
-1
 is caused by the carboxylate band of the salt. 
Ibuprofen 
Sodium Salt
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These factors were then plotted as score images (Figure 8-13 and Figure 8-14), in which 
the score was a measure of how similar the spectra in those images were to the factors 
presented in Figure 8-12, rather than the concentration based images seen in Figure 8-4. 
 
 
Figure 8-13. Score images of crystalline ibuprofen showing the change in the distribution 
of ibuprofen during the course of the dissolution. 
 
The data presented in Figure 8-13 show the distribution of crystalline ibuprofen during 
the dissolution of the tablet loaded with pH 10 basic buffer. These images present the 
same distribution seen in Figure 8-4 in which the ibuprofen dissolution proceeds rapidly 
over the course of the dissolution. 
 
 
Figure 8-14. Score images of sodium ibuprofenate showing the change in the distribution 
of the salt during the course of the dissolution. The images are 1100 µm × 780 µm. 
 
The images presented in Figure 8-14 present a much clearer representation of the 
formation and subsequent dissolution of the sodium ibuprofenate during the dissolution 
of the tablet than Figure 8-11. The images at 10 and 40 minutes in particular show that 
the amount of salt in the matrix increased up to 40 minutes, however, it had begun to 
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Overall, these imaging data demonstrate that the presence of the calcium hydroxide was 
detrimental to the dissolution of ibuprofen, while the sodium carbonate based modifier 
serves to improve the dissolution significantly. Citric acid slowed the dissolution of the 
ibuprofen to the greatest degree, although similar performance was seen from the 
sodium biphthalate. This coincides with other data gathered for microenvironmental pH 
modification in which operating above the pKa increases the rate of drug release, while 
operating below reduces it (Pygall et al., 2009). The FTIR imaging data has provided 
information on dissolution within the tablet matrix. As expected the difference in 
performance is tied to the solubility performance of ibuprofen at various pHs. 
 
8.3.3 Salt formation in storage conditions 
It has been recorded previously that solid state interaction between calcium oxide and 
ibuprofen took several months of storage at 55 ºC (Kararli et al., 1989). It is interesting 
to note that this interaction occurred much more rapidly for calcium hydroxide in the 
presence of only ambient humidity. After about twelve hours at ambient conditions 
much of the ibuprofen had converted into the salt as shown in Figure 8-15. The fresh 
preparation, measured approximately five minutes after preparation of the sample, 
displayed a prominent carbonyl at 1705 cm
-1
. After twelve hours of storage at ambient 
conditions, the carbonyl had diminished significantly and the carboxylate band had 
become far more prominent. Indeed the changes following three weeks further storage 
were minimal, with only a small further reduction in the intensity of the carbonyl band. 
 
It was found that if powders were desiccated before preparation of the samples, the 
propensity of the components to react was significantly reduced. This suggests that a 
small amount of water that was present in the powders due to ambient humidity served 
to facilitate the reaction. It is proposed that water served as a medium through which a 
small amount of the drug and calcium hydroxide could diffuse and react. The products 
of this reaction were the salt and more water which would help the reaction to propagate 
more rapidly. Similar conclusions were drawn when investigating the solid state 
interaction of sodium bicarbonate and benzoic acid derivatives (Wright and Carstensen, 
1986). 
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Figure 8-15. Comparison of spectral changes over time during storage. Spectra measured 
for fresh preparation of sample batch, after 12 hours of storage in ambient conditions, and 
after 3 weeks of storage. 
 
As it was determined that the rate of this reaction was highly dependent on the amount 
of water present in the samples, the powders were stored in dry conditions and 
experiments were performed immediately following preparation of the tablet batches. 
 
8.3.4 Gel layer stability 
Previous studies using other methods demonstrated that the addition of ionic species to 
the tablet matrix may have adverse effects on the formation of the HPMC gel layer 
around the dissolving tablet (Pygall et al., 2009, Bajwa et al., 2006, Mitchell et al., 
1990). However, as seen in seen in Figure 8-16 any interruption to the gel layer in this 
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Figure 8-16. a) Comparison of the amount of swelling of HPMC for the formulations 
presented in Figure 8-2 and Figure 8-4 unloaded tablets. The presented images show the 
degree of swelling after 40 minutes approximately even in magnitude across the three 
formulations. b) Spectra extracted from area denoted by the grey box in each image. The 
HPMC band at 1065 cm
-1
 contains the same features for each formulation as the control 
and a constant height ratio between that band and the water bending mode at 1645 cm
-1
. 
The images are 1100 µm × 780 µm. 
 
The extent of HPMC swelling in each image of Figure 8-16a is consistent across all 
formulations. This indicated swelling was not inhibited by the presence of control 
compounds to a degree which could otherwise overshadow the effects of pH on the 
solubility of the drug. The consistency in the ratio of the intensities of the HPMC and 
water bands seen in Figure 8-16b shows that HPMC hydration was consistent across the 
formulations. This is further supported by the consistency in the shape HPMC band 
between the control sample and the pH modified samples. These spectral features were 
very similar to those of the spectrum extracted from the gelling region by van der 
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8.3.5 Visible optical analysis of dissolving tablets 
The dissolution of the pH modification compounds is a very important factor in 
affecting the dissolution of the ibuprofen. As seen in Figure 8-4, relative to the 
ibuprofen or the polymer matrix, the pH modification compounds were very soluble. 
HPMC was chosen as the polymer as it forms a gel layer, which would help retaining 
the pH modifying compounds within the polymer matrix. As the profiles shown in 
Figure 8-4 displayed differing performance throughout the entire period of dissolution 
this suggested that the pH modifying compounds remained within the matrix over the 





Figure 8-17. Visible optical imaging of distribution of active pH modifying compound 
within dissolving tablet matrices. The tablet in row 1 contained a 10 wt% loading of citric 
acid. The indicator became pink in acidic conditions; therefore pink colour indicates the 
presence of acidic media in the image. The tablet in row 2 contained a 10 wt% loading of 
the sodium carbonate based buffer. The blue regions in the image indicate an area of high 
pH. 
 
Figure 8-17 shows the visible optical video images of the dissolving tablets over the 
course of three hours. As the dissolution medium (which contained universal indicator) 
came into contact with the pH modifying compounds in the matrix of the tablets, the 
indicator became pink in the presence of acid and blue in the presence of a basic 
compound. In row 1 of Figure 8-17, the pink colour remained throughout the 
experiment showing that there was still a large amount of the acid within the matrix at 
the end of the experiment. At the edges of the tablet, there was fainter pink colour, 
which was caused by the presence of citric acid in the gel layer and indicated pH control 
would be exerted over the drug up to the point of delivery from the matrix into the GI 
Dry 10 40 180100Time (min)
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tract. The indicator around the tablet in row 2 was blue. The blue colour revealed that 
the pH within the tablet matrix was higher than 7 due to the presence of the basic 
modifier. The colour remained for the entire 3 h of the experiment. The blue colour was 
also present in the dissolving gel layer of the tablet. 
 
8.4 Conclusions 
In this chapter of the thesis it was demonstrated that the dissolution of ibuprofen from a 
mechanically mixed, model tablet can be adjusted by the addition of pH modifiers to the 
tablet matrix.  The controlled release is dependent on the acidity or basicity of the 
additives.  The relative insolubility of ibuprofen at low pH leads to the addition of acids 
slowing drug dissolution. The sodium carbonate based buffer was able to solubilise the 
ibuprofen via formation of a sodium salt to the extent that it is released more quickly, 
while the calcium hydroxide formed the largely insoluble calcium salt. This is the first 
time that salt formation has been seen within the matrix as a result of micro-
environmental pH modification using FTIR imaging. Using these data it was also shown 
that as water enters the matrix during dissolution, salt formation occurs at the ingressing 
water front, demonstrating the role of the dissolution medium in facilitating this 
reaction. 
 
FTIR imaging has provided information on the internal dissolution processes of the 
tablet, showing that the addition of these pH modifiers changes the rate at which the 
ibuprofen particles within the tablet dissolve. The use of visible optical analysis along 
with the addition of universal indicator to the dissolution medium has shown that the 
HPMC polymer matrix was able to retain the soluble pH modifiers for at least three 
hours. 
 
This work has demonstrated the applicability of FTIR imaging to studying such 
formulations. Ibuprofen is one of a large number of weakly acidic poorly soluble drugs, 
while long term usage of the drug can have side effects such as stomach ulcers. The 
methods used here could be applied to study other pH sensitive formulations. 
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9 Dissolution of Tablet-in-Tablet Formulations 
 
Until now published reports have used ATR-FTIR imaging to study monolithic 
formulations, which are representative of a large fraction of tablets which have simple 
structures. However, ATR-FTIR imaging has the potential to study and reveal new 
information about the dissolution of more complex structures with multiple sections. 
The high chemical specificity of FTIR imaging is well suited to studying multiple 
components simultaneously. The high spatial resolution can show section boundaries in 
great detail and also reveal interfacial effects that may occur during dissolution. 
Multilayer systems have been commonly used to achieve multiphasic and zero-order 
release, though this will be investigated further in Chapter 10. This chapter presents the 
novel application of ATR-FTIR imaging for studying tablet-in-tablet structures, firstly 
for delayed release and secondly for delivery of pH labile drugs. 
 
9.1 Delayed release formulations 
 
9.1.1 Introduction 
This tablet structure, shown in Figure 2-5, can be used for ordered release, in which the 
drug in the central core is wrapped in an outer layer which also contains drug. This 
technique has also been used for biphasic fast/slow release (Hamza and Aburahma, 
2010, Lopes et al., 2007). This work applies similar principles to achieve delayed 
controlled release. Ueda and others have developed and applied a Time-Controlled 
Explosion System (Ueda et al., 1994, Hata et al., 1994). This produces a burst of drug 
release. The lag-time (time by which release is delayed) has been controlled by barrier 
thickness (Spencer et al., 2008, Ueda et al., 1994), the addition of water soluble 
excipients and the molecular weight of any swelling excipients (Matsuo et al., 1996). 
 
The tablets in this chapter use a core consisting of the model drug caffeine and HPMC, 
with a microcrystalline cellulose and glucose shell section. Previous studies have 
largely focused on studying the release profile of the drug from the dissolving system. 
As this work uses ATR-FTIR imaging it will be possible to learn much more about the 
internal physical and chemical dissolution processes of the tablet structures. The work 
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in this section of the thesis will investigate the processes of the components at the 
interface between tablet sections during tablet dissolution.   
 
X-ray microtomography, UV/Vis spectroscopy and visible optical video images were 
used as complementary techniques to study the dissolution, providing a complete 
analysis of the tablet breakup and drug release. 
 
9.1.2 Materials and methods 
 
9.1.2.1 Batch preparation 
Tablets consisting of four components were studied in this investigation. The core of the 
tablets contained caffeine (model drug) and HPMC. The core was mixed to a ratio of 30 
wt% caffeine and 70 wt% HPMC. HPMC was supplied by Colorcon (UK) and caffeine 
by Sigma-Aldrich (UK). The shell section of the tablet contained microcrystalline 
cellulose which was supplied by Merck Sharp & Dohme (UK) and glucose by Sigma-
Aldrich (UK). The shell components were mixed in ratios varying from 100 wt% 
microcrystalline cellulose to 100 wt% glucose in steps of 25 wt%. The powders were 
sieved such that all powders were below 90 µm in size. The core of each tablet had a 
mass of 18 mg and the shell of each tablet had a mass of 42 mg. 
 
9.1.2.2 Compaction procedure 
In order to prepare these tablets in the lab, a custom ex situ compaction cell was 
designed in order to form the tablets as shown in Figure 9-1. The tablets were 5 mm in 
diameter and the core was 2.5 mm in diameter. 
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Figure 9-1. Tablet-in-tablet compaction cell. The compaction cell consists of four separate 
pieces which fit together in order to form a compaction mould for the sections of the tablet 
 
The tablets were compacted in two stages; the outer shell was compacted first, before 
the core powder was then compacted into the middle, the procedure was as follows: 
 
1. The first step was to form the space for the outer shell by inserting the outer shell 
template (section 2 in Figure 9-1) and the punch (section 4) as guides into the base 
(section 1) before pouring the shell powder into the space created.  
 
2. The outer shell punch (section 3) was then inserted on top of the powder 
compacting it to form the shell section of the tablet. 
 
3. The punch was then removed leaving the compacted powder ring in place and the 
outer shell template with the outer shell punch were removed together from the 
base with the tablet shell still inside.  
 
4. The assembly was then clamped on a flat surface and the core powder was poured 





41. Base and punch holder 
 
2. Outer shell template 
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5. The punch was then inserted and the core was compacted inside the ring, this 
compaction firmly secured the core within the shell. 
 
Although the compaction of the tablets was performed ex situ it was important to 
maintain consistency with the procedures reported in the other chapters. As the surface 
area of the outer shell was roughly 2.8 times larger than that of the core a larger 
compaction force was required to achieve the same pressure. The pressure used for both 
sections was 120 MPa as this maintains consistency with procedures performed using in 
situ compaction (Wray et al., 2008). The precision of the manufacturing of the cell was 
also of great importance as variations in the thickness of the shell section around the 
tablet have been seen in standard manufacturing techniques (Ozeki et al., 2003). 
 
9.1.2.3 X-ray microtomography 
The X-ray microtomography was carried out using the Skyscan 1074 Portable X-ray 
microtomograph described in Section 5.5. The step scan angle was set to 0.9° and the 
tablet was rotated through 360°. The exposure time was set to 2 milliseconds and each 
extracted image was an average of 10 frames.  
 
9.1.2.4 FTIR spectroscopic imaging 
 FTIR images were acquired with a 64 × 64 FPA detector with 8 cm
-1
 spectral resolution 
and 20 scans co-addition. The accessory used was a non-imaging Golden Gate™ 
diamond ATR accessory (Supercritical Fluid Analyser, Specac Ltd., UK) described in 
Column 1 of Table 5-2. Image size was 1100 µm × 780 µm. 
 
9.1.2.5 Dissolution procedure 
The transparent Perspex dissolution cell described in Section 5.3.3 was used for tablet 
dissolution. The tablets were compacted using the same method described in Section 
9.1.2.2, they were then placed on the surface of the diamond crystal and the Perspex 
dissolution cell was bolted into place on top (Figure 9-2). A CCD video camera was 
mounted above the system to capture visible optical images of the dissolution (Kazarian 
and van der Weerd, 2008), the setup is illustrated in Figure 9-2. A UV/Vis detector was 
 Chapter 9: Dissolution of Tablet-in-Tablet Formulations 
 
- 192 - 
 
then connected online, in the two pump configuration described in Section 5.6, to 
measure the concentration of the drug in the effluent stream. The dissolution medium 




Figure 9-2. Tablet inside Perspex dissolution cell, showing flow pipes for dissolution and 
effluent stream to be sent for UV/Vis analysis  
 
The tablets were positioned such that the FTIR image produced was at the interface 
between the layers as shown in Figure 9-3. Correct alignment of the tablet interface with 
the centre of the imaging area was non-trivial as the tablet fully covered the diamond 
crystal. Therefore a template was designed that fitted on the top surface of the 




Figure 9-3. Positioning of tablet relative to the top surface of the ATR crystal. Schematic 
of underside of the dissolving tablet showing the imaging area aligned with the interface 














ATR crystal Tablet bottom
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9.1.3 Results and discussion 
 
9.1.3.1 X-ray tomography 
In order to verify the quality of the tablets produced by the manufacturing process, X-
ray microtomography was used to non-destructively construct a three dimensional 
density map of the tablet. This ensured that the tablets had consistent density 
distributions within each section of the tablet, that there were no large voids anywhere, 
and that the two sections had compacted together properly. The data from this 
verification are shown in Figure 9-4. 
 
 
Figure 9-4. X-ray density map of tablet overlaid onto three-dimensional structure of 
tablet. Red and purple domains are regions of high density and the blue domains 
represent areas of lower density 
 
The resulting structure of the tablet is clearly shown in Figure 9-4, this image shows 
that the core of the tablet was less dense than the shell region around it. For this test 
formulation a lower than normal compaction force was used to form the core in order to 
improve the contrast between the sections of the tablet in this image. The image shows 
that there was an approximately homogeneous density distribution throughout each 
section of the tablet. There is seen to be a slight gradient on the front face in the shell 
layer, however, this is not significant as the artificially applied colour range was set to 
cover a very narrow range of densities. Importantly, the image reveals that even with the 
reduced compaction force used to form the core of the tablet, the two sections 
compacted together seamlessly.  
 
Figure 9-4 shows that the core of the tablet was exposed; this was to allow for analysis 
of the dissolution of both tablet sections using ATR-FTIR imaging. In practice this type 
1 mm
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of tablet would be applied for delayed release, however, with the core exposed this 
would not create a delayed release profile. If this formulation were to be studied in a 
standard dissolution test or for in vivo studies, the tablet core would be sealed. More 
shell material would be compacted onto the exposed faces of the tablet as shown by 
Lopes et al. (Lopes et al., 2007). The exposed faces allowed for FTIR images of the 
tablet interior to be obtained from the underside of the tablet and for visible optical 
images to be gathered from above. During the dissolution the “caps” were replaced with 
the tablet being sealed between the diamond and its tungsten carbide surround at the 
bottom and the dissolution cell at the top. 
 
9.1.3.2 ATR-FTIR imaging setup 
The alignment of the interface between the two sections of the tablet with the ATR 
crystal was important. An example image showing the location of the shell material is 






Figure 9-5. FTIR image generated at the interface between the tablet sections, showing 
both core and shell material. 
 
The thickness of the barrier layer was 1.25 mm, whereas the imaging area of the 
diamond was only slightly over 1 mm across. It would have been possible to use an 
imaging crystal with a larger FOV such as zinc selenide, however; this would have 
required sacrificing spatial resolution. As the area of interest in these experiments was 
the interface between the tablet sections, a high spatial resolution was essential for 
accurately tracking the speed of water ingress and any subsequent interfacial processes. 
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sections was visible. This did result in the outer edge of the tablet not being visible, 
however, the visible video camera mounted above the dissolving system had a larger 
FOV in which the full diameter of the tablets could be seen. 
 
The band between 3600 – 3000 cm-1 was used to generate images for the distribution of 
water, which was the largest component of the dissolution medium. The caffeine images 
were generated using the band between 1676 – 1724 cm-1 and the HPMC images were 
generated using the band between 1088 – 1030 cm-1. The integration range used to track 
the microcrystalline cellulose was 961 – 924 cm-1 and the band used for glucose was 
between 1183 – 1224 cm-1. As glucose was applied in these tablets merely to increase 
the solubility of the shell, it will not be shown in the FTIR images, MCC data will be 
used to track the integrity of the shell.  
 
9.1.3.3 Presented formulations 
The experiments were conducted at a range of shell MCC concentrations, varying in 25 
wt% steps. FTIR imaging, optical imaging and UV/Vis spectroscopic data will only be 
shown in detail for the 75 wt% and 25 wt% MCC shell content formulations as 
demonstrations of the types of release mechanism obtained. The range of formulations 
studied is shown in Table 9-1, with presented formulations highlighted in grey. 
 
Table 9-1. Formulations studied in this chapter, with presented examples highlighted in 
grey. 
 
The various formulations used were designed to cause the shell section of the tablets to 
break up at different times. The core section was designed to then provide controlled 
release of the drug following the breakdown of the shell. Similar controlled release 




MCC 100 75 50 25 0 




HPMC 70 70 70 70 70 
Caffeine 30 30 30 30 30 
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sections have been applied in other studies (Maggi et al., 1999, Lopes et al., 2007). 
These studies applied them to biphasic release, which would have been possible from 
these formulations by adding a second drug to the shell section of the formulation. 
However, as the focus of this study was at the interface of the sections and the 
behaviour of the core, the formulations were constructed to achieve delayed release. 
Glucose is normally used as a sweetener or diluent (Ash and Ash, 2007), however, it is 
also highly soluble. In this case, it was paired with microcrystalline cellulose which was 
chosen for its binding and disintegrant properties (Inghelbrecht and Remon, 1998). 
Varying the loading of glucose was used to increase or decrease the rate of water 
ingress, changing the disintegration rate of the shell. Rather than using the shell 
thickness to control water ingress time (Spencer et al., 2008, Ueda et al., 1994), this 
work used changes to the formulation of the shell to control the rate of water ingress. 
 
9.1.3.4  Dissolution of Tablet 2 
The FTIR images in Figure 9-6 show the various components of Tablet 2, the first of the 
two presented formulations as specified in Table 9-1, during dissolution. 
 
 
Figure 9-6. FTIR images of the dissolution of sample with 75 wt% MCC and 25 wt% 
glucose in the shell (Tablet 2). The MCC coating is shown in the top row of images. The 
core components are shown in the second and third row, while the dissolution medium is 
shown in the bottom row. Image size is 1100 µm × 780 µm. 
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The first row of images in Figure 9-6 shows the distribution of the MCC in the shell 
section. The apparent breakup and dissolution of this layer was seen to take three hours. 
However, even following three hours of dissolution this layer had not dissolved, but had 
been moved out of the field of view. The MCC image at 170 minutes shows that the 
MCC layer had moved upwards, towards the periphery of the imaged area. This was 
explained by the behaviour of the HPMC in the core. At 50 minutes when the 
dissolution medium had only just penetrated to the imaged area the shell section 
remained fully intact. It was not until 110 minutes that the ingressing water 
concentration in the interfacial region of the matrix became significant. It was at this 
point that wetting of the HPMC in the core occurred. Upon wetting the HPMC began to 
form a gel and expand, this resulted in a significant change being seen in the HPMC 
images. This expansion of the inner section of the tablet caused the shell to be forced 
outward, displacing it from the imaging field of view as demonstrated in Figure 9-7d. 
 
The tablets were constructed from separately compacted structures, an inconsistency of 
which was, that there was a small discrepancy in the heights of the sections following 
compaction as shown in Figure 9-7a. Ordinarily in ATR imaging of HPMC based 
tablets, formation of the gel phase improves contact with the imaging surface (van der 
Weerd and Kazarian, 2004a). However, as the core became wet and the HPMC gel 
formed, the gel lubricated the interface between the sections so they were no longer 
compacted firmly together and could move independently.  
 
Figure 9-7. Schematic diagram showing the effects of the swelling core on the images of 
the shell and core sections in Figure 9-6. (a) core and shell structure displaying slight 
discrepancy in heights (b) water ingress through shell (c) vertical movement of core due to 
restricted swelling of HPMC (d) outwards expansion of the core displacing the shell from 













Vertical swelling Lateral swelling
Direction of water ingress
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Due to the discrepancy in the heights of the sections and their lubricated interface there 
was a small amount of vertical gelling space and the dry region of the core was lifted a 
short distance from the ATR diamond Figure 9-7c. As the penetration depth of the 
evanescence wave is a few micrometers then the core was lifted outside the ATR 
sampling volume. This lifting effect offered an effective method for tracking the inward 
progression of the water front into the core of the tablet. This is discussed further in 
Section 9.1.3.1.  
 
The caffeine images in the third row of Figure 9-6 show that the caffeine was 
distributed within the core and as the water caused the HPMC to expand, resulting in 
translation of the caffeine particles and providing controlled release properties for the 
formulation (Adler et al., 1999). However, the field of view of the ATR images was 
small and the expansion of the core resulted in the breakup of the shell and the 
dissolution of the drug being outside this domain. FTIR imaging provided important 
chemical and spatial information about the interface between the tablet sections; 
however, complementary techniques were also used to give a fuller description of the 
dissolution processes occurring. Visible optical video images, from the camera mounted 
above the system, of the dissolution are shown in Figure 9-8. 
 
 
Figure 9-8. Visible optical images for sample with 75 wt% MCC and 25 wt% glucose shell. 
Time is given in minutes below. Image size is 6.5 mm × 5 mm. 
 
The images in Figure 9-8 show the dissolution of the tablet with 75 wt% MCC coating 
captured by a video camera. The field of view of these images is approximately 6.5 mm 
× 5 mm. While this technique lacks the chemical specificity of FTIR imaging it was 
Dry 0 10 50 
110 170 230 290 
Time (min) 
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able to study a much larger area of the dissolution procedure simultaneously with FTIR 
imaging. The two sections of the tablet were clearly defined; the core was slightly lower 
than the surrounding shell material (c.a. 0.2 mm), indeed it is still in focus despite the 
small depth of field of the camera. It is important to note that the thickness of the shell 
section was uniform around the whole tablet, this is important as variations in shell 
thickness have been shown the significantly affect lag-time (Ozeki et al., 2004, Spencer 
et al., 2008). 
 
The ingress of water into the shell, in the image at ten minutes in Figure 9-8, is seen as 
darker regions of the tablet matrix around the edge of the shell. The ingressing water 
took 50 minutes to approach close to the core, which was in agreement with the FTIR 
imaging data. The image at 110 minutes highlights one of the advantages of using the 
chemically specific FTIR imaging approach. At this point in the optical images it did 
not appear that any water had penetrated the core, whereas, the FTIR images clearly 
show that it was this point at which the HPMC began to swell. 
 
At 110 minutes there was very little breakup of the shell of the tablet; this was not 
unexpected as there was a high concentration of MCC in the shell and this would have 
dissolved slowly. At 170 minutes two large cracks appeared in the shell, while at the 
same point there was significant wetting and expansion of the core. The shell material 
was pushed outward on the left of the tablet where the wetting of the HPMC was the 
greatest. This expansion of the core and the fracturing of the shell continued as more 
water ingressed into the core. Very little of the shell dissolved and the major route of 
exposure of the core to the flowing dissolution medium was through the cracks in the 
shell.  
 
Figure 9-9 shows the UV/Vis delayed release profile for the tablet with 75 wt% MCC 
coating. The data were normalised to give values between 0 and 1. The data are shown 
to the point where the lag-time and release mechanism had been established. This 
profile shows that no caffeine is released for the first 2.1 hours of the dissolution, giving 
a lag-time for this sample of approximately 130 minutes. Establishment of the 
dissolution profile required around 45 minutes.  
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Figure 9-9. Graph showing dissolution profile for sample with 75 wt% MCC and 25 wt% 
glucose shell. Establishment of the dissolution profile is indicated by the grey box. The lag-
time is defined as being from t = 0 to the first response in the UV/Vis profile, at the left 
edge of the gray box. 
 
This coincided well with the information gathered from the optical and FTIR data. At 
170 minutes in the FTIR images in Figure 9-6 the MCC coating had been displaced 
outward significantly by the core due to the HPMC expansion. In the visible optical 
images (Figure 9-8) major cracks started to appear in the shell, exposing the core to the 
flowing dissolution medium and providing a route for the caffeine to be released. At 
first the cracks in the shell were small leading to only a slow rate of release. As the 
HPMC continued to expand the cracks in the shell became more severe leading to an 
increased dissolution rate. It was this slow breaking of the shell that led to the gradual 
establishment of the dissolution profile. 
 
These data show that, for tablets with high MCC content shells, the lag-time was 
controlled by the ingress of water to the core causing the expansion of the core and the 
fracturing of the shell. As the inelastic shell fractured, however, rather than exhibiting 
burst release, this formulation featured a gradual establishment of the release profile as 
shown in Figure 9-9. 
 
9.1.3.5  Dissolution of Tablet 4 
The FTIR imaging data for the sample with a shell formulation containing 25 wt% 
MCC and 75 wt% glucose (Tablet 4) are shown in Figure 9-10. The most apparent 
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shell sample occurred much more rapidly in Tablet 2 (Figure 9-10 row 1). The shell 
section of Tablet 4 had disappeared from the FTIR image field of view in 30 minutes. 
This also significantly reduced the time taken for the water to reach the core. In the 
Tablet 4 the dissolution medium penetrated the shell in 30 minutes compared to 110 
minutes for Tablet 2. The shell of Tablet 4 broke up before there had been any 
significant expansion of the core. The high loading of glucose (75 wt%), which was 
highly soluble, encouraged rapid water ingress and facilitated a much more rapid 
breakup of the shell and hence a drastically reduced lag-time. 
 
The speed ingress of the water front into the core was also much more rapid (Figure 
9-10 row 4), achieving a similar level of core hydration to Tablet 2 at 290 minutes in 
approximately half the time. The definition of the water front is clarified in Section 
9.1.3.1. The subsequent speed of water ingress into the core was also different between 
Tablets 2 and 4. The rate of water ingress through the core in Tablet 2 was found to be 
approximately 2.5 µm/min, whereas in Tablet 4 it was found to be approximately 4 
µm/min. This broadly agrees with values found in the literature for monolithic HPMC 
tablets (van der Weerd and Kazarian, 2004b, Bettini et al., 2001), although the 
additional loading of drug in this case makes direct comparison impossible. It does 
show that the remaining shell material in the tablets with greater MCC loading did 
impede water ingress. The increased rate of core hydration combined with the rapid rate 
of shell dissolution led to rapid and unconfined core expansion (Figure 9-10 row 3). The 
gelling core material expanded to the edge of the field of view in 80 minutes, whereas 
this event occurred at 200 minutes for Tablet 2. Indeed, without the protection of the 
shell section, there was a greater exposure of the core to the flowing dissolution medium 
causing the HPMC to swell more rapidly.  
 
This was reflected in the dissolution behaviour of the caffeine seen in row 3. As in 
Tablet 2 the caffeine particles in the core moved with the expansion of the HPMC gel. 
However, there was a decrease in the absorbance corresponding to the amount caffeine 
in these domains towards the top of the image suggesting they were being dissolved. In 
Figure 9-6 there was no significant decrease in the absorbance of the caffeine domains 
during the course of the experiment. 
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Figure 9-10. FTIR images of the dissolution of sample with 25 wt% MCC and 75 wt% 
glucose shell (Tablet 4). The MCC coating is shown in the top row of images. The core 
components are shown in the second and third row, the dissolution medium is shown in 
the bottom row. Image size is 1100 µm × 780 µm. 
 
In Figure 9-10 the vertical swelling of the HPMC, seen in the HPMC data from Figure 
9-6, which lifted the core from the surface of the ATR diamond, was not present. This 
can be explained by the fact that the outer shell had lost any significant structural 
integrity by the time the water reached the core. This allowed the HPMC to expand 
outwards freely, without it being forced to expand vertically, so the dry unexpanded 
regions of the core were no longer lifted from the face of the diamond. The data in 
Figure 9-11 confirm and explain the observations made in the FTIR images. 
 
The images in Figure 9-11 show the dissolution of Tablet 4, captured using the video 
camera mounted above the dissolution cell. The dissolution process of this tablet was 
significantly different to that of Tablet 2. The highly soluble glucose caused the water to 
move through the shell in approximately 10 minutes, by which time the shell had started 
to dissolve throughout.  The shell continued to rapidly dissolve through to 30 minutes, 
wetting the core, and only the region close to the core still maintained any structure. 
This observation is consistent with the data from the FTIR images in Figure 9-10. 
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Figure 9-11. Visible optical visible images for sample with 25 wt% MCC and 75 wt% 
glucose shell (Tablet 4). Time is given in minutes below. Image size is 6.5 mm × 5 mm. 
 
As in the FTIR images, significant wetting of the core was seen at 30 minutes and by 50 
minutes there was a dark ring around the core. This ring shows the formation of the 
translucent HPMC gel. The dark colour was due to the tungsten carbide plating below 
the tablet being visible through the gel. The HPMC continued to swell over time and 
expand outwards. The white powder at the outer edge of the ring was the remnants of 
the shell; it remained present as it was trapped in the outer layers of the gel. At 50 
minutes the integrity of the shell was compromised, exposing the dissolving core to the 
dissolution medium. 
 
These data show that this tablet had a different mechanism of drug release to Tablet 2. 
In Tablet 2 the release of the drug was governed by the speed of ingress of dissolution 
medium through the shell of the tablet and the subsequent expansion of the core 
material breaking the shell layer of the tablet, exposing the core. The mechanism of 
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Figure 9-12. Graph showing dissolution profile for sample with 25 wt% MCC and 75 wt% 
glucose shell (Tablet 4).  
 
The dissolution profile in Figure 9-12 shows that the lag-time for Tablet 4 was greatly 
reduced compared to Tablet 2 coating tablet, taking under 1 hour. The transition to 
establishing a consistent release profile was significantly sharper than for Tablet 2. 
These effects were due to the more rapid breakdown of the shell, resulting in a shorter 
time to the initial exposure of the core to the dissolution medium and thereafter a more 
rapid establishment of a stable dissolution regime. The absolute release rate of the drug 
from this formulation after the lag-time was also significantly faster than for Tablet 2. 
The amount of drug released in the first hour after dissolution was approximately ten 
times larger from Tablet 4 than Tablet 2. 
 
These data confirm the dissolution of the drug from this formulation was controlled by 
another mechanism of release for this tablet type. The lag-time was determined by the 
disintegration of the shell layer, as opposed to the MCC rich shells in which the lag-
time was determined by the ingress of water through the coating and the expansion of 
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9.1.3.1 Analysis of HPMC swelling front 
In order to determine the time at which the dissolution medium reached the core 
(penetration time), it was necessary to define a concentration of water which could be 




Figure 9-13. Analysis of water front showing extracted images from Figure 9-6 showing (a) 
water distribution at 110 minutes and spectral extraction points and (b) swelling front of 
HPMC at 110 minutes (c) water spectra in the region of the water stretching vibrations 
extracted from corresponding extraction points, legend denotes extraction point 
 
The water images in Figure 9-6 show that the concentration of the water did not have a 



















































 Chapter 9: Dissolution of Tablet-in-Tablet Formulations 
 
- 206 - 
 
the line in Figure 9-13a, shown in Figure 9-13c revealed a gradual increase in water 
concentration across the image. The intensity of these peaks was plotted in Figure 9-14 
and water ingress presented in the images as a smooth gradient across the image, with a 
plateau towards the as yet unwetted core. It was not possible to pick a water front based 
on water concentration alone. However, as seen in Figure 9-13b, point 6 of extraction 
was at the swelling front of HPMC. The intensity of the HPMC band as a function of 
extraction point was plotted alongside that of water in Figure 9-14.  
 
 
Figure 9-14. Integrated absorbance the corresponding spectral bands of HPMC and water 
spectra from Figure 9-13 (a) and (b) plotted as a function of extraction point. 
 
Therefore, the concentration of water at which HPMC gelation commenced was 
determined as the front concentration. It was necessary to determine this water 
concentration, as not all of the formulations exhibited this lifting phenomenon, as 
shown in Figure 9-15. 
 
 
Figure 9-15. HPMC distribution in formulations at time point when water concentration 
had reached swelling concentration in the core. Formulations given by MCC:Glucose 
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The imaging time step, at which the water concentration in the HPMC reached the 
swelling concentration seen in Figure 9-13, is shown for each formulation in Figure 
9-15. This shows that only the formulations with a 75 wt% and 50 wt% (Tablets 2 and 
3) loading of MCC in the shell exhibited this phenomenon. The reason for this is 
explained by Figure 9-16; the tablet with a 100 wt% loading of MCC (Tablet 1) in the 
shell of the tablet showed no height difference between the shell and the core sections 
Figure 9-16. Due to the high solubility of glucose in water, the shell section of the tablet 
with a 100 wt% loading of glucose in the shell, dissolved very rapidly. Therefore, upon 
wetting of the core the shell section was so disintegrated that it did not serve as a 
swelling barrier to the core, such that no vertical swelling occurred. 
 
 
Figure 9-16. Visible optical images of shell dissolution for tablet with 100 wt% MCC in 
shell (Tablet 1). Image size is 6.5 mm × 5 mm. 
 
9.1.3.2 Comparison of formulation performance 
As stated previously, these experiments used a range of different shell concentrations 
and the two formulations analysed in detail here, have been shown in order to explain 
the numerous processes occurring during the dissolution in a fully comprehensive 
manner. These two experiments only show that there was a difference between the low 
and high MCC concentration shell, however, in order to study the trend, the lag-time 
data for the whole range of concentrations analysed is shown in Figure 9-17. 
 
Dry 0 70 160 
260 360 470 540 
Time (min) 
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Figure 9-17. Graph showing comparison of lag-time (time taken before a response is seen 
in UV/Vis dissolution profile) and penetration time (time taken for dissolution medium to 
reach core). Data points are shown as the mean value of three experiments with error bars 
generated based on standard deviation. 
 
Figure 9-17 compares the penetration and lag-times for the full range of shell 
concentrations. The lag-times were obtained from the UV/Vis dissolution profiles 
recorded for each dissolution experiment. The penetration times were obtained by 
finding the exact time at which the dissolution medium had penetrated the shell of the 
tablet and reached the core, from the FTIR data, as explained in Section 9.1.3.1. FTIR 
imaging shows a small region of the total core circumference, whereas the video images 
in Figure 9-8 show the entire circumference. It was decided not to use the video images 
for this as in the analysis of Figure 9-6 and Figure 9-10 it was demonstrated that the 
FTIR data detected the presence of water much more sensitively. 
 
The data showed, as expected, that with increasing MCC shell concentration both lag-
time and penetration time became larger. As the MCC concentration increased the 
penetration time of the dissolution medium increased, as without the presence of the 
soluble glucose the shell was less soluble, permeable and had better structural integrity. 
The most notable observation is that for tablets of 50 wt% MCC shell concentration and 
below, the lag-time and penetration time are very similar. This is because glucose is 
very soluble, so when it was present in high concentrations it caused the shell to 
disintegrate very quickly as it became wet and was dissolved. The result of this was that 
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outside it was already reduced significantly. The disintegrated state of the shell was 
confirmed by the video images in Figure 9-11. The lack of integrity of the shell then 
allowed the dissolution of the drug in the core to proceed. 
 
It was also seen in Figure 9-17 that when the concentration of MCC was above 50 wt% 
the values for lag-time and penetration time started to deviate significantly from one 
another. This was because; the mechanism of drug release changed significantly with 
high MCC concentrations. The dissolution medium penetrated the core however, before 
drug release was seen, the expanding core material had to break the shell. When the 
MCC concentration was higher the shell layer was stronger, requiring a greater 
expansion force to be broken and longer time for water ingress to soften it. This led to a 
longer time for the required swelling to occur for the HPMC to break the shell. The 
insolubility of shell combined with its greater structural integrity, are what lead to the 
deviation between the lag-time and penetration time. 
 
9.1.4 Conclusions 
The work in this section of the chapter has studied the dissolution of delayed-release 
pharmaceutical tablet formulations using ATR-FTIR spectroscopic imaging. 
 
For the tablet-in-tablet structured tablets studied, two release mechanisms were 
established. The first was seen for tablets in which the shell concentration of MCC was 
low. In these tablets the release was dependent upon the rapid dissolution of the shell 
which was facilitated by the high concentration of glucose. It was established that the 
lag-time and the penetration time were identical up to a shell MCC concentration of 50 
wt% for these formulations. 
 
The second type release mechanism was found in tablets with a high concentration of 
MCC in the shell. The lag-time was controlled by the rate at which the dissolution 
medium progressed through the shell and also by the subsequent expansion of the core 
and the amount of force required to break the shell. 
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This type of tablet is important, as adjustment of the concentrations of the shell 
components could allow for very fine control over the in vivo release point and 
mechanism of the drug, resulting in more targeted delivery. 
 
FTIR spectroscopic imaging played a very important role in this work of accurately 
determining the swelling of the HPMC core and its relation to the rate of water ingress. 
This was essential in determining the release mechanism of the drug, information which 
would otherwise have been unobtainable. 
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9.2 pH resistant formulations 
 
9.2.1 Introduction 
Previous work discussed in Chapter 8 has shown that the addition of basic buffer to a 
tablet matrix containing ibuprofen can raise the solubility of the drug within the matrix. 
However, once the basic compound in that area of the formulation has been neutralised 
by any acidic environment through which it may pass, the solubility of the drug in those 
areas is no longer enhanced. 
 
One method by which to deliver drugs such as ibuprofen, which crystallises in low pH 
conditions causing ulcers, or pH labile drugs which may be damaged by acidic 
conditions, is to deliver them straight into the large intestine. This has been done 
through the use of enteric coatings such as Eudragit® S, which dissolves above pH 7 
due to deprotonation of its carboxylic acid groups (Van den Mooter and Kinget, 1995).   
 
These formulations can be very effective and have been used for a wide range of 
applications including delivery of insulin (Touitou and Rubinstein, 1986, Dew et al., 
1982). These formulations do have some control issues, as variations in the pH of the 
digestive system can delay the breakup point (Rubinstein, 1990) and poor site 
specificity has been demonstrated (Ashford et al., 1993). 
 
This chapter proposes a pH resistant formulation for the delivery of NSAIDs such as 
ibuprofen based on the tablet-in-tablet structure seen in Section 9.1. However, the 
formulations in this section of the chapter use a pH modified barrier layer with a PEG 
and ibuprofen core. The pH active compound used was the sodium carbonate based 
buffer that was found to be effective at enhancing the solubility of ibuprofen in Chapter 
8. The buffer in these formulations was designed to work in two ways: 1) to neutralise 
the acidic environment in which the tablet was dissolved and 2) to enhance the 
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9.2.2 Materials and methods 
 
9.2.2.1 Batch preparation 
The tablets studied in this work consisted of five components. The core of the tablets 
contained ibuprofen (Whitehall International, UK), used as a model drug, Poly(ethylene 
glycol) (PEG) (Sigma-Aldrich, UK), the molecular weight of the PEG used was 4000. 
The core was mixed to a ratio of 20 wt% ibuprofen and 70 wt% PEG. The shell section 
of the tablet contained HPMC (Colorcon, UK), the same sodium carbonate buffer used 
in Chapter 8, and glucose (Sigma-Aldrich, UK). The powders were ground and sieved 
such that all powders were below 90 µm in size.   
 
9.2.2.2 Tablet formation 
The compaction procedure was the same as that described in Section 9.1.2.2 for the first 
three steps. The core was then formed using a novel injection method. The assembly 
was placed on a flat surface and a shorter outer shell punch was inserted, this served as a 
guide for the injected core, and ensured the outer edges of the tablet were sealed leaving 




Figure 9-18. Schematic of injection method of core preparation 
 
The mixture for the core was prepared by melting the PEG and ibuprofen, the still 
molten formulation was then injected into the core space of the compacted shell, as 
shown in Figure 9-18 and was left to solidify. Once the formulation had cooled the 
tablet was then extracted from the compaction cell. 
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This chapter presents data from two of the formulations studied, one of which was used 
as a control and contained no pH active compounds, while the second formulation 
contained basic buffer, as shown in Table 9-2. The difference between the two 
formulations was made up by glucose. 
 
Table 9-2. Control and pH active formulations 




HPMC 50 50 
Glucose 50 20 




PEG 80 80 
Ibuprofen 20 20 
 
9.2.2.3 Experimental 
The experimental procedure was much the same as that described in Section 9.1.2.5. 
However, the dissolution medium used was pH 2 hydrochloric acid, in order to replicate 
stomach conditions; this was then changed after 2 hours to pH 6.8 phosphate buffer to 
replicate post stomach conditions. 
 
9.2.2.4 FTIR imaging 
The FTIR imaging data of the dissolving tablets were acquired using the same imaging 
set up as described in Column 1 of Table 5-2. The images measured of the dissolving 
PEG/ibuprofen melt, were measured on a Varian imaging system with a 64 × 64 array 
detector with a zinc selenide accessory producing a field of view of 3 mm × 2 mm as 
described in column 4 of Table 5-2. 
 
9.2.3  Results and discussion 
 
9.2.3.1 FTIR spectroscopic imaging 
Six different compounds were used in these experiments: PEG and ibuprofen for the 
core, HPMC, buffer and glucose for the shell and water for the dissolution medium. 
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FTIR data of the dissolution of the excipients are shown for PEG in the core, HPMC in 
the shell alongside the FTIR data for water. This will suffice to demonstrate the location 
and any physical changes that occur to the core, shell and dissolution medium. 
 
The integration ranges used were 980 – 900 cm-1 for the PEG, 1080 – 1008 cm-1 for 
HPMC and 3600 – 3000 cm-1 for water. The crystalline state of the ibuprofen was 
monitored by examining the position of the carbonyl peak.  
 
 
Figure 9-19. Integration ranges for molecularly dispersed (amorphous) ibuprofen, 
crystalline ibuprofen and wet crystalline appearing as a shoulder on the OH bending mode 
of water. 
 
FTIR imaging has been used to study the spatial distribution of the crystalline and 
amorphous forms of ibuprofen previously (Kazarian and Chan, 2003). A position of 
around 1730 cm
-1
 corresponds to the non-crystalline form, in this case molecularly 
dispersed in PEG. A band at 1705 cm
-1
 corresponds to the crystalline form. The 
integration ranges used were 1730 - 1685 cm
-1
 for the wet crystalline and 1740 - 1720 
cm
-1
 for the non-crystalline as shown in Figure 9-19. 
 
9.2.3.2 Dissolution of Tablet 6 
Figure 9-20 shows the dissolution of the various sections of the control tablet (Tablet 6). 
The dissolution process of the shell can be seen in the first row of images. Removal of 
the shell section from the imaging FOV required approximately one hour, this process 






















 Chapter 9: Dissolution of Tablet-in-Tablet Formulations 
 





Figure 9-20. FTIR images showing the dissolution of control sample (Tablet 6). The first 
line of images show the dissolution of the HPMC shell, the second line shows the ingress of 
water into the tablet while the bottom line shows the dissolution of the PEG in the core. 
Image size is 1100 µm × 780 µm. 
 
The dissolution medium reached the core after 50 minutes and rapidly dissolved the 
PEG from the core section of the tablet. As this tablet had no pH modification and PEG 
dissolved fairly rapidly, it would be expected that the ibuprofen may crystallise. The 
dissolution of the ibuprofen is shown in Figure 9-21. 
 
 
Figure 9-21 FTIR images of the presence of amorphous ibuprofen (row 1) and crystalline 
ibuprofen (row 2) during dissolution of Tablet 6. Image size is 1100 µm × 780 µm. 
 
The dissolution images of the ibuprofen from Tablet 6 in Figure 9-21 show that initially 
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tablet. The core remained relatively unchanged until 50 minutes when the dissolution 
medium initially penetrated the shell. While the concentration of the PEG remained 
high, crystallisation of the ibuprofen did not occur in significant quantities. By 90 
minutes the dissolution medium had achieved a much greater degree of penetration into 
the core as shown in row 2 of Figure 9-20. In row 1 of Figure 9-21 the coverage of 
amorphous ibuprofen is much reduced, with only a small amount remaining near the 
bottom of the image. However, the population of the crystalline species had increased 
drastically across the image. This trend continued till the end of the experiment when 
there was no remaining trace of the amorphous form of the drug, while a large amount 
of the insoluble crystalline material had formed.  
 
These data demonstrated that as expected this formulation is unsuitable for delivery of 
ibuprofen in acidic conditions due to the low solubility of the large amount of 
crystalline material. 
 
9.2.3.3 Dissolution of Tablet 7 
Tablet 7 included the basic buffer as a pH modifier to protect the pH labile drug payload 
of the formulation from the acidic environment in which the formulation was being 
dissolved. The same components of dissolution will be shown for this tablet as for 
Tablet 6 in Section 9.2.3.2, but the time steps shown are slightly different. The 
dissolution of this formulation required more time as the buffer material was not as 
soluble as the glucose by which it was replaced in Tablet 6. 
 
The distributions of the HPMC, PEG and water components during the dissolution are 
shown in Figure 9-22. The behaviour of these components was very similar to that seen 
in Figure 9-20. However, dissolution to the same stage of completeness required 40 
minutes longer. The HPMC in the shell was removed from the imaging area by 210 
minutes; while the PEG was fully dissolved by 250 minutes and full water ingress 
required 250 minutes. 
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Figure 9-22. FTIR images showing the dissolution of pH modified sample (Tablet 7). Row 
1 shows the dissolution of the HPMC shell, row 2 shows the dissolution of PEG while row 
3 shows the ingress of water into the tablet. Image size is 1100 µm × 780 µm. 
 
As Tablet 7 had the basic buffer in the shell section it should be expected that there 
would have been improved dissolution of the drug as seen in Chapter 8. This was 
indeed the case in Figure 9-23. The ibuprofen, which was molecularly dispersed in the 
PEG, dissolved roughly in line with the PEG in Figure 9-22. The same behaviour for the 
amorphous species was seen in Figure 9-21; however, the crystalline behaviour was 
significantly different in this formulation. 
 
 
Figure 9-23. FTIR images of the presence of amorphous ibuprofen (row 1) and crystalline 
ibuprofen (row 2) during dissolution of Tablet 7. Image size is 1100 µm × 780 µm. 
 
In Figure 9-21 a large amount of crystalline material is seen to deposit, whereas in 
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basic buffer neutralised the acidic dissolution medium, but that it had raised the pH in 
the core somewhat above neutral, as ibuprofen dissolving in neutral conditions from 
PEG dispersions will still crystallise as shown by Kazarian and Chan  (Kazarian and 
Chan, 2003) using PEG 8000. This experiment was repeated with PEG 4000 as used in 
Tablets 6 and 7 and the results are shown in Figure 9-24. 
 
 
Figure 9-24. Dissolution of ibuprofen from PEG 4000 in water. Ibuprofen loading was 20 
wt%. Images show PEG and crystalline ibuprofen. Image size is 3 mm × 2 mm. 
 
The ibuprofen was not soluble in the pH neutral aqueous media used and readily 
crystallised as the PEG dissolved. The completeness of the dissolution of the PEG and 




Figure 9-25. Visible optical images of the dissolution of the shell and core material for 
Tablet 7. Image size is 6.5 mm × 5 mm. 
 
Dry 250 90 Time (min) 
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The data in Figure 9-25 illustrate that by 250 minutes of dissolution the core of Tablet 7 
had dissolved to such an extent that the diamond underneath the tablet was visible to the 
camera mounted above the system. The advantage of having a tablet made of a PEG and 
ibuprofen melt is that the drug is molecularly dispersed, however, this system exhibits 
relatively uncontrolled release and the ibuprofen will readily recrystallise. The addition 
of the shell structure containing the basic buffer and HPMC minimised this effect. The 
rate of release of the drug from the tablet would have been controlled by the rate at 
which it diffused through the HPMC gel (Matsuo et al., 1996, Ozeki et al., 2004). 
Through this the ibuprofen inherited the controlled release properties of the HPMC. 
 
The data thus far have implied that the pH neutralisation did indeed work as intended, 
however, there has been no direct evidence. In order to verify this, a similar 
methodology to that seen in Chapter 8 for investigating pH change in the matrix was 
applied. The acidic dissolution medium was dosed with universal indicator, turning it 
red, which, as neutralised by the buffer, should have turned green in colour. The results 
are shown in Figure 9-26. 
 
 
Figure 9-26. Video images of dissolving tablet with basic buffer. As the HPMC formed the 
gel it became translucent, which against the dark background of the diamond plating, 
made it difficult to see therefore, a 20 wt% loading of MCC was added to the matrix to 
improve contrast. Image size is 6.5 mm × 5 mm. 
 
In the images in Figure 9-26, it is clear that the pH neutralisation worked effectively. 
The gel layer appears cloudier than that in Figure 9-25, this is due to the addition of 
MCC, which was added to the tablet matrix to improve the visibility of the colour of the 
indicator. The image at 20 minutes shows a clear pink colour of the outer edge of the 
matrix. However, by 50 minutes, following a greater degree of establishment of the gel 
layer, the pink colour had faded and the matrix had a slightly green tinge, indicating 
neutralisation of the acid within the matrix. 
20 dry 5 0 Time (min) 
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9.2.4  Conclusions 
This work has developed a formulation specifically for the improved delivery of 
ibuprofen. FTIR spectroscopic imaging provided a methodology by which to accurately 
track the multiple dissolving components of the tablets. It also confirmed the 
effectiveness of the formulation, through monitoring of the crystalline state of the drug.  
 
The use of the PEG based core and basic HPMC shell prevented the crystallisation of 
the ibuprofen upon dissolution. The tablet structure also ensured that the drug was 
carried in a molecularly dispersed state, while also exhibiting controlled release. 
 
This formulation could easily be transferred to work with other NSAIDs such as 
flurbiprofen which can be dispersed in PEG. The formulation could also be modified to 
carry other pH labile drugs for oral ingestion. Moreover this tablet form should also 
help mitigate the long-term side effects of using NSAIDs, such as stomach ulcers by 
reducing crystallisation in the gut. 
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10 Biphasic and Zero-Order Release Formulations 
 
The work presented in Chapter 9 showed the potential information that FTIR imaging 
can provide when studying structured tablet formulations. The work in this chapter sees 
the novel application of ATR-FTIR spectroscopic imaging to study the formation and 
dissolution of multilayer pharmaceutical tablets. Multilayer formulations were used to 
create biphasic and zero-order release formulations. The work on zero-order 
formulations was then extended to investigate the effects of flow regime and geometry 
in the custom ATR flow cell. 
 
10.1   Biphasic release formulations 
 
10.1.1   Introduction 
The multilayer structure has been successfully used to achieve biphasic delivery for the 
purpose of quick/slow release, which can simply be achieved by using one fast release 
layer and another controlled release matrix layer (Uekama et al., 1990). There are 
multiple types of tablet structure that can be used for this type of delivery, Lopes et al. 
have made use of a tablet-in-tablet structure in which a slow release compressed core 
was formed and coated in a fast release compressed shell (Lopes et al., 2007). 
 
This chapter focuses on the use of FTIR imaging to study these fast/slow release 
formulations. Uekama et al. used cyclodextrin in the fast release layer and HPMC in the 
slow release layer (Uekama et al., 1990). Maggi et al. used double layer tablets for 
biphasic release of two different drugs in which the behaviour of the quick release phase 
was determined by the addition of a super disintegrant to the layer (Maggi et al., 1999). 
 
In this work FTIR imaging was used to study the processes which occur during 
dissolution at the interfaces between the tablet sections, in order to understand how the 
more soluble layer affected water ingress into the less soluble layer, and hence the 
release of the drug. 
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10.1.2   Materials and methods 
 
10.1.2.1 Tablet formulations 
The biphasic tablets were designed to release the two different soluble drugs, 
buflomedil (Lisapharma SpA, Italy) and nicotinamide (Sigma Aldrich, UK) from 
separate halves of the tablet. Each half of the matrix also contained microcrystalline 
cellulose (Merck Sharp & Dohme, UK) and glucose (Sigma Aldrich, UK) in varying 
amounts to produce differing dissolution properties for each half. The mass fraction of 
drug was 20 wt% in each section of the tablet, while the full range of concentrations of 
the remaining components used is shown in Table 10-1.  
 
Table 10-1. Tablet formulations studied for biphasic release. Concentration of components 
of studied formulations are given in wt%.  
 
10.1.2.2 Tablet compaction 
The powders were all ground down and sieved to particle sizes of less than 90 µm, and 
then mechanically mixed. For the purpose of compaction a custom designed compaction 
cell was created as shown in Figure 10-1. The cell consisted of three sections:  
1. The cell block, which was a square piece of metal with a 3 mm × 2 mm section 
cut out of it for inserting and compacting the tablet powders. 
2. The punch, a 3 mm × 2 mm rectangular punch. 
3. The faceplate, which bolted onto the face of the compaction cell to create the 
compaction chamber, and could be removed, simplifying extraction of the tablets. 
The tablets created by the cell were 3 mm wide and 2 mm deep, with each half of the 
tablet weighing 10 mg. 
 
  Tablet A Tablet B Tablet C Tablet D Tablet E Tablet F 
Buflomedil Side Glucose 0% 0% 10% 20% 30% 40% 
MCC 80% 80% 70% 60% 50% 40% 
Nicotinamide 
Side 
Glucose 40% 10% 30% 20% 10% 0% 
MCC 40% 70% 50% 60% 70% 80% 
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Figure 10-1. Schematic presentation of multilayer tablet compaction cell. 
 
The tablets were compacted with a total pressure of 120 MPa, however, in order to 
ensure good adherence of the tablet sections the pressure was applied in stages. The first 
section of the tablet was compacted with 60 MPa, then the powder for the second 
section of the tablet was added and everything was compacted to 120 MPa. 
 
10.1.2.3 FTIR spectroscopic imaging 
The FTIR images were acquired with a 64 × 64 FPA detector with 8 cm
-1
 spectral 
resolution and 32 scans co-addition.  The Golden Gate™ diamond ATR accessory 
(Supercritical Fluid Analyser, Specac Ltd., UK) was used. The field of view was 690 
µm × 610 µm as shown in Column 2 Table 5-2. An FTIR microscope with a Ge 
objective was also used for checking the integrity of the interface, it was a 64×64 FPA 
detector with an image area of approximately 64 µm × 64 µm as described in column 5 
of Table 5-2. 
 
The characteristic bands use for generating the images were as follows: buflomedil: 
1166 – 1088 cm-1, nicotinamide: 1412 – 1374 cm-1, glucose: 922 – 903 cm-1, MCC: 
1026 – 1010 cm-1, water: 1665 – 1620 cm-1. 
 
10.1.2.4 Dissolution procedure 
A transparent Perspex dissolution cell was used. The tablets were compacted ex situ, 
they were then placed on the imaging crystal and the Perspex dissolution cell bolted into 
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interface between the layers while also showing some of the dissolution medium as 
shown in Figure 10-2. Images of the dissolving tablet were acquired every 2.5 minutes 
throughout the duration of the experiments. The dissolution medium used was deionised 
water and the flow rate was set to 1 ml/min. 
 
 
Figure 10-2. Position of tablet relative to ATR diamond and the images produced using 
this arrangement. The images show one drug on the left of the image, and the other on the 
right. The top half of the images is left empty in order to show the dissolution medium. 
 
10.1.3   Results and discussion 
 
10.1.3.1 Compaction validation 
In order to verify that the custom compaction cell had formed tablets with a defined 
interface and consistent structure, both FTIR imaging and X-ray tomography were used 
to study the interface.  
 
Figure 10-3. Non-uniform tablet interface 
 
It was found, following the initial compaction procedure that the interface produced was 






Nicotinamide section Buflomedil section
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punch not being completely flat. Due to the relatively small imaging area used, this non-
uniformity manifested in the FTIR images which are aligned at the interface of the 
tablet sections, as seen in the first row of images in Figure 10-4. Therefore it was 
necessary to manually adjust the interface to be straight. 
 
 
Figure 10-4. FTIR images of tablet interface showing before correction (row 1) and after 
correction (row 2). In the formulations used for dissolution, the polymer in each half of the 
tablet was MCC, however, in order to highlight the interface, one half of this tablet was 
made using HPMC as the polymer. Image size is 690 µm × 610 µm. 
 
The interface of the tablet was straightened using a razor blade. After the first section of 
the tablet had been compacted, the faceplate of the cell was removed and the blade was 
used to cut away excess material. The tablets were weighed before and after and the loss 
due to cutting was approximately 2% of the mass of the tablet. 
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Figure 10-5 shows both halves of the tablet, the section which appears as the lower half 
of the tablet in the image was intentionally compacted using 80% of the force of that 
used on the upper half in order to produce contrast for the X-ray data. The data 
demonstrate that a tablet with relatively uniform density in each section was formed.  
 
Figure 10-6. Density profile through interface of tablet shown in Figure 10-5. Interface is 
shown by step change in density between 300 and 400 µm on the x-axis. 
 
The interface shown in Figure 10-5 is relatively sharp, although some gradient can be 
seen. This is because the spatial resolution of the X-ray microtomograph was relatively 
low (~80 µm (Kohout et al., 2006)), as shown in Figure 10-6. In order to study the 
particles at the interface with higher spatial resolution, it was necessary to use the 
infrared microscope. These data are shown in Figure 10-7. 
 
   
Figure 10-7. FTIR microscope images of tablet section interface. Image size is 
approximately 64 µm × 64 µm, with spatial resolution 4 µm. This tablet was created using 
MCC as the polymer in the right of the images and HPMC in the left of the image. The 
images were generated based on the absorbance of MCC in the range 961 – 924 cm-1. 
 
The microscope images in Figure 10-7 show a well defined interface between the two 
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second image was purely a result of the interlocking geometry of the particles which 
had all been sieved down to < 90 µm in size.  
 
10.1.3.2 Dissolution of Tablets A and B 
As described in Section 10.1.2.1 the tablets were designed to release two different 
readily soluble drugs, buflomedil and nicotinamide, although nicotinamide is more 
soluble than buflomedil. The rest of the bulk of the tablets consisted of microcrystalline 
cellulose (MCC) and glucose. The MCC was used to slow tablet dissolution due to its 
low solubility and good binding properties, whereas the glucose was used as a highly 
soluble agent, which expedited water ingress and caused the tablet to breakup more 
rapidly. Each tablet contained buflomedil in one half of the tablet and nicotinamide in 
the other and as such the halves of the tablet will be referred to as either the 
nicotinamide or buflomedil sections. 
 
As shown in Figure 10-2 the tablet was positioned such that the imaging area showed 
the interface between the tablet sections and the edge of the tablet. This allowed 
investigation of how the two drug release mechanisms proceeded simultaneously and 
their interactions with each other. 
 
Although a full range of formulations was tested, the data for Tablets A and B will be 
presented in detail (highlighted in Table 10-1). These formulations represent the 
extremes of the formulation range. Tablet A had a low loading of glucose in the 
buflomedil section of the tablet, while the nicotinamide section had a high loading of 
glucose. This formulation should highlight the effect of interference between the 
behaviour of the tablet sections. Tablet B contained a relatively low loading of glucose 
in both sections of the tablet and so serves to compare against the performance of 
Tablet A. 
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Figure 10-8. Dissolution of drugs and disintegrant from Tablet B. Buflomedil side – 
glucose: 0 wt% / MCC: 80 wt%, Nicotinamide side – glucose: 10 wt% / MCC: 70 wt%. 
Image size is 690 µm × 610 µm. 
 
Figure 10-8 shows the dissolution of buflomedil, nicotinamide and glucose from the 
matrix of Tablet B. It is clear from the images that the buflomedil was entirely located 
in one half of the tablet while the nicotinamide was clearly confined to the other half. It 
is also seen that the glucose was distributed in the nicotinamide half of the tablet as 
would be expected by the formulation’s constitution. The nicotinamide dissolved 
slightly faster than the buflomedil. This was approximately in line with the dissolution 
of the glucose from the tablet. 
 
In Figure 10-9 the dissolution of the drugs and glucose from Tablet A’s matrix can be 
seen. This formulation had a high loading of glucose in the nicotinamide section of the 
tablet. It appears in the images as though there is less nicotinamide in the sample than 
buflomedil. This was actually not the case, as shown by in Table 10-1 there was an 
equal loading of both drugs. The uneven distribution of the nicotinamide was a result of 
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Figure 10-9. Dissolution of micotinamide, buflomedil and glucose from Tablet A. 
Buflomedil side – glucose: 0 wt% / MCC: 80 wt%, Nicotinamide side – glucose: 40 wt% / 
MCC: 40 wt%. Image size is 690 µm × 610 µm. 
 
It is immediately apparent from the data that the nicotinamide dissolved out of the 
matrix very rapidly; there was nothing left of the nicotinamide in the imaging field of 
view after five minutes. This was much faster than the buflomedil in the other section of 
the tablet, or the nicotinamide in Tablet B.  
 
The buflomedil section of the tablet was not completely unaffected by this and indeed 
the buflomedil did dissolve more rapidly. The buflomedil in tablet A only required 20 
minutes to completely dissolve whereas 40 minutes were required for dissolution of 
buflomedil from Tablet B. These data indicated that the high loading of glucose in 
Tablet A not only increased the dissolution rate of the nicotinamide, but also increased 
the dissolution rate of the buflomedil. In order to fully understand why this difference 
occurs it is necessary to investigate the behaviour of the water and polymer components 
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Figure 10-10. Polymer dissolution and water ingress for Tablet B. Buflomedil side – 
glucose: 0 wt% / MCC: 80 wt%, Nicotinamide side – glucose: 10 wt% / MCC: 70 wt%. 
Image size is 690 µm × 610 µm. 
 
The dissolution of the polymer shown in Figure 10-10 shows that the microcrystalline 
cellulose swelled slightly. It also reveals that a channel in the nicotinamide half of the 
matrix opened up towards the end of the dissolution. If compared to glucose dissolution 
in Figure 10-8 it can be seen that this region corresponds to a void created in the matrix 
by the dissolving glucose. The images in row 2 of Figure 10-10 show that this void 
promoted the ingress of water into the tablet bulk, expediting the dissolution of the 
nicotinamide. As for the ingress of water it is clear that in this tablet the water ingressed 
into the more soluble nicotinamide half (containing the glucose) more rapidly than into 
the less soluble section. Indeed it appears that the water ingress rates for each section 
were relatively decoupled. 
 
 
Figure 10-11. Polymer dissolution and water ingress for tablet A. Buflomedil side – 
glucose: 0 wt% / MCC: 80 wt%, Nicotinamide side – glucose: 40 wt% / MCC: 40 wt%. 
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The dissolution performance seen in Figure 10-11 was significantly different to that 
seen in Figure 10-10. While the polymer did still undergo some expansion on the less 
soluble side of the tablet, it can be seen that by the end of the experiment the polymer in 
the nicotinamide section of the sample had been severely eroded. The buflomedil 
section of the tablet had somewhat more eroded compared to Tablet B. 
 
The greater level of disintegration was due to the greatly increased rate of water ingress. 
As would be expected water ingress happened much more rapidly on the nicotinamide 
half of Tablet A, however, faster water ingress was also seen in the buflomedil section 
relative to the buflomedil section of tablet B. In Tablet B the water ingress in each half 
of the tablet appeared quite independent. Whereas in Tablet A, probably due to the 
longer period for which the tablet interface was wetted, there was a significant 
movement of water moved across interfacial line into the buflomedil section. This had 
the effect of significantly increasing the rate of overall water ingress into the buflomedil 
section. 
 
As the increase in glucose loading increased the rate of water ingress, which ultimately 
led to faster disintegration of the tablet, it is important to compare the water ingress 
rates for the two formulations in both tablet halves. As seen in Figure 10-11 there was 
lateral movement of the water within the tablet matrix. Therefore it was not possible 
simply to record the time taken for ingressing water to reach the top of the imaged area. 
Water ingress was measured by the wetted fraction of the matrix. This was calculated 
based on the initial area of the tablet section before the initiation of dissolution and the 
remaining unwetted area at each timepoint. Wetted was defined as the point at which 
the intensity of the water band between 1665 – 1620 cm-1 reached 50% of the maximum 
value of the band in the lower half of the image in which there was no polymer. The 
results of this analysis are shown in Figure 10-12. 
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Figure 10-12. Comparison of wetted fraction for the buflomedil and nicotinamide sections 
of Tablets A and B. Data generated by extracting the wetted area as a function of time 
from Figures 6 and 7. 
 
Figure 10-12 clarifies the various rates of water ingress seen in Figure 10-11 and Figure 
10-10. The most significant difference between the formulations was that the rate of 
water ingress into the nicotinamide section of the tablet was greatly increased in Tablet 
A over Tablet B. This led to approximately a 50% reduction in the time required for 
water ingress to cover the entire visible area of the tablet half.  
 
It is also seen from Figure 10-12 that the increase in the amount of glucose in the 
nicotinamide side of the tablet had a significant effect on the buflomedil dissolution. 
Indeed the 40% increase in the rate of water ingress into the buflomedil half of the tablet 
from Tablet B to Tablet A was almost as much as that for the nicotinamide half. This 
was because as can be seen in Figure 10-10 and Figure 10-11, the increased water 
ingress in the nicotinamide section of Tablet A almost doubled the wetted perimeter of 
the buflomedil section. 
 
These data have shown that the rate of the dissolution of the two drugs in these 
formulations can be controlled. Most importantly though, it has shown the importance 
of gathering ATR-FTIR images with high chemical specificity and spatial resolution at 
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10.1.3.3 Dissolution performance summary 
Following the detailed comparison of Tablets A and B it is important to analyse the 
behaviour of the rest of the formulations from Table 10-1. The data plotted in Figure 
10-13 are the time taken for total water ingress into a tablet section and the time taken 
for total dissolution of the drug from that section for formulations A, C-F. Complete 
water ingress was defined as the time at which the wetted fraction of that tablet half 
reached 1. Complete drug dissolution was defined as the point at which the maximum 
absorbance of the drug in the image was less than 20% of the maximum absorbance 




Figure 10-13. Summary of dissolution data for Tablets A, C-F shown in Table 10-1. The 
graph plots time required for complete dissolution of the drug and time taken for the 
water ingress cover the entire visible area of the tablet half for both the buflomedil and 
nicotinamide sections of tablets A,C,D,E,F. Two different axes are used due to the 
differences in time scales involved. Points are plotted as the mean value of three 
experiments, error bars generated from standard deviation. 
 
The graph in Figure 10-13 illustrates that the rate release of each drug was controlled 
despite the interference seen in Figure 10-11. The concentrations of glucose for the 
formulations in Figure 10-13 varied inversely such that when the glucose loading in the 
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Overall the nicotinamide dissolved much faster than the buflomedil due to it being more 
soluble, hence the dissolution times for both drugs are plotted on separate axes.  Tablets 
A and F had a 40 wt% loading of glucose in one tablet section and a 0 wt% loading in 
the other. Therefore these formulations posed the greatest chance for interfacial 
interference, as one half dissolved rapidly potentially leaving the internal face of that 
tablet section exposed to the dissolution medium. Nonetheless the dissolution rate of the 
drug was controlled across the range of formulations with the maximum release rate for 
each drug seen with the highest glucose loading and conversely the slowest release seen 
with the highest loading.  
 
The glucose, despite being in the same loadings as the buflomedil halves, had a less 
significant effect on the rate of dissolution due to the high intrinsic solubility of 
nicotinamide. Indeed there was no significant change in the dissolution performance of 
nicotinamide until the glucose loading reached 30 wt%.  
 
It is clear from Figure 10-13 that, as expected for two soluble drugs, the time taken for 
the drugs to dissolve and the time taken for the water to ingress across the whole of the 
imaged area for the tablets were linked, as both sets of curves are roughly parallel. 
Indeed for the nicotinamide the curves are overlapped for all but a zero loading of 
glucose. This indicates the nicotinamide dissolved almost instantaneously (within the 
sampling rate of the images) upon contact with the dissolution medium. The match was 
less exact for the dissolution of buflomedil; there was a consistent lag of approximately 
5 minutes between complete water ingress and complete dissolution of the drug.  
 
The FTIR imaging data here demonstrate the applicability of this approach to studying 
these formulations. This work has shown that FTIR imaging can study the release of 
these two drugs from the tablet simultaneously. It has also shown that FTIR imaging has 
provided important information concerning the complex break up mechanisms of these 
structured formulations, such as cross-diffusion of the dissolution medium and 
identifying the dissolution front of the drug. 
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10.1.4   Conclusions 
ATR-FTIR spectroscopic imaging has been successfully applied to study the release of 
drugs from multilayer formulations. Bilayer tablets were applied to study biphasic 
release of drugs. It was found that FITR imaging served as a useful approach for 
effectively studying the complex process of water ingress into structured formulations 
where the dissolution performance of one side could have an effect on the performance 
of the other. 
 
In formulations with high loadings of glucose in one half of the tablet and low loadings 
in the other, the increased rate of water ingress into the more soluble section of the 
tablet caused it to dissolve rapidly. The high rate of dissolution increased the surface 
area of the less soluble section exposed to high concentrations of the dissolution 
medium. This led to an increased rate of dissolution being seen from the slow release 
section. 
 
It was also established that despite the level of interfacial interference a sufficient 
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10.2   Zero-order release 
 
10.2.1 Introduction 
The USP industry standard dissolution tests are the most commonly used approaches for 
assessing the dissolution profiles of formulations in pharmaceutical science (Achanta et 
al., 1995). These important tests were specifically designed as a necessary step in 
determining drug bioavailability and product performance (Cohen et al., 1990). 
 
The biphasic release studies showed ATR-FTIR imaging is an approach which can 
obtain direct insight into the complex drug release mechanisms and water ingress 
through structured tablets. However, such a layered structure can also produce tablets 
which exhibit zero-order release profiles. Colombo et al. (Colombo et al., 1990) 
achieved a close to linear release profile by applying impermeable barrier coatings to 
the top and bottom face of HPMC based tablets to control the direction of swelling, 
restricting changes in the surface area for release. Further work found that manually 
applied film barriers could be replaced in favour of swellable HPMC barriers that would 
swell with the core maintaining the surface area of the exposed core (Conte et al., 
1993).  
 
While FTIR imaging has great potential for studying the release of drugs from tablets, it 
is still a relatively specialised niche option for studying tablet dissolution. One of the 
reasons for this is that it is hard to compare the release data gathered from this method 
to that obtained from the industry standard USP dissolution tests. The major differences 
are found in the flow regimes and the geometry in the systems. The USP I and USP II 
type apparatuses are stirred tank systems, whereas the custom ATR dissolution cell is a 
flow-through system (van der Weerd and Kazarian, 2004b). In the USP systems the 
tablet is exposed to the dissolution medium on all sides, whereas in the ATR flow cell it 
is sandwiched top and bottom restricting the surface area, similar to a barrier layered 
tablet. 
 
This section of work for the first time links the UV/Vis dissolution profile data that can 
be gathered from the apparatus, to the industry standard dissolution tests. 
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10.2.2 Materials and methods 
 
10.2.2.1 Monolithic/barrier layer tablet formulations 
A monolithic tablet and a barrier layer tablet were constructed for dissolution in USP I 
type apparatus; the formulation of the core of the barrier layer tablet was the same as the 
monolithic tablet: 45 wt% buflomedil (Lisapharma SpA, Italy), 35 wt% HPMC K4M 
(Colorcon, UK), 20 wt% MCC (Merck Sharp & Dohme, UK). The tablets were 
compacted to be 10 mm in diameter, the monolithic tablet and the middle section of the 
multilayer tablet weighed 222 mg. The barrier layered tablet also had two outer layers 
of HPMC (100 mg each) compacted onto the flat faces of the middle section. These 




Figure 10-14 Formulations used for studies dissolution in USP I apparatus. a) Barrier 
layer formulation with cutaway showing ingredients of each layer b) Monolithic tablet 
formulation. 
 
For comparison a tablet with the same percentage component loadings as the monolithic 
tablet above was dissolved using the FTIR flow-through apparatus. This tablet was 3 
mm in diameter and contained 7 mg of buflomedil.  
 
10.2.2.2 FTIR imaging 
The FTIR imaging equipment used for this work was the same as that described in 
Section 10.1.2.3. The formulations were positioned differently as seen in Figure 10-15. 
The tablets were positioned, such that the tablet half covered the diamond. 
 
a) b)
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Figure 10-15. Alignment of tablet formulations relative to ATR crystal. 
 
10.2.2.3 Dissolution procedures 
The larger tablets were then dissolved using a USP I dissolution test with rotation speed 
set to 50 rpm. The smaller tablet was dissolved in the ATR flow cell at two flow rates, 1 
ml/min and 9 ml/min. Rather than using the two pump configuration shown in Figure 
5-11, the single pump system as used, as shown in Figure 5-12.  
 
10.2.3 Results and discussion 
 
10.2.3.1 FTIR and USP dissolution procedures 
As the USP dissolution tests are the standard and most widely used dissolution tests 
throughout the industry, it is important to compare the dissolution performance of the 
dissolution cell apparatus used with the ATR-FTIR imaging approach with standard 
USP dissolution apparatus.  
 
The differences between the methodologies are highlighted in the schematic diagrams 
of the ATR flow cell and USP I dissolution apparatus, which are shown in Figure 10-16. 
In the ATR flow cell, the tablet is sandwiched between the Perspex cell and the ATR 
diamond, while a rubber ring is used to seal the system, so the tablet is only exposed to 
the medium on its vertical side. In the USP I dissolution apparatus, the tablet is placed 
in the basket and is rotated during the whole dissolution test, so the tablet is totally 
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Figure 10-16. Comparison of design of USP dissolution cell and ATR flow through cell. 
The tablet in the FTIR dissolution cell is sandwiched between the cell and the diamond 
plating creating two barriers, whereas the tablet in the USP system is by virtue of the wire 
mesh of the basket, exposed on all sides to the dissolution medium. 
 
It has been demonstrated that tablet geometry plays a significant role in governing the 
dissolution profile of a drug from a tablet (Conte and Maggi, 1996, Kim, 1995). As can 
be seen in Figure 10-16 the effective geometry of the tablet in each case is significantly 
different, which should manifest itself in distinct differences in the dissolution profile. 
The Perspex cell and the diamond plating in the ATR flow cell can be approximated as 
barrier layers which have in particular been used for establishment of zero-order release 
profiles (Colombo et al., 1990) with swellable polymers in place of the hard surfaces. 
Therefore dissolution of a monolithic tablet, with a similar composition to the middle 
section of a barrier layered tablet designed to produce zero-order release in the USP 
dissolution apparatus, may be expected to yield a release rate which tends towards 
constant in the ATR flow cell with the correct flow conditions. 
 
10.2.3.2 Dissolution of formulations in USP I 
The first step was to construct and dissolve a monolithic and a barrier layer tablet in the 
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Table 10-2. USP I dissolution tablet formulations. 
 
 Buflomedil HPMC MCC 
Monolithic Tablet    
Constituents (wt%) 45 35 20 
Layered tablet    
Core Constituents (wt%) 45 35 20 
Barrier Constituents (wt%) - 100 - 
 
The monolithic tablet contained a soluble drug mixed with a swellable matrix of 
HPMC, a formulation which should have resulted in a tablet exhibiting a non-linear 
release profile for the drug (Lapidus and Lordi, 1966), while the addition of swellable 
barriers to the outside of the layered tablet should have yielded a more linear release 
profile (Conte et al., 1993). 
 
 
Figure 10-17. UV/Vis dissolution profiles for monolithic and barrier layer tablets in USP I 
dissolution apparatus. The data in this graph were also fitted using the model in Equation 
10-1. 
 
The data for the monolithic tablet in Figure 10-17 show as expected a non-linear release 
profile, whereas the release profile for the barrier layer tablet exhibited a significant 
shift towards constant release rate of the drug. These data are in good agreement with 
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1990, Conte et al., 1993). The release rate of the barrier layered formulation was also 
obviously much reduced as the surface area exposed to the dissolution medium was 
much smaller. The dissolution profile from the ATR flow cell would be expected to be 
more similar to the barrier layer tablet than the monolithic sample. 
 
10.2.3.3 Dissolution of tablets in ATR flow cell 
The formulations tested for dissolution in the ATR flow cell had the following 





Figure 10-18. UV/Vis dissolution profiles for tablets dissolving in ATR flow cell at low flow 
rate (1 ml/min) and high flow rate (9 ml/min). The data in this graph were also fitted using 
the model in equation 1. 
 
The dissolution in the ATR flow cell was performed at two different flow rates. A low 
flow rate of 1 ml/min still resulted in a rather non-linear dissolution profile; however, an 
increase in flow rate to 9 ml/min caused the release rate to shift towards constant as 
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10.2.3.4 Modelling of dissolution profiles 
The data from these experiments were fitted using a model developed by Peppas and 
Sahlin which separated the Fickian and non-Fickian components of release, shown in 
Equation 10-1 (Peppas and Sahlin, 1989). 
 
   
  
    
      
   
Equation 10-1 
 
Where the term on the left hand side is the fraction of drug released at time t and the 
first term on the right hand side describes the Fickian contribution to dissolution and the 
second term describes the relaxational (non-Fickian) contribution. This equation has its 
limitations as it fails to take into account the effects of moving boundary conditions; it 
is a simplistic model, but can give an indication as to the level of contribution from 
each, via the magnitude of the k1 and k2 terms. The m term is the diffusion exponent and 
is dependent on the aspect ratio of the sample, with the value for cylindrical samples, 
such as the monolithic tablet dissolved in the USP I apparatus, being 0.45 (Peppas and 
Sahlin, 1989). The tri-layered tablets and those in the ATR flow cell had restricted 
geometries, therefore the value for the cylinder was no longer appropriate. Indeed these 
formulations were closer to slab geometries and so a value of 0.5 was used for m. The k 
values for the fitted curves in Figure 10-17 and Figure 10-18 are shown in Table 10-3. 
 
Table 10-3. Summary of k values for fitted dissolution curves 
 k1 k2 
USP Dissolution   
Monolithic fit 0.16 0.094 
Tri-layer fit 0.00024 0.0362 
FTIR-ATR Flow Cell   
 Low flow-rate fit 0.11 0.044 
High flow-rate fit 0.0045 0.11 
 
From Table 10-3 it can be seen that for the monolithic tablet the Fickian term was large 
indicating that it was diffusion of drug out of the tablet that was the dominating process 
for release. However, as this was a swelling and eroding tablet, there was a significant 
contribution from the polymer relaxation term. For the tri-layer tablet the results were 
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markedly different, as would be expected for the data which so closely approximates a 
straight line, the Fickian contribution was small compared to the non-Fickian term, 
indicating the relaxational contribution dominated. 
 
The results from the ATR flow cell were similar to those from the USP dissolution 
apparatus, the low flow system produced a largely diffusion dominated result, while the 
high flow rate system produced a release profile in which release was controlled more 
by the relaxational term. Direct comparison of k values is not possible as the units are 
not the same, k1 has units of s
-m
 and k2 has units of s
-2m
. Therefore a better way to 
compare the dissolution data are to use Equation 10-2 which plots the fraction of release 
















Figure 10-19. Graph showing fraction of drug released by Fickian diffusion against total 
drug released. This graph illustrates the relative importance of the drug release 
mechanisms to the linear and Fickian release profiles. The fit of the model is only valid up 
to 60% release 
 
The release of the drug from the zero-order formulations shown in Figure 10-19 was 

































Fraction of drug released
USP Tri-layer fit
ATR-FTIR High flow-rate fit
USP Monolithic fit
ATR-FTIR low flow-rate fit
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zero-order formulations relied significantly more on Fickian diffusion to release the 
drug. However, for the non-zero-order formulations, it can be seen that over time the 
contribution of Fickian diffusion dropped significantly over the course of the dissolution 
of the tablets. At the beginning of the dissolution the release was diffusion controlled as 
there had been little swelling, so this was the rate determining feature. However, once 
matrix swelling occurred the regime of release shifted towards being swelling controlled 
as the drug was released from the relaxing polymer matrix (Siepmann and Peppas, 
2001), it is this which caused deviation from the standard square root of time kinetics 
(Korsmeyer et al., 1983, Urtti et al., 1985). 
 
10.2.3.5 Zero-order release from barrier layered tablet 
The mechanisms producing zero-order release for the barrier layer tablet and the ATR 
flow cell at high flow rate were not identical, although the similar geometries played a 
role in producing similar release profiles. The barrier layers of the tri-layer tablet in the 
USP dissolution apparatus initially reduced the surface area for interaction of the drug 
and the dissolution medium and therefore the rate of water ingress into the core (Conte 
et al., 1993, Conte and Maggi, 1996). The barrier layers restricted the swelling of the 
core to being primarily in the axial direction. Following this, as the polymers began to 
gel, swelling and erosion processes started to dominate.  The core of the barrier layer 
tablet swelled leading to an increase in the diffusion path length of the drug through the 
swollen polymer slowing drug release. This was partially limited by erosion of the gel 
layer while the polymer barrier layers also began to erode, increasing the area of the 
core exposed to the dissolution media. These two effects counterbalanced the increased 
diffusion path length and as the effects were controlled and balanced correctly it was 
possible to generate zero-order release (Conte et al., 1993).  
 
10.2.3.6 Dissolution of monolithic tablets in the ATR flow cell 
In the case of the ATR flow cell, while the flow cell and diamond plating acted as 
barrier layers, they were not erodible as in the case of the HPMC in the barrier layers; 
therefore the mechanism for maintaining zero-order release was slightly different. 
While the barriers still had the same effects as the swellable barriers, of restricting water 
ingress and resulting in only axial swelling, they did not erode. Therefore erosion of the 
 Chapter 10: Biphasic and Zero-Order Release Formulations 
 
- 246 - 
 
radially swelled gel surrounding the core was more important, which is why zero-order 
release was only seen at higher flow rates when the rate of gel erosion was higher. This 
maintained the effective thickness of the gel layer through which the drug had to 
dissolve as being roughly constant with respect to time, resulting in a close to zero-order 
profile (Möckel and Lippold, 1993). It is for this reason that at a low flow rate, zero-
order release was not achieved, as there was little erosion of the gel layer and so the 
diffusion path length became increasingly long for the drug.  
 
A comparison of the effects on polymer swelling can be seen in Figure 10-20. The 
increased flow rate, shown in the second row of images, is seen to erode the polymer 
faster than the lower flow rate, as total dissolution of the polymer from the field of view 
occurred about an hour earlier in the high flow-rate system. 
 
 
Figure 10-20. FTIR images of dissolution of tablets in ATR flow-cell at low and high flow 
rates. The data show the initial 15 minutes of swelling ad gel formation, and the last 3 
hours of final erosion of the swollen gel. Image size is 690 µm × 610 µm. 
 
Dissolution in the FTIR-ATR flow cell does share some similarities with the dissolution 
profile features of barrier layered tablets. While the mechanisms responsible for the 
zero-order release were not identical, the similarities between the geometries of the two 
systems were important. At low flow rates the level of Fickian diffusion involved in 
drug release was very similar to that of a monolithic tablet, whereas at high flow rates 
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10.2.4 Conclusions 
In this section of this chapter zero-order release formulation were explored as an 
analogue to the constricted geometry of the ATR-FTIR flow through system. The 
barrier layered formulations exhibited a similar geometry to the custom ATR flow 
through cell. The ATR flow through dissolution cell had the dissolution cell and 
diamond plating above and below the tablet. These acted as barrier layers similar to 
those seen in zero-order release formulations 
 
Based on the comparison of the levels of Fickian and non-Fickian release from the 
formulations studied in this section of the chapter, it was found that in low flow-rate 
conditions the dissolution performance of a tablet in the ATR flow cell did not differ 
significantly the performance of a monolithic tablet in a standard USP dissolution 
apparatus. The Fickian and non-Fickian contributions to the drug release mechanism 
were in roughly equal magnitude. However, it was found that higher flow-rates the 
dissolution performance did shift towards that of a barrier layered zero-order release 
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11 Conclusions and Future Work 
 
11.1   Conclusions 
The results presented in this thesis discussed novel applications of FTIR imaging to the 
study of pharmaceutical formulations. The work contains three major research themes: 
 
1. Validation of the approach, through the use of complementary techniques and 
comparison with existing methodologies. 
 
2. ATR-FTIR imaging was applied to study the dissolution of pH modified, 
biphasic and delayed release formulations. 
 
3. The novel application of ATR-FTIR imaging to study tablets with multilayer 
and tablet-in-tablet structures. 
 
FTIR spectroscopic imaging is a powerful and versatile analytical approach for which 
the potential applications to studying pharmaceuticals have yet to be fully realised. This 
work sought to exploit the chemically specific and spatially resolved information 
provided by ATR-FTIR imaging to study model tablets. The ability to use this approach 
with complementary techniques such as UV/Vis spectroscopy and X-ray 
microtomography was also leveraged where applicable. 
 
The work began with studies of tablet compaction, where it was found that the 
compaction of lactose can be improved by the presence of caffeine particles. Statistical 
analysis of the FTIR imaging data demonstrated that ATR-FTIR imaging was also able 
to reveal changes in the distribution of the components in matrices based on HPMC and 
MCC. This work has shown the applicability of FTIR imaging to study the effects of 
formulation and compaction pressure on component distribution and the density of the 
compacts. 
 
It was also shown that X-ray tomography can be used in conjunction with FTIR 
imaging to produce a density map of the tablets that verifies the data from the FTIR 
imaging. As X-ray tomography can only differentiate components based on density, this 
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necessitated the use of simple two component systems. Analysis of tablets with many 
components required the use of a technique with greater chemical specificity. 
 
A more thorough analysis of compacted tablets was then conducted, in which two 
aspects of the tablet properties were investigated: the relationship between component 
loading and observed component fraction at the surface layer with varying particle size 
and the ability of ATR-FTIR imaging to determine particle size. A model two 
component system consisting of paracetamol as the minor and caffeine as the major 
component was studied. When the particle size of paracetamol was smaller than that of 
the caffeine, the surface area fraction paracetamol was over estimated relative to 
component loading, whereas when the particle size of paracetamol was larger than that 
of the bulk, the surface area was an underestimate compared to the overall volume 
fraction. It was also determined that ATR-FTIR imaging is capable of differentiating 
samples based on differences in particle size. However, it was found that the accuracy 
of this information was highly sensitive to the loading of drug in the sample, and 
analysis parameters such as the thresholding values used for image processing.  
 
By adding basic and acidic pH modifiers to HPMC based ibuprofen tablets, it was 
shown that the solubility of the drug within the matrix could be adjusted. Acidic 
additives lowered the pH, slowing the dissolution of the drug. The basic additives 
reacted with the acidic drug to both increase and decrease the rate of dissolution through 
the formation of salts. This was the first time that salt formation had been seen within 
the matrix as a result of micro-environmental pH modification using FTIR imaging. The 
retention of the pH modifiers for the length of the dissolution experiments was also 
verified, through the use of a visible imaging using a CCD camera to monitor the 
dissolution and the addition of universal indicator to the matrix. 
 
The next section of work investigated tablet-in-tablet structures to create delayed release 
and pH resistant formulations. For the delayed release formulations studied, two release 
mechanisms were seen. For the first mechanism, lag-time was dependent upon 
disintegration of the shell section of the tablet. For the second type of release 
mechanism, lag-time was determined by the time taken for the dissolution medium to 
reach the core and also by the resulting expansion of the core which then broke through 
the shell section. FTIR imaging accurately monitored the swelling of the HPMC core 
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and was used to determine the point at which water ingress reached the core. This work 
represented the first application of FTIR imaging to studying structured tablets. 
Although these were model tablets, this work indicates that FTIR imaging can provide 
information which could help design formulations exhibiting fine control over the 
release point of the drug providing highly targeted delivery. 
 
Using the information gathered studying tablets containing pH modifiers, a formulation 
was developed which was designed to mitigate the solubility issues of ibuprofen in low 
pH environments. FTIR spectroscopic verified the ability of this formulation to 
minimise ibuprofen crystallisation by monitoring presence of the crystalline form of the 
drug. Complementary analytical approaches were used to check the structure of the 
resulting tablets and confirmed the neutralisation of the acidic dissolution media. The 
PEG based core maintained the drug in a molecularly dispersed state, while the pH 
modified HPMC shell raised the solubility of the drug and provided controlled release. 
This formulation served as a model, the concepts of which could be applied to the 
delivery of other NSAIDs and pH labile compounds. The principles employed in this 
formulation could help to reduce the side effects of long term use of NSAIDs such as 
stomach ulcers by minimising the amount of crystalline material deposited in the gut. 
 
Continuing the theme of studying structured tablets, bilayer tablets were studied. ATR-
FTIR imaging was able to monitor the progression of water into structured tablets, the 
independent breakdown of the sections and the influence that the dissolution 
performance of one section had on the adjacent section. HPMC based barrier layered 
tablets were also used to replicate some aspects of the dissolution cell geometry in a 
USP I type apparatus. At low flow-rate conditions the dissolution performance in the 
ATR flow cell was similar to the performance of a monolithic tablet in a standard USP 
dissolution apparatus. At higher flow-rates the dissolution performance did shift 
towards that of a barrier layered zero-order release formulation due to an increase in the 
role played by polymer gel erosion. 
 
To conclude, the chemical specificity and imaging capabilities of ATR-FTIR imaging 
have been used in conjunction with a number of complementary approaches to 
investigate a range of model pharmaceutical formulations. The applicability of the 
approach to studying pharmaceutical formulations has been further demonstrated 
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through studies of compacted pharmaceutical formulations. This has highlighted the fact 
that image data gathered at the surface layer is representative of the bulk as long as 
certain assumptions are considered. Previous work highlighting the utility of ATR-FTIR 
imaging to studying poorly soluble drugs has been extended by investigating the 
mitigation of these issues. Structured model tablets were then investigated demonstrate 
the power of leveraging spatially resolved nature of the data acquired to study the 
dissolution of these formulations. The data presented in this thesis have furthered the 
investigation of using FTIR imaging to study the compaction and dissolution of 
pharmaceutical formulations for the future. 
 
11.2   Future work 
The main goal of this thesis has been to further the application of FTIR imaging to 
pharmaceutical formulations through the use of model tablets. This work could also 
serve as a platform for new investigative opportunities in this field, potentially 
providing new insight into pharmaceutical technologies. Through the continued 
development of this approach to study pharmaceuticals, FTIR imaging is fully capable 
of becoming an important tool for product development to the pharmaceutical industry. 
Some recommendations for future research based on this work are outlined below. 
 
 In order to confirm the mechanisms behind changes seen in the surface area 
fraction of the components and particle sizes, it would be useful to combine the 
experimental data with modelling. A particle packing algorithm combined with a 
discrete element based particle deformation model could help to explain the 
processes of particle arrangement and compaction during the tabletting process 
at the surface layer of the tablet. 
 
 A logical continuation of the work regarding the solubility of ibuprofen would 
be to study ibuprofen dispersed in polymers such as polyethylene glycol 
(Kazarian and Chan, 2003) or complexed with cyclodextrins (Mura et al., 1998) 
mixed with a controlled release polymer such as HPMC. This work could also 
be extended to study other NSAIDs such as flurbiprofen and ketoprofen. 
 
 The tablet-in-tablet structure was effectively applied to create controlled release 
and pH resistant formulations. Ideally these properties could be combined with 
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targeted drug delivery through the application of enteric coatings (Weiß et al., 
1993).  
 
 The bilayer tablet structure was used to demonstrate the capability of FTIR 
imaging to simultaneously study the dissolution of two drugs and monitor the 
effects of water ingress. An interesting study would be to place components in 
each half that may react at the tablet interface upon wetting, before proceeding 
to investigate methods to minimise the issue, such as an intermediate layer or 
enteric coatings. 
 
 Polymorphic transitions present a significant problem to the pharmaceutical 
industry. It is possible to detect these transitions using FTIR imaging as shown 
for ibuprofen. Various aspects of the environment can be controlled in situ, such 
as temperature, humidity and compaction pressure. It is also possible to study 
the stability of drugs in their final product form within the tablet matrix in order 
to determine formulation stability. It would be advantageous to carry out this 
process on multiple samples simultaneously. High throughput methodologies 
offer the opportunity to do this (Chan and Kazarian, 2006d). High throughput 
applications could also be extended to study flowing dissolution of multiple 
samples. This would require the design of a custom multichannel dissolution 
system constructed from a material such as PDMS. 
 
 When studying tablet-in-tablet structures in order to preserve the spatial 
resolution of the images, only the interfacial region was studied, while video 
analysis was used to provide a global view. Larger crystals such as zinc selenide 
and silicon in accessories with expanding optics could be applied to investigate 
the entire tablet structure in each image (Chan and Kazarian, 2006a). 
 
 An important factor in the dissolution of drugs is the dissolution medium used. 
In order to more closely mimic the in vivo performance of a drug, the use of 
more biorelevant media such as FeSSIF and FaSSIF would be applicable 
(Aiache et al., 1997). Indeed an advantage of the flow through dissolution 
system primarily used in this thesis, is the option to vary the dissolution medium 
throughout the experiment. This could be used to develop a replica of the 
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changes in dissolution medium encountered by a tablet as it passes through the 
digestive system. 
 
 Throughout this thesis the work has been performed with model tablets which, 
were designed to investigate some facet of the formulation using FTIR imaging. 
It would be important to apply the information learned here to study commercial 
samples which share some of the same properties. 
 
 For studying static samples measurement time is not as important as it is for 
dynamic samples such as dissolution. For these samples it is possible to study 
larger fields of view without sacrificing spatial resolution, using the imaging and 
mapping methodology (Chan and Kazarian, 2008). This could be used for 
particle and surface area fraction analysis to obtain data from a greater area of 
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